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Ca2+ uptake by energized mitochondria regulates bioenergetics, apoptosis, and global Ca2+ signaling. 
Ca2+ entry into mitochondria is mediated by the Ca2+ uniporter-channel complex containing MCU, the 
Ca2+-selective pore, and associated regulatory proteins. The precise roles of these regulatory proteins 
and their relative stoichiometry in the complex have yet to be elucidated. MICU1 was proposed to be 
necessary for MCU activity whereas subsequent studies suggested a role for MICU1 and its paralog 
MICU2 in channel inhibition in the low-cytoplasmic Ca2+ ([Ca2+]c) regime, a mechanism referred to as 
“gatekeeping”. EMRE is required for MCU channel function and coupling of MICU1/2-mediated 
gatekeeping, but its stoichiometry relative to MCU in the native complex is unclear. We measured MCU 
activity over a wide range of quantitatively controlled and recorded [Ca2+]c to identify the regulatory 
function of the MICU1 and 2 and introduced mutations into Ca2+-binding sites in each protein to 
determine the mechanism by which [Ca2+]c controls channel activity. We then addressed the functional 
consequences of manipulating the relative stoichiometry of EMRE and MCU by introducing tagged MCU 
and EMRE in MCU/EMRE double-knockout cells to directly compare their expression and created a series 
of MCU-EMRE concatemers with multiple concatenated MCU subunits fused to EMRE, allowing us to “fix” 
their stoichiometry. MICU1 alone can mediate gatekeeping as well as highly cooperative activation of 
MCU activity, whereas the fundamental role of MICU2 is to regulate the threshold and gain of 
MICU1-mediated inhibition and activation of MCU. Our results provide a unifying model for the roles of the 
MICU1/2 heterodimer in MCU-channel regulation and suggest an evolutionary role for MICU2 in spatially 
restricting Ca2+ uptake to mitochondria localized to nanodomains of high (>2 μM) [Ca2+]c. Furthermore, 
while incorporation of a single EMRE reconstitutes channel activity, additional EMRE subunits increase 
the [Ca2+]c-threshold required for relief of gatekeeping. Endogenous channels most likely contain two 
EMRE subunits which tether two MICU1/2-dimers to the complex. These findings have important 
implications for developing new therapies to target diseases arising from dysregulation of mitochondrial 
Ca2+-transport. 
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ABSTRACT 
THE MOLECULAR BASIS FOR RAPID CA2+ TRANSPORT ACROSS THE INNER 
MITOCHONDRIAL MEMBRANE 
 
Riley J. Payne 
Prof. J. Kevin Foskett, Ph.D. 
Ca2+ uptake by energized mitochondria regulates bioenergetics, apoptosis, and global 
Ca2+ signaling. Ca2+ entry into mitochondria is mediated by the Ca2+ uniporter-channel complex 
containing MCU, the Ca2+-selective pore, and associated regulatory proteins. The precise roles of 
these regulatory proteins and their relative stoichiometry in the complex have yet to be 
elucidated. MICU1 was proposed to be necessary for MCU activity whereas subsequent studies 
suggested a role for MICU1 and its paralog MICU2 in channel inhibition in the low-cytoplasmic 
Ca2+ ([Ca2+]c) regime, a mechanism referred to as “gatekeeping”. EMRE is required for MCU 
channel function and coupling of MICU1/2-mediated gatekeeping, but its stoichiometry relative to 
MCU in the native complex is unclear. We measured MCU activity over a wide range of 
quantitatively controlled and recorded [Ca2+]c to identify the regulatory function of the MICU1 and 
2 and introduced mutations into Ca2+-binding sites in each protein to determine the mechanism 
by which [Ca2+]c controls channel activity. We then addressed the functional consequences of 
manipulating the relative stoichiometry of EMRE and MCU by introducing tagged MCU and 
EMRE in MCU/EMRE double-knockout cells to directly compare their expression and created a 
series of MCU-EMRE concatemers with multiple concatenated MCU subunits fused to EMRE, 
allowing us to “fix” their stoichiometry. MICU1 alone can mediate gatekeeping as well as highly 
cooperative activation of MCU activity, whereas the fundamental role of MICU2 is to regulate the 
threshold and gain of MICU1-mediated inhibition and activation of MCU. Our results provide a 
unifying model for the roles of the MICU1/2 heterodimer in MCU-channel regulation and suggest 
an evolutionary role for MICU2 in spatially restricting Ca2+ uptake to mitochondria localized to 
nanodomains of high (>2 µM) [Ca2+]c. Furthermore, while incorporation of a single EMRE 
reconstitutes channel activity, additional EMRE subunits increase the [Ca2+]c-threshold required 
for relief of gatekeeping. Endogenous channels most likely contain two EMRE subunits which 
tether two MICU1/2-dimers to the complex. These findings have important implications for 
developing new therapies to target diseases arising from dysregulation of mitochondrial Ca2+-
transport. 
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CHAPTER 1: Introduction to Mitochondrial Ca2+ Transport 
 
The physiological importance of mitochondrial Ca2+ uptake 
 
In the early 1960’s, pioneers in the field of mitochondrial bioenergetics discovered that 
organs such as the heart and kidney have the capacity to take up large amounts of calcium 
(Ca2+) (DeLuca and Engstrom, 1961)(Vasington and Murphy, 1962). Subsequent work revealed 
that Ca2+-uptake served to stimulate mitochondrial respiration to a similar extent as ADP and 
free-phosphate (Pi), both of which are substrates for the production of ATP (Chance, 1965). In 
fact, such large quantities of Ca2+ were taken up by mitochondria that it was initially proposed that 
they represented the primary intracellular Ca2+ storage organelles in the cell. Later it was 
discovered that this role was actually a specialized function of the sarco/endoplasmic reticulum 
(ER) (Streb et al., 1983). However, studies in the 1990’s led to a renewed interest in 
mitochondrial Ca2+-signaling when it was discovered that agonist-induced mobilization of Ca2+ 
into the cytoplasm stimulated rapid, transient increase in matrix free-Ca2+ ([Ca2+]m) (Rizzuto et al., 
1992). Today, it is well known that mitochondrial Ca2+-uptake plays important roles in regulating 
cell metabolism, cell death and global Ca2+ signals by buffering cytoplasmic [Ca2+] ([Ca2+]c). The 
inner mitochondrial membrane (IMM) voltage (m) generated by the respiratory chain provides a 
tremendous thermodynamic driving force for Ca2+ uptake from the cytoplasm into the matrix. 
Nevertheless, mitochondrial-matrix Ca2+ concentration ([Ca2+]m) must be tightly controlled to 
maintain a balance between optimal energy production and toxic effects, including IMM 
depolarization and activation of the permeability transition pore.  
Regulation of TCA cycle enzymes by Ca2+ ions 
 
Ca2+-ions that enter the matrix regulate the activity of three mitochondrial 
dehydrogenases: pyruvate dehydrogenase (PDH), isocitrate dehydrogenase (IDH), and -
ketoglutarate dehydrogenase (KGDH) (Denton, 2009). First, the dehydrogenase activity of PDH 
is dependent on the activity of two regulatory enzymes also found in the matrix, pyruvate 
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dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) (Kolobova et al., 
2001). Phosphorylation by PDK at multiple sites inactivates PDH, reducing the flux of pyruvate 
into mitochondria and subsequently inhibiting mitochondrial respiration. Opposing this process is 
PDP, whose activity increases the activity of PDH by de-phosphorylation. Importantly, the 
catalytic subunit of PDP isoform 1 (PDPC1) is allosterically activated by free-Ca2+ in the matrix, 
which in turn stimulates PDH activity, and facilitates transfer of electrons from Coenzyme A to 
oxidized nicotinamide adenine dinucleotide (NAD+) to form reduced nicotinamide adenine 
dinucleotide (NADH) and allows entry of pyruvate into the TCA cycle in the form of Acetyl-CoA. 
Prior work has shown that maximal activation of PDH activity requires a [Ca2+]m of ~2 µM. 
However, in the presence of > 10 µM pyruvate as a substrate, PDH flux was unaffected by 
changes in [Ca2+]m, indicating that under some physiological conditions this mode of regulation 
may be irrelevant (Wan et al., 1989).  
In contrast to PDH, IDH and KGDH are directly allosterically regulated by Ca2+-ions in 
the matrix (Denton, 2009). Binding of Ca2+ increases the affinity of both enzymes for their 
respective substrates, thus increasing flux through the TCA cycle. This is particularly interesting 
considering the fact that IDH is the rate-limiting step in the TCA cycle (Stueland et al., 1988). Like 
PDH, both IDH and KGDH also require NAD+ as a co-factor, which is reduced to NADH to serve 
as an electron carrier and substrate for NADH:ubiquinone oxidoreductase, also known as 
respiratory Complex I. Some of the energy from oxidation of NADH by Complex I is used to pump 
4 protons (H+) (for each electron pair) out of the matrix into the intermembrane space, 
contributing to the large negative membrane potential (m) as well as a pH gradient (pH) 
across the IMM. Together, these gradients comprise the proton-motive force that drives protons 
through the F1/F0 ATP synthase to produce ATP from ADP and Pi in the matrix (Jonckheere et al., 
2012).  
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Physiological effects of mitochondrial Ca2+ overload  
 
Despite the fundamental role of Ca2+ in promoting mitochondrial bioenergetics, excessive 
uptake into the matrix can have profound negative consequences for cell physiology. Transient or 
constitutive elevations in [Ca2+]m can induce the formation of the mitochondrial permeability 
transition pore (mPTP) by interacting with the regulatory protein Cyclophilin D (Basso et al., 
2005), allowing non-specific ion and solute transport across both the IMM and outer mitochondrial 
membrane (OMM). This in turn leads to mitochondrial depolarization and subsequent failure in 
ATP production (Hajnóczky et al., 2009). Referred to in the literature as “mitochondrial Ca2+-
overload”, this toxic elevation in [Ca2+]m  can also promote the generation of reactive oxygen 
species (ROS) and free-fatty acids which further potentiate mPTP formation (Scorrano et al., 
2001)(Starkov et al., 2004).  
Mitochondrial depolarization has been linked to the initiation of mitophagy, the selective 
elimination of damaged mitochondria through lysosome-dependent degradation (Lemasters, 
2014)(Galluzzi et al., 2017). Mitophagy occurs through a series of molecular mechanisms, the 
first of which is the PINK1/Parkin pathway (Yoo and Jung, 2018). PTEN-induced putative kinase 
1 (PINK1) is normally targeted to the mitochondrial matrix through m-dependent import 
processes and eventually degraded, but upon depolarization is translocated to the OMM where it 
accumulates on the surface of mitochondria (Matsuda et al., 2010). Autophosphorylation 
activates PINK1, which phosphorylates ubiquitin and leads to the recruitment of Parkin, an E3-
ubiquitin ligase. On the OMM, Parkin is directly activated by PINK1 and polyubiquitinates several 
mitochondrial protein substrates (Nguyen et al., 2016). Interestingly, the K63-linked polyubiquitin 
chains on these targets have been shown to be involved in non-proteolytic pathways, in contrast 
to K48-linked chains that are known to target proteins for proteasomal degradation (Li and Ye, 
2008). In mitophagy, K63-linked, polyubiquitinated substrates on the OMM recruit various 
microtubule-associated protein 1A/1B-light chain 3 (LC3) adapter proteins, the most important of 
these being optineurin (OPTN) (Moore and Holzbaur, 2016). These adapters then are recognized 
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by LC3 and target the damaged mitochondria to the autophagosome for degradation (Lazarou et 
al., 2015). 
 In addition to promoting m depolarization, mPTP opening plays a fundamental role in 
initiating apoptosis, a specific type of “controlled” cell death that occurs through two distinct 
pathways: the extrinsic pathway, which is induced by extracellular signal molecules acting 
through specific cell surface receptors, and the intrinsic pathway, which is initiated by the release 
of mitochondrial proteins into the cytoplasm through opening of the mPTP (D’Arcy, 2019). While a 
number of mitochondrial proteins that exit mitochondria through the mPTP, including Smac/Diablo 
and HtrA2/Omi, have been implicated in promoting apoptosis, the most well studied of these is 
cytochrome C (CytC) (Cain et al., 2002). Upon its release into the cytoplasm CytC binds to the 
monomeric form of apoptotic protease activating factor 1 (APAF1), leading to conformational 
changes that promote its oligomerization to form a complex known as the apoptosome (Acehan 
et al., 2002). Once assembled, the apoptosome directly activates procaspase 9, which itself 
activates procaspase 3 and commits the cell to apoptotic death.  
Even under circumstances when enhanced mitochondrial Ca2+-uptake is insufficient to 
induce mPTP formation, constitutive elevations in [Ca2+]m can lead to a cellular energy deficiency. 
Bhosale et al., (2017) have proposed that this is through a “futile cycling” of Ca2+ ions across the 
IMM, in which the energy (in the form of adenosine triphosphate (ATP)) required to sustain 
mitochondrial Ca2+-efflux mechanisms, and thus Ca2+ homeostasis, exceeds the Ca2+-induced 
increase in ATP production. 
Molecular identity of the uniporter: the primary pathway for Ca2+ across the IMM 
 
The primary mechanism for rapid Ca2+ entry into the mitochondria is the mitochondrial 
calcium uniporter (MCU) (Gunter and Gunter, 1994), which was named for its ability to mediate 
unidirectional Ca2+-transport from the cytoplasm into the matrix and characterized by its 
sensitivity to ruthenium red (RuR). The uniporter was later shown by mitoplast patch-clamp 
electrophysiology to be a highly selective Ca2+ channel with high carrying-capacity (Kirichok et al., 
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Figure 1.1. The protein subunits MCU, 
EMRE and MICU1/2 comprise the core of 
the functional uniporter complex 
2004). As such, mechanisms must be present to ensure that the rate of Ca2+ influx does not 
exceed extrusion capacity and cause Ca2+ overload. Previously, it was suggested that an 
intrinsically-low Ca2+affinity of the channel prevented mitochondrial Ca2+ uptake unless the 
channel was exposed to high cytoplasmic [Ca2+] ([Ca2+]c) that exist in nanodomains associated 
with activated Ca2+ channels in the plasma membrane or intracellular organelles, especially the 
endoplasmic reticulum (ER), the major Ca2+ storage organelle in cells. Nevertheless, the 
uniporter channel was shown to have a very-high Ca2+ affinity, < 2 nM (Kirichok et al., 2004), 
suggesting that whereas mitochondrial Ca2+ uptake required high [Ca2+]c, it was unlikely to be due 
to an intrinsic low-Ca2+ affinity, but rather to regulatory mechanisms that keep the channel closed 
until [Ca2+]c reaches sufficiently high levels. 
MCU: the pore-forming subunit of the uniporter 
 
In 2010 the first human gene involved in rapid mitochondrial Ca2+-uptake (CBARA1), was 
discovered by Perocchi et al., and subsequently renamed mitochondrial calcium uptake Protein 1 
(MICU1), ushering in the molecular era of the uniporter 
(Figure 1.1). One year later, two groups identified the 
gene CCDC109A, which encodes the pore-forming 
subunit of the uniporter, a two-transmembrane (TM1 & 
2) protein also named MCU (Baughman et al., 
2011)(De Stefani et al., 2011). The latter group later 
identified the related protein MCUb (encoded by the 
gene CCDC109B), which has been described as a 
dominant negative subunit that assembles with MCU 
and inhibits channel activity (Raffaello et al., 2013). 
Although it was originally believed that human MCU 
assembled as a pentamer (Oxenoid et al., 2016), recent 
cryo-EM structures of full-length fungal and metazoan 
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 A      B 
 
Figure 1.2. Molecular architecture of human MCU (adapted from Wang 
et al., 2019) 
(A) MCU monomer with transmembrane domains (TM1 and TM2), 
DIME motif, juxtamembrane loop (JML) region, coiled-coil domain 
(CCD), linker-helix domain (LHD), and N-terminal domain (NTD) 
specified. (B) MCU tetramer with TMDs, CCDs, LHDs, and NTDs 
specified. Colors represent individual MCU monomers. The TMDs and 
CCDs assemble with 4-fold symmetry that is not preserved in the NTDs.  
 
Figure 1.3. Ca2+ coordination in the selectivity filter of the MCU pore 
(adapted from Wang et al., 2019) 
Top view of MCU tetramer showing the coordination of a Ca2+ ion 
(green) by residues D261 and E264 (atoms rendered by charge: red = 
(-1), blue = (+1)).  
MCU channels revealed that the 
pore assembles as a 
homotetramer, in which the 
transmembrane domains (TMDs) 
adopt a 4-fold symmetry that 
stabilizes the selectivity filter 
(Baradaran et al., 2018)(Yoo et 
al., 2018)(Wang et al., 2019)(Fan 
et al., 2018)(Nguyen et al., 2018). 
In addition to the TMDs, human 
MCU contains a coiled-coil 
domain (CCD) that is linked to 
TM2 by a juxtamembrane loop 
(JML) region, and an N-terminal domain (NTD) connected to the CCD by a linker-helix domain 
(LHD), all of which are localized to the matrix (Wang et al., 2019). The conserved aspartate-
isoleucine-methionine-glutamate 
(DIME) motif in the IMS between 
TM1 and TM2 contains two 
negatively charged residues 
(D261 and E264) that coordinate 
Ca2+ ions in the assembled 
tetramer (Figure 1.3) (Yoo et al., 
2018)(Baradaran et al., 
2018)(Wang et al., 2019), and 
mutation of either residue to 
alanine abolishes channel activity 
(Baughman et al., 2011)(De 
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Stefani et al., 2011). Whole-mitoplast patch clamp experiments have shown that MCU can 
conduct monovalent (e.g. Na+) ions only in the absence of external Ca2+ (Kirichok et al., 
2004)(Fieni et al., 2012)(Vais et al., 2016), a phenomenon that is attributed to the high affinity of 
the D261 and E264 binding site for Ca2+ ions (KD < 2nM) and the channel with high Ca2+ 
selectivity (Ca2+  Sr2+ >> Mn2+  Ba2+). 
Considering the pleiotropic nature of Ca2+ uptake in regulating mitochondrial physiology, 
it is surprising that mice with global ablation of Mcu (MCU-/-) are essentially healthy and show no 
overt developmental or morphological defects (Pan et al., 2013)(Holmström et al., 2015). While 
mitochondria from these mice exhibit no uptake of Ca2+ in response to elevations in [Ca2+]c, 
measures of basal metabolism such as oxygen consumption rate (OCR) are largely unaffected, 
with only a small reduction in spare respiratory capacity and PDH activity relative to MCU(+/+) 
littermates. Likewise, increases in [Ca2+]c fail to induce mPTP opening in MCU-/- mice, but this 
does not protect cells from ischemia-reperfusion injury or pharmacological agents that induce 
apoptosis. The only phenotypes reported were in skeletal muscle, characterized by an 
“impairment in their ability to perform strenuous work” (Pan et al., 2013), and cortical neurons, 
which displayed elevated levels of glycolysis in response energetic stress (Nichols et al., 2017). 
Interestingly, while whole-body MCU-/- mice exhibit no apparent cardiac phenotype (Holmström et 
al., 2015), cardiomyocyte-specific deletion of Mcu in adult mice has been shown to protect 
against Ca2+-induced mPTP opening and acute ischemia reperfusion injury (Luongo et al., 
2015)(Kwong et al., 2015). Moreover, mitochondria from these mice have reduced basal ATP 
production and a delayed increase in OCR upon stimulation with the β-adrenergic receptor 
agonist isoproterenol. These discrepancies are attributed to genetic compensation that allows 
normal mitochondrial development, which is further evidenced by the finding that MCU-/- mice are 
only viable when maintained on a mixed genetic background, in this case the outbred (CD1) 
strain. Global ablation of Mcu in inbred C57BL/6 mice is embryonic lethal, with death occurring 
between E11.5 and E13.5 (Murphy et al., 2014).  
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Figure 1.4. Crystal structure of the MICU1 homodimer in the Ca2+-free and Ca2+-bound states (adapted from Wang 
et al., 2014) 
(A) MICU1 monomers (red and orange) dimerize when the EF hand domains (EF1 and EF2 – atoms rendered by 
charge: red = (-1), blue = (+1) ) are in their Apo (Ca2+-free) states. (B) Binding of Ca2+ ions (green) to EF1 and EF2 
leads to conformational changes that disrupt the MICU1 dimer. 
MICU1, 2 and 3: Accessory proteins that regulate uniporter activity 
 
While MCU protein constitutes the pore-forming subunit of the channel, interactions with 
several auxiliary proteins are required to regulate its activity, including MICU1 (Perocchi et al., 
2010), and its paralogs MICU2 and MICU3 (Plovanich et al., 2013).  In humans, MICU1 and 
MICU2 are widely expressed, whereas MICU3 appears to be largely restricted to the central 
nervous system (Plovanich et al., 2013)(Patron et al., 2019). Although their cellular localization is 
still the subject of debate (Hoffman et al., 2013), MICU proteins are generally thought to reside in 
the IMS and associate with the outer leaflet of the IMM (Perocchi et al., 2010)(Csordás et al., 
2013)(Patron et al., 2014). In the Apo (Ca2+-free) state, MICU1 forms homodimers (Figure 1.4) as  
well as heterodimers with MICU2 (Patron et al., 2014)(Petrungaro et al., 2015) and MICU3 
(Patron et al., 2019). However, once Ca2+ is bound, significant structural rearrangements occur 
that disrupt the dimer and are presumably coupled to modulation of channel activity. Two EF-
hand domains in each MICU protein were identified by sequence homology (Perocchi et al., 
2010)(Plovanich et al., 2013) and confirmed to bind Ca2+ ions in structures of MICU1 (Wang et 
al., 2014), MICU2 (Kamer et al., 2019)(Wu et al., 2019)(Xing et al., 2019) and MICU3 (Xing et al., 
2019). Ion transport across the OMM is generally passive, while transport across the IMM is 
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tightly regulated by channels and transporters (O’Rourke, 2007). As such, Ca2+-binding EF-hand 
domains in MICU1, 2, and 3 have been proposed to sense [Ca2+]c and modulate channel activity. 
It has been suggested that MICU1 associates with the channel complex in part by a direct 
interaction with MCU by an electrostatic mechanism that involves positively-charged residues in 
MICU1 and negatively-charged residues associated with  the pore domain of MCU (Paillard et al., 
2018)(Phillips et al., 2019). MICU2 lacks analogous basic residues, in agreement with previous 
findings that MICU2 requires dimerization with MICU1 for its association with the complex. The 
number of MICU1/2 dimers that associate with one MCU channel is unknown. 
The importance of understanding regulation of MCU-channel activity by MICU proteins is 
underscored by human loss-of-function mutations in MICU1 that result in apparent mitochondrial-
Ca2+ overload and cause early-onset muscle weakness and CNS defects (Logan et al., 
2013)(Lewis-Smith et al., 2016).  Similar pathology and effects on mitochondrial Ca2+ observed in 
surviving MICU1 knockout mice suggested that constitutive MCU-activity in vivo caused disease 
(Liu et al., 2016), but the etiology of pathogenesis is still the subject of debate (see Chapter 4). 
Likewise, human loss-of-function mutations in MICU2 have been linked to severe neurological 
defects in development (Shamseldin et al., 2017), and genetic knockdown of MICU3 expression 
in primary cortical neurons leads to dysregulation of neuronal function (Patron et al., 2019). The 
specific roles of MICU1 and 2 in MCU channel regulation are addressed in Chapter 2. 
EMRE: A small transmembrane subunit with a dual role in MCU regulation 
 
 The small (~100 a.a.) transmembrane protein essential MCU regulator (EMRE) is aptly  
named; it is required for both uniporter function and coupling of MICU1/2-mediated gatekeeping 
(Sancak et al., 2013)(Kovács-Bogdán et al., 2014)(Yamamoto et al., 2016)(Vais et al., 2016)(Tsai 
et al., 2016)(Figure 1.5A). A conserved polyacidic C-terminus of EMRE faces into the IMS where  
it interacts with a polybasic region in the N-terminus of MICU1 (but not MICU2) (Sancak et al., 
2013)(Hoffman et al., 2013)(Yamamoto et al., 2016)(Tsai et al., 2016)(Vais et al., 2016). This  
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Figure 1.5. Cryo-EM structure of human EMRE in complex with MCU (adapted from Wang et al., 2019) 
(A) EMRE is a single-TM protein with an N-terminal β-hairpin motif in the matrix and the C-terminus in the IMS. The 
polyacidic region in the C-terminus was not resolved (dashed line). (B) Four EMRE proteins associate with the 
assembled MCU tetramer. 
interaction is required for the gatekeeping function of MICU1/2 since deletion of the polyacidic 
region or neutralization of its charge abolishes normal gatekeeping, causing mitochondrial Ca2+ 
overload (Tsai et al., 2016)(Vais et al., 2016). In addition, binding of EMRE to MCU is necessary 
for channel activity. In the absence of EMRE, MCU is expressed normally but it lacks function.  
The association of EMRE with the channel complex is mediated in part by 
transmembrane interactions with MCU (Tsai et al., 2016). A recent cryo-electron microscopy 
structure of human MCU in complex with EMRE (Wang et al., 2019) revealed a 4 EMRE:1 
channel stoichiometry (Figure 1.5 B), with hydrophobic interactions between the transmembrane  
domain (TMD) of EMRE and TM1 in MCU (Figure 1.6A). Two additional interactions were also  
observed: one between the N-terminal end of the EMRE TMD and TM2 (Figure 1.6A), and the 
second between the N-terminal β-hairpin of EMRE and the CCD domain of an adjacent second 
MCU subunit (Figure 1.6B), the latter proposed to enable gating of the channel. This structure  
revealed an asymmetric distribution of NTDs among subunits, a structure quite dissimilar from a 
dimer-of-NTD-dimers observed in the fungal MCU channels (Baradaran et al., 2018)(Yoo et al., 
2018)(Wang et al., 2019)(Lee et al., 2016). In addition, dimerization between the NTDs of two 
assembled MCU tetramers was observed (Figure 1.7), suggesting that metazoan MCU channels 
may form dimers in situ. It is unclear, however, whether this dimerization of MCU channels is  
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Figure 1.6. Interactions between MCU and EMRE in the assembled channel complex (adapted from Wang et al., 
2019) 
(A) The TMD of EMRE forms multiple contacts with TM1 of one MCU subunit (blue) and TM2 of an adjacent MCU 
subunit (orange) to stabilize its association with the channel (atoms rendered by charge: red = (-1), blue = (+1); pink 
lines show atomic contacts between MCU and EMRE). (B) The β-hairpin motif in the N-terminus of EMRE are 
proposed to mediate channel gating my affecting conformational changes in the CCD domain of MCU. 
 
Figure 1.7. The human MCU-EMRE complex forms a dimer (adapted from Wang et al., 2019). 
The MCU-EMRE channel complex dimerizes through interactions between the NTDs of two MCU tetramers 
related to the presence of EMRE since a high-resolution structure of a metazoan MCU in the 
absence of EMRE has not been determined. The relative stoichiometry of MCU and EMRE in the 
assembled uniporter complex in vivo and the consequences of altering this stoichiometry on 
channel activity and regulation are addressed in Chapter 3. 
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MCUR1: An assembly factor that regulates uniporter activity 
 
 First identified in 2012 by Mallilankaraman et al., mitochondrial calcium uniporter 
regulator 1 (MCUR1) is a protein integral to the IMM that was shown to be required for MCU 
function. ShRNA-mediated knockdown of MCUR1 (MCUR1 KD) abolished mitochondrial Ca2+ 
uptake and decreased oxidative phosphorylation in HEK-293T and HeLa cells, with no apparent 
effect on m or MCU localization. Subsequent studies in human immortalized fibroblasts 
conflicted with these findings, attributing a lack of Ca2+ uptake and impaired respiration to a 
reduction in m caused by defective cytochrome c oxidase (COX) assembly (Paupe et al., 
2015). Nevertheless, reduced MCU-mediated Ca2+ currents in mitoplast patch-clamp experiments 
from MCUR1 KD (HEK-293T) cells provided further evidence for direct regulation of channel 
activity (Vais et al., 2015). Furthering the debate, Tomar et al. (2016) showed that genetic 
ablation of MCUR1 in HEK-293T cells disrupted proper formation of the channel complex, serving 
as an assembly factor through interactions with both MCU and EMRE. To date, the precise role of 
MCUR1 in regulating mitochondrial Ca2+ uptake and bioenergetics remains unclear. 
Other mechanisms for Ca2+ transport in mitochondria 
 
 In addition to the uniporter, several alternative pathways for Ca2+ transport across the 
IMM have been described. First, the “rapid mode of uptake” (RaM) has been described as a  
mechanism to rapidly take up Ca2+ from the cytoplasm in response to transient increases in 
[Ca2+]c with characteristics distinct from the uniporter; the RaM appears to function at low (~200 
nM) [Ca2+]c, is capable of sustaining only small Ca2+ fluxes, and is less sensitive to inhibition by 
RuR by an order of magnitude (Sparagna et al., 1995). Single-channel recordings of inward Ca2+ 
currents in mitoplasts isolated from HeLa cells revealed the presence of two distinct 
conductances: “intermediate mitochondrial Ca2+ currents” (i-MCC), and ”extra-large mitochondrial 
Ca2+  currents” (xl-MCC) (Bondarenko et al., 2013). Knockdown of MCU in these cells lead to a 
decrease in i-MCC and increase in xl-MCC, leading to the conclusion that i-MCC was mediated 
by the uniporter and xl-MCC by a second, unidentified molecular mechanism (Bondarenko et al., 
13 
 
2014). However, the lack of genetic evidence for the existence of the RaM as a distinct molecular 
entity and technical concerns regarding the methods used in these studies have led many to 
hypothesize that both modes of Ca2+ uptake are mediated by the MCU complex. Nevertheless, it 
is also possible that the RaM is attributable to other Ca2+ channels in the IMM such as 
mitochondrial ryanodine receptors, which are also inhibited by RuR (Ryu et al., 2010). 
The primary efflux pathway for Ca2+ that enters the matrix through MCU is the 
mitochondrial Na+/Ca2+ exchanger (NCLX), which mediates Na+-driven antiport of Ca2+ ions 
across the IMM (Palty et al., 2010). NCLX is distinct from the plasma membrane Na+/Ca2+ 
exchanger (NCX) in its ability to transport Li+ ions in the absence of Na+. Genetic knockdown of 
NCLX reduces mitochondrial Ca2+ efflux in cells (Palty et al., 2010)(Luongo et al., 2017), and 
conditional, cardiomyocyte-specific deletion of Slc8b1 (the gene encoding NCLX) in adult mice 
leads to sudden death from severe myocardial dysfunction (Luongo et al., 2017), a phenotype 
attributed to [Ca2+]m driven ROS generation and subsequent necrotic cell death. Additionally, 
pharmacological inhibition of NCLX activity by the small molecule CGP37157 (Cox et al., 1993), 
has been shown to be protective in neuronal models of excitotoxic injury (Ruiz et al., 2014). The 
role of NCLX in extrusion of Ca2+ from the matrix also demonstrates its fundamental importance 
in balancing Ca2+ influx through MCU to prevent matrix Ca2+ overload (De Marchi et al., 2014). 
Interestingly, when mitochondria are depolarized and [Ca2+]m is low, NCLX has been proposed to 
function in reverse, mediating a coupled influx of cytoplasmic Ca2+ and efflux of Na+ ions from the 
matrix (Samanta et al., 2018). This is compelling considering the normal basal [Ca2+]m observed 
in MCU-/- mice, suggesting that NCLX may be responsible for supplying enough influx of Ca2+ into 
the matrix under resting conditions to sustain respiration in the absence MCU. However, it is 
unclear whether the antiport activity of NCLX is electroneutral (i.e. 1 Ca2+ for 2 Na+) or, like its 
counterpart in the plasma membrane, electrogenic (i.e. 1 Ca2+ for 3 Na+) (Boyman et al., 2013). 
The gene encoding leucine zipper, EF-hand containing transmembrane protein 1 
(LETM1) was first identified as a homolog of the YOL027 gene in yeast, both of which encode 
proteins with a single predicted transmembrane domain that localize to mitochondria (Nowikovsky 
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et al., 2004). Deletion of YOL027 leads to mitochondrial swelling, an increase in matrix [K+], and 
reduced m. These phenotypes are rescued by expression of human LETM1, suggesting a 
conserved function between the yeast and human homologs. Moreover, loss of function 
mutations in LETM1 have been associated with Wolf-Hirschhorn syndrome in humans, a disease 
characterized by seizures and other related neuromuscular pathologies. Later worked showed 
that the human LETM1 protein is integral to the IMM and its downregulation causes fragmentation 
of the mitochondrial network in HeLa cells (Dimmer et al., 2008). Treatment with nigericin, a 
pharmacological catalyst of K+/H+ exchange, restores normal mitochondrial morphology, leading 
to the conclusion that LETM1 functions as a K+/H+ antiporter. However, work from other groups 
identified LETM1 as a mitochondrial Ca2+/H+ exchanger in a genome-wide RNAi screen (Jiang et 
al., 2009) that plays a role in mitochondria Ca2+ transport (Jiang et al., 2009)(Waldeck-Weiermair 
et al., 2011)(Waldeck-Weiermair et al., 2011) and influences mitochondrial bioenergetics and cell 
proliferation (Doonan et al., 2014). Functional reconstitution of LETM1 in liposomes confirmed 
that it is necessary and sufficient to mediate electroneutral antiport of Ca2+ and H+ (Jiang et al., 
2009)(Tsai et al., 2014) independently of K+ (Tsai et al., 2014). Interestingly, these studies also 
revealed that LETM1 activity is abolished by the known MCU inhibitor RuR (and its derivatives), 
and partially reduced by the NCLX inhibitor CGP37157. Moreover, recent studies have shown 
that, unlike NCLX, LETM1 does not mediate Ca2+ efflux from the mitochondria (De Marchi et al., 
2014). Nevertheless, stable genetic knockdown of LETM1 in HeLa cells impedes both K+/H+, 
Na+/H+, and NCLX-mediated Na+/Ca2+ exchange across the IMM (Austin et al., 2017), suggesting 
a fundamental role in mitochondrial ion homeostasis. 
 
15 
 
CHAPTER 2: Regulation of MCU Channel Activity by MICU1 and 2 
 
The roles of MICU proteins in MCU regulation are controversial. MICU1 was originally 
proposed to be necessary for MCU-channel activity (Perocchi et al., 2010). Subsequent studies 
suggested that it instead plays a critical role in inhibiting MCU activity in the low-[Ca2+]c regime, a 
mechanism referred to as “gatekeeping”, that imposed a [Ca2+]c threshold for channel activation 
at ~1-3 µM (Mallilankaraman et al., 2012b)(Csordás et al., 2013)(Patron et al., 2014)(Bhosale et 
al., 2015).  
Other studies suggested that MICU1 is necessary to promote mitochondrial Ca2+ uptake 
in response to [Ca2+]c elevations (Perocchi et al., 2010)(Csordás et al., 2013)(Patron et al., 
2014)(Kamer and Mootha, 2014)(Antony et al., 2016), with some suggesting that it plays dual 
roles in gatekeeping and cooperative channel-activation (Csordás et al., 2013)(Antony et al., 
2016). It is debated whether the EF-hand domains play a role in MICU1-mediated channel 
inhibition in low [Ca2+]c (Mallilankaraman et al., 2012b)(Hoffman et al., 2013)(Kamer and Mootha, 
2014). Early studies of MICU1 were complicated by the discovery that its knockdown affected 
expression of MICU2 (Plovanich et al., 2013)(Patron et al., 2014)(Kamer and Mootha, 2014). 
Under physiological conditions, MICU1 forms an obligate heterodimer with MICU2, stabilizing 
MICU2 expression (Patron et al., 2014)(Petrungaro et al., 2015). On the other hand, 
overexpression of MICU1, or knockdown of MICU2, generates MICU1 homodimers (Patron et al., 
2014)(Petrungaro et al., 2015). Conversely, MICU2 does not form homodimers in cells, nor can it 
associate with MCU in the absence of MICU1 (Patron et al., 2014)(Kamer and Mootha, 2014). It 
has been suggested that loss of gatekeeping in MICU1 knock-down cells is due to loss of MICU2 
(Patron et al., 2014). In this model, MICU2 is the “true gatekeeper”, inhibiting the channel in its 
Ca2+-free form, whereas cooperative channel activation requires Ca2+ binding to MICU1, as well 
as to MICU2, to relieve channel inhibition. Alternatively, it has been suggested that both MICU1 
and MICU2 play roles in gatekeeping, with MICU2 having no role in channel activation 
(Matesanz-Isabel et al., 2016). Finally, it has been suggested that both MICU1 and MICU2 
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contribute to setting the threshold for MCU activation (Kamer and Mootha, 2014). The functions of 
both proteins are controversial in part because overexpression strategies have been used with 
channel-component stoichiometries not well known, and because MCU-specific Ca2+-uptake 
rates were not rigorously quantitated over a wide range of quantitatively-controlled and recorded 
[Ca2+]c.  
We employed cells with MICU1 or MICU2 genetically deleted to address the molecular 
mechanisms by which MICU1 and MICU2 regulate MCU function, particularly in the previously 
uncharacterized [Ca2+]c regime below 500 nM. Our results suggest that MICU1 alone can mediate 
gatekeeping as well as highly cooperative activation of MCU channel activity, whereas the 
fundamental role of MICU2 is to regulate the threshold and gain of MICU1-mediated inhibition 
and activation of MCU. Our results provide a unifying model for the role of the MICU1/2 
heterodimer in MCU channel regulation and suggest an evolutionary role for MICU2 in spatially 
restricting Ca2+ crosstalk between single InsP3R and MCU channels. 
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Materials and methods: 
Cell lines and cDNA expression constructs 
 
All HEK-293T cell lines were grown in DMEM containing 10% fetal bovine serum (FBS) 
and 1x anti-biotic/anti-mycotic (complete medium) at 37˚C and 5% CO2. MCU knockout (KO), 
MICU1 KO and MICU2 KO HEK-293T cells were a generous gift from Dr. Vamsi Mootha. 
Plasmids of full-length Flag-tagged MICU1 and MICU2 cDNAs in pCMV6-A-BSD vectors were 
obtained from Origene. Plasmids of mito-CAR-GECO1 cDNA in pCDNA3.1 vector; and MCU-V5-
His cDNA in pDEST40 vector were purchased from Addgene. Plasmids of MICU1EF1-Flag, 
MICU1EF2-Flag and MICU1EF1/2-Flag cDNA in pCMV6-A-BSD vector, together with 
MICU2EF1-Flag, MICU2EF2-Flag, MICU1EF1/2-Flag and untagged MICU2 cDNA in pCMV6-
A-Puro vector were generated using a PCR-based cloning strategy (see Appendix A). MICU1-
rescue, [MICU1 KO + MICU1EF1 + MICU2], [MICU1 KO + MICU1EF2 + MICU2], and [MICU1 
KO + MICU1EF1/2 + MICU2] cell lines were created by stable transfection using Transit LT1 
(Mirus) as per manufacturer’s protocol. Transfected cells were maintained in complete medium 
with 5 µg/mL Blasticidin and 2 µg/mL Puromycin until stable expression of each plasmid was 
achieved. [MICU2 KO + MICU2-Flag] (rescue), [MICU2 KO + MICU2EF1-Flag], [MICU2 KO + 
MICU2EF2-Flag] and [MICU2 KO + MICU2EF1/2-Flag] cells were created by stable 
transfection and maintained in complete medium with 5 µg/mL Blasticidin. Clones were isolated 
by limiting dilution for each condition and maintained in complete medium with antibiotics. 
Expression levels of each protein were evaluated by Western blot, and clones with uniform cell 
expression of MICU1 and MICU2 as assessed by immunofluorescence microscopy were used for 
experiments. 
Simultaneous determination of mitochondrial Ca2+ uptake and m in permeabilized cells 
 
Simultaneous measurement of mitochondrial Ca2+ uptake and IMM potential (m) in 
permeabilized HEK-293T cells was performed as described (Mallilankaraman et al., 2012a), with 
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fluorescence measurements calibrated to represent bath [Ca2+] ([Ca2+]c). Cells were grown in 10 
cm tissue-culture coated dishes for 48 hr prior to each experiment. 6-8×106 cells were trypsinized, 
counted, and washed in a Ca2+-free extracellular-like medium, centrifuged, suspended in 1.5 mL 
of intracellular-like medium (ICM - in mM: 120 KCl, 10 NaCl, 1 KH2PO4, 20 HEPES, and 5 
succinate [pH 7.2]) that had been treated with BT Chelex® 100 resin (Bio-Rad, 143-2832) prior to 
use to attain an initial free [Ca2+] of ~20 nM, and transferred to a cuvette. The cuvette was placed 
in a temperature-controlled (37°C) experimental compartment of a multi-wavelength-excitation 
dual wavelength-emission high-speed spectrofluorometer (Delta RAM, Photon Technology 
International). Membrane-impermeable Fura-2 K+ salt (KD = 140 nM) or Fura-FF K+ salt (KD = 5.5 
µM) (final concentration 1 µM) and JC-1 (final concentration 800 nM) or Tetramethylrhodamine, 
Ethyl Ester, Perchlorate (TMRE - final concentration 1 µM) were added at 25 sec to measure 
[Ca2+]c and m concurrently. Fluorescence at 490-nm excitation/535-nm emission for the 
monomer and 570-nm excitation/595-nm emission for the J-aggregate of JC1 or 560-nm 
excitation/595-nm emission for TMRE, along with 340 nm excitation/535 nm emission and 380 
nm excitation/535 nm emission for the Ca2+-bound and Ca2+-free Fura-2/Fura-FF species, 
respectively was measured at 2-5 Hz. 40 µg/mL digitonin was added at 50 sec to permeabilize 
cells and allow the cytoplasm to equilibrate with the bath solution such that the JC-1 fluorescence 
ratio (570 nm/490 nm) or TMRE fluorescence reports the relative m. Fura-2/Fura-FF 
fluorescence under these conditions is related to the cytoplasmic [Ca2+] ([Ca2+]c) per the equation 
below, where R is the measured fluorescence ratio (340/380 nm) and Sf2 and Sb2 are the 
absolute 380 nm excitation/535 nm emission fluorescence under 0-[Ca2+] and saturating [Ca2+], 
respectively.  
 𝐶𝑎2+ =   
𝑅 −  𝑅𝑚𝑖𝑛
𝑅𝑚𝑎𝑥 − 𝑅
  
𝑆𝑓2
𝑆𝑏2
 ∗  𝐾𝐷  
 
Thapsigargin (2 µM) was added at 100 sec to inhibit Ca2+ uptake into the endoplasmic 
reticulum (ER) and CGP37157 was added at 400 sec to inhibit NCLX-mediated mitochondrial-
Ca2+ extrusion. After [Ca2+]c reached a steady state at 700 sec, MCU-mediated Ca2+ uptake was 
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initiated by adding boluses of 1-7.5 µL of either 0.5 or 5 mM CaCl2 to the cuvette to achieve 
increases in [Ca2+]c between ~100 nM and 10 µM. The volume of CaCl2 required to achieve the 
desired increase in [Ca2+]c for each addition was calculated based on the activity coefficient for 
Ca2+ in ICM. Differences between the target [Ca2+]c and the observed value recorded immediately 
after addition were due to unavoidable sources of experimental variability, including KD limitations 
of Fura-2 and pipetting errors. After [Ca2+]c was monitored for 300 sec following addition of each 
Ca2+ bolus, 2 µM CCCP was added to uncouple m and allow unimpeded Ca2+ efflux from 
mitochondria as a measure of the total extent of uptake. Under our conditions, the magnitude of 
the Ca2+ boluses added to initiate mitochondrial Ca2+ uptake did not significantly affect steady 
state m as measured with JC-1, while additions > 1µM caused a transient depolarization as 
measured with TMRE that recovered after ~50-60 sec. 
Quantitative measurement of basal [Ca2+]m 
 
HEK-293T cells grown in 25-mm glass-bottom tissue-culture dishes coated with 0.2% 
gelatin (~5×105 cells/dish) were transfected with a plasmid encoding a mitochondria-targeted 
version of the fluorescent calcium-indicator protein CAR-GECO1 (mito-CAR-GECO1) using 
TransIT-LT1 transfection reagent (Mirus). CAR-GECO1 exhibits an increase in fluorescence 
emission at ~610 nm upon Ca2+ binding with a KD of ~490 nM. To verify localization of the probe 
in mitochondria, cells were imaged 48-hr post-transfection using confocal microscopy with a 40x-
oil objective at 37°C. Fluorescence images of mito-CAR-GECO1 (560-nm excitation/600-750-nm 
emission) and MitoTracker Green (488 nm excitation/510-550 nm emission), and a transmitted-
light image of each individual field, were collected within 30 sec. To qualitatively estimate basal 
[Ca2+]m, cells grown in 10-cm tissue-culture dishes were transfected with mito-CAR-GECO1 and 
imaged 24-hr post-transfection using an epifluorescence microscope with a 20x objective at RT. 
Images of live cells in complete medium in resting conditions were obtained at 545-nm 
excitation/620-nm emission with identical gain- and exposure-settings among experiments. 
Calibrated measurements of [Ca2+]m were determined at 48-hr post-transfection by suspending 
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cells in a high Na+/low K+ extracellular-like medium with 2 mM CaCl2. Mito-CAR-GECO1 
fluorescence was monitored continuously in a high-speed spectrofluorometer until a stable 
intensity was achieved. Ionomycin was added to promote Ca2+ influx into mitochondria to saturate 
the probe (Fmax), which was followed by the addition of EGTA to chelate Ca2+ to determine Fmin. 
Fluorescence measurements were transformed to [Ca2+]m using the equation  
 𝐶𝑎2+ =   
𝐹 −  𝐹𝑚𝑖𝑛
𝐹𝑚𝑎𝑥 − 𝐹
 ∗  𝐾𝐷 
 
where F represents the fluorescence at steady state prior to ionomycin addition. 
Simultaneous measurement of [Ca2+]c and [Ca2+]m in response to ATP stimulation 
 
WT and MICU2 KO (HEK-293T) cells were transiently transfected with mito-CAR-GECO1 
48 hrs prior to loading with 1 µM Fura-2 AM, in HBS dye-loading solution (in mM: 135 NaCl, 5.9 
KCl, 1.2 MgCl2, 1.5 CaCl2, 11.6 HEPES-NaOH, [pH 7.4] with 0.01% (wt/vol) pluronic F127) for 15 
min at RT. After loading, ~3x106 cells were transferred to a cuvette in the temperature-controlled 
(37°C) experimental compartment of a multi-wavelength-excitation dual-wavelength-emission 
high-speed spectrofluorometer (Delta RAM, Photon Technology International). Fluorescence at 
560-nm excitation/610-nm (long-pass) emission for mito-CAR-GECO1, along with 340 nm 
excitation/535 nm emission and 380 nm excitation/535 nm emission for the Ca2+-bound and Ca2+-
free Fura-2 species, respectively was measured at 5 Hz. 500 µM Na2ATP was added at 100 sec 
to stimulate purinergic receptors and induce InsP3R-mediated ER-Ca2+ release. Mito-CAR-
GECO1 fluorescence was calibrated as described above.  
Western blotting and co-immunoprecipitation 
 
 Cells grown in in 100 mm plates were washed with PBS and lysed with RIPA buffer 
supplemented with protease inhibitors (cOmplete, Roche), and protein concentrations were 
calculated using Pierce BCA Protein Assay kit.  NuPAGE© gels (4-12%) were transferred to 
Immobilon© P PVDF membranes and probed with various antibodies.  Antibodies used were anti-
21 
 
MICU1 (Cell Signaling, 12524), anti-MICU2 (Abcam, ab101465), anti-MCU (Sigma, HPA016480), 
anti-β-Actin (Cell Signaling, 3700S). Membranes were blocked in 5% fat-free milk for 1 hr at RT, 
incubated overnight at 4°C with primary antibody, and then for 2 hrs at RT with anti-rabbit IgG-
HRP (Cell Signaling, 7074S) or anti-mouse IgG-HRP (Cell Signaling, 7076S) secondary 
antibodies conjugated to horseradish peroxidase (HRP). Chemiluminescence detection was 
carried out using SuperSignal West Chemiluminescent Substrate (Thermo). For co-
immunoprecipitation experiments, HEK-293T cells transfected with various constructs were 
grown to semi-confluency at 37°C, 5% CO2 in DMEM + 10% FBS + antibiotic/antimycotic in 150 
mm plates. Cells were washed with PBS and lysed with 1 ml cold lysis buffer (50 mM HEPES-
KOH pH 7.4, 150 mM NaCl, 0.2% n-dodecyl-β-D-maltoside, 0.5 mM EGTA) supplemented with 
protease inhibitors (cOmplete, Roche). Cells were lysed at 4°C for 30 min and centrifuged at 
16,000 x g.  Protein concentrations were determined, and 1 mg protein was added to anti-Flag 
agarose- or anti-V5 agarose-beads.  Lysates and beads were rocked at 4°C for 2 hr, washed 3x 
with PBS before 100 µL of 2x Laemmli Sample buffer was added.  Samples were boiled for 5 
min, loaded into NuPAGE© 4-12% gels for electrophoresis, transferred to PVDF membranes, and 
probed with antibodies as described previously. All experiments were done at least in triplicate. 
The mean pixel density of bands for Figure 2.4E was quantified using ImageJ (NIH). 
Statistical analyses 
 
 Initial Ca2+ uptake rates in permeabilized cells were determined for each experiment 
using single-exponential fits from the time of CGP37157 or Ca2+ addition (t = 0 sec) to 
achievement of a new steady state (t = 300 sec) to obtain parameters A (extent of uptake) and  
(time constant) (Igor 6 Pro). The instantaneous rate of uptake (R) at t = 0 is equal to the first 
derivative of the fit, and error bars (R+SD and R-SD) were calculated from standard deviations of 
A (SDA) and  (SD) as follows:  
R = A/ 
R+SD = (A+SDA)/(-SD) 
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R-SD = (A-SDA)/(+SD) 
Independent, normally distributed rate measurements and mean resting [Ca2+]m from 
bulk-cell assays were analyzed using one-way ANOVA and Bonferroni’s multiple comparisons t-
test. Only pairwise comparisons between WT and each cell line are shown for clarity. Whereas 
unequal variances between populations are evident, assumption of equal variances rendered it 
less likely to find significant differences. Western blot quantification of band intensity from n = 3 
independent experiments and quantification of the increase in [Ca2+]m divided by the increase in 
[Ca2+]c ([Ca2+]m/[Ca2+]c) in agonist-stimulated intact cells display normal distributions and 
approximately equal variances, and were analyzed using Student’s t-test. All statistical tests were 
performed using GraphPad Prism 7.0. P-values < 0.05 (*) and < 0.01 (**) were considered 
statistically significant. 
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Results: 
MICU1 is required to suppress MCU activity in low [Ca2+]c 
 
We first examined the role of MICU1 in the previously unexplored [Ca2+]c range between 
100 nM and 300 nM. To measure MCU activity in this low-[Ca2+]c regime, we studied 
permeabilized cells (Mallilankaraman et al., 2012a) in an intracellular-like medium (ICM) lacking 
Ca2+ buffers (free [Ca2+] ~20 nM), using the high-affinity indicator Fura-2 to measure [Ca2+]c, and 
JC-1 or TMRE to simultaneously monitor m. In order to avoid changes in m due to an 
increase in [Ca2+]m, the contribution of Ca2+-dependent complex I activity to proton pumping by 
the respiratory chain must be minimized. To achieve this, cells are permeabilized in an 
intracellular-like medium (ICM – see Materials and methods) containing ~20 nM free [Ca2+] and 
devoid of substrates (e.g. pyruvate) that could promote complex I enzymatic activity. Instead, 5 
mM (K+) succinate is added directly to the cell suspension as a substrate for succinate 
dehydrogenase, known as respiratory complex II, that oxidizes succinate to fumarate and 
transfers electrons to respiratory complexes III and IV, which then pump a total of 6 protons (for 
each electron pair) out of the matrix and allow m  to be sustained independently of [Ca2+]m. 
To verify that m under these conditions is dependent exclusively on complex II activity, 
we used a pharmacological approach to selectively inhibit either complex I or complex II activity 
and measured m in real-time using TMRE in quench mode (1 µM) as previously described 
(Payne et al., 2017). As shown in Figure 2.1, as soon as HEK-293T cells suspended in ICM with 
5 mM succinate are permeabilized by addition of digitonin (Dg), TMRE fluorescence is quenched 
as the cationic dye is sequestered by mitochondria due to the large negative m and reaches a 
steady state within 30-50 sec. Subsequent addition of 2 µM thapsigargin (Tg) to prevent Ca2+-
reuptake by the ER at t = 100 sec has minimal effect of on the steady-state m. Similarly, a 
series of five bolus additions of 500 nM rotenone, which has been shown previously to inhibit 
complex I at concentrations between 100 nM and 1 µM (Han et al., 2014)(Passmore et al., 2017), 
has no effect on the steady-state TMRE fluorescence, providing strong evidence that m  is 
24 
 
 
Figure 2.1. Inner mitochondrial membrane potential is maintained 
exclusively through complex II activity in permeabilzed cells 
m measured with TMRE for permeabilized HEK-293T cells suspended in 
ICM with 5 mM succinate. Cells were treated with 0.004% digitonin (Dg) to 
permeabilize plasma membrane and 2 µM thapsigargin (Tg) to block ER 
Ca2+ uptake at t = 50 and 100 sec respectively, as indicated. Addition of 500 
nM Antimycin A (red trace) inhibits proton pumping by complexes III and IV 
leading to a complete depolarization of m. 0.5-2.5 µM Rotenone to inhibit 
complex I activity (black trace) has minimal effect on m. CCCP (2 µM) 
was added at t = 400 sec to dissipate m and induce efflux of accumulated 
mitochondrial Ca2+.TMRE fluorescence is normalized to the steady-state 
after addition of CCCP. Traces are the mean of n = 3 independent 
experiments (dark traces) +/- SEM (light shading) for each condition. 
 
independent of complex I activity under these conditions. The mitochondrial uncoupler CCCP (2 
µM) is then added at the end of each experiment (t = 400 sec) to measure the TMRE 
fluorescence in the absence of 
m. 
Antimycin A has been 
shown previously to 
specifically inhibit the activity of 
complex III at concentrations of 
~10 µM (Wang et al., 2015). 
Because complex II does not 
itself pump protons out of the 
matrix, but rather transfers 
electrons to complex II to 
provide energy to power its 
proton transport activity, 
antimycin A should fully inhibit 
all complex II-dependent 
respiration. Unlike rotenone, addition of 500 nM antimycin A to permeabilized cells with 2 µM Tg 
causes a rapid increase in TMRE fluorescence. Subsequent additions of 500 nM antimycin A or 2 
µM CCCP cause no additional increase in TMRE fluorescence. This result indicates that, even at 
low concentrations, antimycin A completely inhibits complex III and in turn prevents activity of 
complex II from maintaining m. Thus, under these assay conditions mitochondria establish and 
maintain their large negative m exclusively through succinate dehydrogenase activity in the 
presence of excess (5 mM) substrate, allowing them to remain energized independently of 
[Ca2+]m. 
Under these conditions, the MCU plays a dominant role in determining [Ca2+]c since, 
addition of a Ca2+ bolus to rapidly raise [Ca2+]c to 5 µM was followed by clearance of Ca2+ over 
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Figure 2.2. Rapid Ca2+ uptake is mediated by MCU 
Mitochondrial clearance of bath [Ca2+] ([Ca2+]c) in response to 
acute increase of [Ca2+]c by 5 µM in permeabilized MCU KO and 
WT (HEK-293T) cells. Cells were treated with Dg, Tg, and 20 
µM CGP37157 to inhibit mitochondrial Ca2+ efflux at t = 50, 100 
and 400 sec, respectively. CCCP was added at t = 1000 sec to 
dissipate m and induce efflux of mitochondrial Ca
2+. 
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Figure 2.3. Ca2+ efflux through NCLX compensates for constitutive MCU activity in MICU1 KO cells 
(A) [Ca2+]c in WT or MICU1 KO cells measured with the high-affinity indicator Fura-2. A series of bolus addition of 
200 nM free-Ca2+are added beginning at t = 500 sec. 2 µM CCCP was added at t = 1000 sec. Representative traces 
from n > 3 independent replicates for each cell line shown. No Ca2+-uptake is observed in either cell line. (B) [Ca2+]c 
measurements as described in (A) with 20 µM CGP37157 (CGP) added t = 300 sec to inhibit NCLX activity. 
Representative traces from n > 3 independent replicates for each cell line shown. Inhibition of mitochondrial Ca2+ 
efflux through NCLX reveals constitutive MCU-mediated Ca2+ uptake at low [Ca2+]c in MICU1 KO cells (red trace) 
whereas minimal uptake is observed in WT cells (black trace). 
100-200 seconds in wild-type (WT) cells but not in cells with MCU genetically-deleted (MCU KO) 
(Figure 2.2). Subsequent dissipation of m by CCCP caused a rapid [Ca2+]c increase in WT 
cells, providing further evidence that 
mitochondria were responsible for Ca2+ 
uptake in response to a rise of [Ca2+]c 
(Figure 2.2).  
Upon attainment of a quasi-
steady state [Ca2+]c ~300 sec following 
thapsigargin (Tg) treatment to eliminate 
confounding influences of the ER, 
addition of CGP37157 to inhibit NCLX 
caused no change in [Ca2+]c in WT or 
MCU KO cells (Figure 2.4A-B), indicating that mitochondrial Ca2+ uptake and extrusion were 
inactive. In contrast, it resulted in a prompt decrease in [Ca2+]c in cells lacking MICU1 (Figure 
2.3B; Figure 2.4A-B: red), indicating that Ca2+ uptake was ongoing, balanced by NCLX-mediated 
extrusion (Figure 2.3A).  
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Figure 2.4 
Figure 2.4 
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Figure 2.4.  MICU1, but not MICU2, is required to suppress MCU activity in low [Ca2+]c 
(A) [Ca2+]c in WT, MCU KO, MICU1 KO, MICU1 KO cells with MICU2 re-expressed, and MICU1 KO cells with MICU2 
and MICU1-Flag expressed (rescue) measured with the high-affinity indicator Fura-2. Cells were treated with Dg, Tg, 
and CGP at t = 50, 100 and 400 sec, respectively, as indicated. Representative traces from n  5 independent 
replicates for each cell line shown. As shown in schematic inset, rates of MCU-mediated Ca2+ uptake and NCLX-
mediated Ca2+ extrusion are equal in the steady-state. Inhibition of extrusion by CGP reveals ongoing MCU-mediated 
Ca2+ uptake in MICU1 KO and [MICU1 KO+MICU2] cells, whereas no effect is observed in the other cell types, 
indicating that MCU was not active. (B) Quantification of initial mitochondrial Ca2+-uptake rate in response to 
inhibition of NCLX-mediated Ca2+ efflux for cell lines in (A). Each point represents initial Ca2+ uptake rate from an 
independent experiment (n = 5 for each condition) determined by single-exponential fit to reduction of [Ca2+]c. Bars: 
mean +/- SEM (*P < 0.05;  **P < 0.01; n.s, not different; Bonferroni’s multiple comparisons test). (C) Basal mito-CAR-
GECO1 fluorescence in WT or MICU1 KO HEK-293T cells stably expressing MICU1 and/or MICU2, imaged at 20x 
magnification. Surface plots: relative fluorescence intensity histograms. (D) [Ca2+]m for cell lines in (C), calibrated 
from mito-CAR-GECO1 fluorescence. Each point represents an independent experiment. (WT: n = 12; MICU1 KO: n 
= 7; [MICU1 KO+MICU2]: n = 4; MICU1-rescue: n = 5) Bars: mean [Ca2+]m +/- SEM. (*P < 0.05; **P < 0.01; n.s, not 
different; Bonferroni’s multiple comparisons test). (E) Western blots of MICU1, MICU2, MCU and -actin from cells 
as labeled. Quantification from n = 3 independent experiments normalized for b-actin intensity shown at right. (* P < 
0.05; ** P < 0.01; n.s, not different; Student’s t-test). 
 
Clearance of cytoplasmic Ca2+ in MICU1 KO cells was blocked by Ru360 (1 µM – not 
shown), indicating that it was mediated by MCU. These results recapitulate previous observations 
that MCU-mediated Ca2+ uptake in low [Ca2+]c is strongly enhanced in the absence of MICU1 
(Mallilankaraman et al., 2012b)(Csordás et al., 2013)(Patron et al., 2014) (Liu et al., 2016). Using 
a genetically-encoded Ca2+ indicator targeted to the mitochondrial matrix (mito-CAR-GECO1; KD 
= 490 nM; Figure 2.4C) (Wu et al., 2013), [Ca2+]m in WT cells was ~100 nM whereas it was 
increased over 3-fold to ~300-400 nM in MICU1 KO cells (Figure 2.4D). Thus, MICU1 is required 
to inhibit MCU activity in the low-[Ca2+]c regime, and in its absence the rate of Ca2+ influx is 
sufficient to raise resting [Ca2+]m.  
MICU2 expression was substantially reduced in cells lacking MICU1 (Figure 2.4E). 
Accordingly, loss of MCU gatekeeping and constitutively elevated [Ca2+]m observed in MICU1 KO 
cells here and other studies could be caused or modified by loss of MICU2. Expression of 
MICU1-Flag alone in MICU1 KO cells rescued MICU2 expression to endogenous levels only 
when MICU1-Flag was expressed at greater than endogenous levels (Figure 2.5A-B). In contrast, 
stable expression of both MICU1-Flag and MICU2 (Figure 2.4E & 2.5B) in MICU1 KO cells 
(hereafter defined as MICU1-rescue cells) completely rescued gatekeeping (Figure 2.4A-B) and 
restored [Ca2+]m to WT levels (Figure 2.4C-D). Together, these results demonstrate that MICU1 is 
required for MCU gatekeeping in the low-[Ca2+]c regime. 
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Figure 2.5. Expression of MICU1-Flag in MICU1 KO cells does not rescue MICU2 expression 
(A) Western blots of MICU1, MICU2, and -actin from WT and four clonal MICU1 KO cell lines with stable expression 
of MICU1-Flag. Endogenous MICU2 expression is rescued when MICU1-Flag is overexpressed. (B) Western blots of 
anti-Flag (MICU1) in MICU1 KO cell lines with stable expression of MICU1-Flag with or without expression of MICU2. 
MICU1-MICU2 heterodimers are observed only when both MICU1-Flag and MICU2 are overexpressed.  
 
Gatekeeping of MCU is cooperatively relieved when [Ca2+]c exceeds ~1.3 µM 
 
Physiological [Ca2+]c signals can generate increases in [Ca2+]m, indicating that MCU 
gatekeeping is relieved when [Ca2+]c is elevated. Nevertheless, quantitative measurements of the 
precise [Ca2+]c that govern this process are limited. We therefore evaluated the [Ca2+]c-
dependence of MCU-mediated Ca2+-uptake over a range of [Ca2+]c in WT and MICU1 KO cells. In 
each experiment, cells were challenged with a calibrated bolus of CaCl2 to increase [Ca2+]c to 
between 100 nM and 10 M, and [Ca2+]c was monitored until a steady state was reached (Figure 
2.7A-B). m remained essentially unchanged when measured with JC-1. TMRE, a m probe  
with faster kinetics, revealed only small transient depolarizations (Figure 2.6). 
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In WT cells in the presence of CGP37157, mitochondrial Ca2+ uptake was negligible in 
response to Ca2+ additions that raised [Ca2+]c to 800 nM, such that the measured [Ca2+]c was 
approximately equal to that which had been added. Thus, gatekeeping was fully intact up to 800 
nM [Ca2+]c (Figure 2.7C – black traces). Between 800 nM and 1.5 µM [Ca2+]c, very slow Ca2+ 
uptake reduced [Ca2+]c < 20% over the subsequent 300 sec. To quantify the [Ca2+]c threshold 
above which gatekeeping is relieved, the final [Ca2+]c at steady state was plotted as a function of 
the initial [Ca2+]c after bolus addition. This relationship was approximately linear with a slope of ~1 
for MCU KO cells, as expected (Figure 2.7D & F). A plot for WT cells also yielded a slope of ~1 in 
the [Ca2+]c regime up to ~1 μM (Figure 2.7D), reflecting strong inhibition of MCU channel activity. 
In contrast, Ca2+ uptake in MICU1 KO cells was robust (Figure 2.7C – red traces), reflecting lack 
of gatekeeping, which reduced the steady state post-pulse [Ca2+]c to below 150 nM (Figure 2.7C 
& D). Plots of final steady state [Ca2+]c as a function of the initial [Ca2+]c had slopes of ~0 for both 
MICU1 KO and [MICU1 KO+MICU2] cells, demonstrating loss of gatekeeping in the absence of 
MICU1 (Figure 2.7D). In contrast, WT behavior was recapitulated in MICU1-rescue cells.  
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Figure 2.6. m during Ca
2+ uptake in WT, MICU1 KO, and MICU2 KO cells measured with TMRE 
(A) [Ca2+]c responses to acute increase of [Ca
2+]c by 5 µM in low-[Ca
2+] intracellular-like medium of WT (black), 
MICU1 KO (red), and MICU2 KO (blue) cells treated with digitonin (Dg), thapsigargin (Tg) and CGP37157 (CGP).  
Mean (dark traces; n = 3 replicates) +/- SEM (light shading). (B) TMRE fluorescence during experiments in (A). 
Transient increase in TMRE fluorescence in response to addition of 5 µM Ca2+ represents IMM depolarization 
followed by a repolarization after ~50-60 sec. 
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 Figure 2.7 
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Figure 2.7. Gatekeeping of MCU is relieved above ~1.3 µM [Ca2+]c 
(A-B) Mitochondrial Ca2+ uptake in suspensions of permeabilized WT (A) and MICU1 KO (B) cells in response to 
acute increases of [Ca2+]c to between ~0.1 and 10 µM. Individual traces from independent experiments with different 
bolus additions shown. Insets show relative m over the same period. After monitoring uptake for 300 sec, CCCP 
uncoupled m and released matrix Ca
2+ content. (C) Mitochondrial Ca2+-uptake in WT (black traces) and MICU1 KO 
(red) in response to Ca2+ additions that elevated [Ca2+]c to 0.3-1.5 µM. (D) Steady state [Ca
2+]c 300 sec after initiation 
of uptake, plotted as function of initial [Ca2+]c between 0-1.5 µM. Each point represents an independent experiment. 
Dashed lines: theoretical fits representing no uptake (gray, slope = 1) or 100% uptake (yellow, slope = 0). WT and 
MICU1-rescue cells demonstrated negligible uptake at [Ca2+]c < 1 µM. (E) Mitochondrial Ca
2+ uptake in WT (black 
traces) and MICU1 KO (red traces) cells in response to Ca2+ additions that elevated [Ca2+]c to 3-8 µM. (F) Same as in 
(D) for [Ca2+]c between 0-8 µM. Above 2 µM [Ca
2+]c, uptake proceeds until [Ca
2+]c reaches ~1.5 µM. (G) Ca
2+-uptake 
rates in response to acute challenge with [Ca2+]c between 0.1-9 µM. Each point represents an independent 
experiment. Solid lines: Hill-Equation fits of Ca2+-uptake rate vs. [Ca2+]c plotted on linear scale. Dashed yellow line: 
upper limit of Ca2+-uptake rate determinations. Error bars: standard deviation in fit parameters A (extent) and  (time 
constant). Error bars for some points are too small to be visible. (H) Linear fits of log10 transformed values in (G) that 
demonstrate cooperativity of MCU activation and highlight differences in Ca2+-uptake rates at low (< 1 M) [Ca2+]c. 
Dashed lines represent upper (yellow) or lower (gray) limits of Ca2+-uptake rate determinations. 
 
Ca2+ boluses that elevated [Ca2+]c to between 2-10 µM activated Ca2+ uptake in WT cells, 
which rapidly reduced post-pulse [Ca2+]c to near the gatekeeping threshold of 1.2-1.5 µM within 2-
3 minutes (Figure 2.7E – black traces). Plots of final steady state [Ca2+]c as a function of the initial 
[Ca2+]c exhibited a slope of ~0 (no gatekeeping) above this [Ca2+]c threshold (Figure 2.7F). In 
contrast, in MICU1 KO cells (Figure 2.7E – red traces) as well as in MICU1 KO cells with MICU2 
re-expressed, Ca2+ uptake reduced steady state [Ca2+]c to below 150 nM. MICU1-rescue cells 
recapitulated WT behavior (Figure 2.7F – green). These results suggest that MICU1-dependent 
MCU gatekeeping is relieved when [Ca2+]c exceeds a threshold of ~1 µM, but then becomes re-
engaged following MCU activation when uptake reduces [Ca2+]c to 1-1.5 µM. Moreover, the 
transition of MCU from inactive to active states in WT cells is [Ca2+]c dependent, with MCU activity 
in WT cells surpassing the activity observed in MICU1 KO cells at [Ca2+]c > 5 µM (Figure 2.7E).  
To gain insights into the mechanisms that underlie [Ca2+]c-dependent MCU activation, we 
measured uptake rates over a wide range of imposed [Ca2+]c. There was a non-zero Ca2+ uptake 
in MCU KO cells that increased linearly with [Ca2+]c, mediated by an unknown MCU-independent 
mechanism. MCU was active in cells lacking MICU1 up to ~5 µM [Ca2+]c, with the uptake rate a 
linear function of initial [Ca2+]c (Figure 2.7G), suggesting that uptake in these cells is driven solely 
by the imposed [Ca2+] gradient across the IMM at constant m. In contrast, Ca2+ uptake in WT 
and MICU1-rescue cells was suppressed relative to MICU1 KO cells until [Ca2+]c exceeded ~5 
µM, but then increased with higher [Ca2+]c to rates exceeding those observed in MICU1 KO cells 
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(Figure 2.7E & G - red). Accordingly, the relationship between the initial [Ca2+]c and rate of MCU-
mediated Ca2+ uptake was non-linear (Figure 2.7G), indicating cooperativity in the transition from 
“gatekeeping on” to “gatekeeping off” states. This suggests that MICU1 contributes to cooperative 
activation of MCU, as suggested in some studies, although the cooperativity here did not require 
Mg2+ (Csordás et al., 2013).  
The role of MICU1 in gatekeeping at low (< 1 µM) [Ca2+]c and activation at higher [Ca2+]c 
is more clearly seen in a logarithmic plot (Figure 2.7H). A slope of 1.4 was observed for cells 
lacking MICU1, whereas slopes of 3.1 and 2.5 were observed for WT and MICU1-rescue cells, 
respectively (Table 2.1). These findings demonstrate that, in addition to establishing a [Ca2+]c 
threshold below which MCU activity is suppressed, MICU1 is necessary for the cooperative 
[Ca2+]c-dependent activation of mitochondrial Ca2+ uptake once the threshold is exceeded. 
MICU2 interacts with MICU1 to increase the [Ca2+]c threshold and reduce the gain of cooperative 
activation of MCU activity 
 
MICU1 and MICU2 exist as a disulfide-linked heterodimer (Patron et al., 2014) 
(Petrungaro et al., 2015). In non-reducing western blots, a single band with reactivity to both 
MICU1 and MICU2 antibodies was observed at ~95 kDa in WT cells, representing a MICU1/2 
heterodimer (Figure 2.8A). MICU1 was detected as a homodimer at ~100 kDa in MICU2 KO cells 
(Figure 2.8A). MICU1 was also detected as a ~100 kDa band by co-immunoprecipitation with 
MCU (Figure 2.8B), suggesting that the MICU1-homodimer can interact with the MCU complex. 
In WT cells expressing V5-tagged MCU, MICU2 was co-immunoprecipitated with MCU, whereas 
MCU failed to pull down MICU2 in the absence of MICU1 (Figure 2.9). Thus, MICU1 is required 
for interaction of MICU2 with the MCU complex, in agreement with previous studies (Patron et al., 
2014)(Kamer and Mootha, 2014)(Petrungaro et al., 2015).  
It has been proposed that MICU2 rather than MICU1 is responsible for inhibition of MCU 
activity in the low-[Ca2+]c regime (Patron et al., 2014). Two results argue against this: First, 
genetic deletion of MICU2, which did not reduce MICU1 expression (Figure 2.4E) or abolish 
interaction of MICU1 with MCU (Figure 2.8B), had no effect on gatekeeping in the 100-300 nM  
33 
 
A                                                                                    B 
 
Figure 2.8. MICU1 homodimers interact with MCU 
(A) Western blots of whole-cell lysates for MICU1 (top row), MICU2 (middle) or β-actin (bottom) from WT, MICU1 
KO, MICU2 KO or [MICU1 KO+MICU2] HEK-293T cells under non-reducing conditions. Bands at ~95 kDa represent 
disulfide-linked MICU1-MICU2 heterodimers in WT cells and MICU1-MICU1 homodimers in MICU2 KO cells. Bands 
near 90 kDa observed in MICU1 KO, MICU2 KO and [MICU1 KO+MICU2] cells are due to non-specific antibody 
binding. (B) Immunoblots of whole-cell lysates with anti -MCU and anti-MICU1 antibodies shown. A homodimer of 
MICU1 (~100 kDa) is immunoprecipitated with MCU-V5 (bottom/lane 4) in MICU2 KO cells while a smaller molecular 
weight band (~95 kDa) corresponding to the size of the MICU1-MICU2 heterodimer is immunoprecipitated with MCU-
V5 in WT cells (bottom/lane 2). 
 
Figure 2.9. MICU2 cannot interact with MCU in MICU1 KO 
cells 
anti-V5 immunoprecipitation in WT, MICU1 KO (with or 
without stable expression of MICU2, or with MICU1-Flag 
and MICU2 expressed together (MICU1-rescue)), or 
MICU2 KO HEK-293T cells with (+) or without (-) transient-
transfection of MCU-V5-His. MCU immunoprecipitation 
failed to co-precipitate MICU2 in the absence of MICU1. 
 
[Ca2+]c regime (Figure 2.10A) or on resting [Ca2+]m (Figure 2.10B-C). Second, re-expression of 
MICU2 in MICU1 KO cells (Figure 2.4E) 
failed to rescue loss of gatekeeping (Figure 
2.4A-B & 2.11A - orange) or restore [Ca2+]m 
(Figure 2.4C-D and 2.11B-C - orange). 
Thus, MICU2 does not mediate MCU 
gatekeeping in the low-[Ca2+]c regime, and 
gatekeeping in MICU2 KO cells was 
mediated by MICU1 monomers or 
homodimers. 
To further examine the role of 
MICU2, we measured Ca2+ uptake and m 
in cells challenged with boluses of Ca2+  
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between 100 nM and 10 M (Figure 2.10D). MICU2 KO cells exhibited strong gatekeeping at 
[Ca2+]c < 500 nM (Figure 2.10E). Remarkably, the Ca2+-uptake rate increased dramatically when  
Figure 2.10 
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Figure 2.10.  MICU1-MICU2 heterodimers increase the [Ca2+]c threshold for MCU activation 
(A) Initial rates of mitochondrial Ca2+ uptake in low [Ca2+]c (100-300 nM) revealed by inhibition of NCLX. Each point 
represents an independent experiment (n = 5 for each condition). Bars: mean +/- SEM (* P < 0.05; ** P < 0.01; n.s, 
not different; Bonferroni’s multiple comparisons test). (B) Basal mito-CAR-GECO1 fluorescence at 20x magnification. 
Surface plots: fluorescence intensity histograms. (C) [Ca2+]m calibrated from mito-CAR-GECO1 fluorescence (MICU2 
KO: n = 8). Bars: mean [Ca2+]m +/- SEM. (*P < 0.05; **P < 0.01; n.s, not different; Bonferroni’s multiple comparisons 
test). (D) Mitochondrial Ca2+ uptake in MICU2 KO cells in response to Ca2+ additions that elevated [Ca2+]c to 0.2-7 
µM. Each color represents an independent experiment with a single Ca2+ bolus. Relative m for each corresponding 
trace shown (inset). (E-F) [Ca2+]c responses to bolus additions of Ca
2+ to increase [Ca2+]c to 300-400 nM (E) or 2.5-
3.5 µM (F). Representative traces shown from n > 2 independent replicates for each cell line. (G) Steady-state 
[Ca2+]c 300 s after initiation of uptake, plotted as function of initial [Ca
2+]c between 0.1 – 7 µM. [Ca
2+]c achieves 
steady-state at ~500 nM in MICU2 KO cells compared with 1-1.5 µM in WT cells. (H-I) Ca2+-uptake rates in response 
to acute challenge with [Ca2+]c between 0.1-9 µM. Each point represents an independent experiment. Solid lines: Hill-
Equation (H) or linear (I) fits of Ca2+-uptake rate vs. [Ca2+]c plotted on linear (H) or log10 (I) scales. Activation of Ca
2+ 
uptake in MICU2 KO cells exhibits similar cooperativity to WT cells, but the entire curve is left-shifted. (J-K) 
Simultaneous measurements of [Ca2+]c (J) and [Ca
2+]m (K) in permeabilized cells in response to successive bolus 
additions of Ca2+ each increasing [Ca2+]c by 200 nM. Lines (dark colors) represent mean of n = 3 independent 
experiments with error bars (light colors) representing SEM. Concurrent decrease in [Ca2+]c and increase in [Ca
2+]m is 
observed in MICU2 KO cells above ~400 nM [Ca2+]c. 
[Ca2+]c was elevated to ~3 µM, exceeding that in WT and MICU1 KO cells (Figure 2.10F). This 
behavior was rescued by re-expression of MICU2-Flag. When final steady state [Ca2+]c was 
plotted against initial [Ca2+]c, the slope of the line at [Ca2+]c < 500 nM was ~1 (gatekeeping on), 
but it decreased to a slope of ~0 at higher initial [Ca2+]c (gatekeeping off), to a final steady state 
~500 nM, a level between that observed in WT cells and MICU1 KO cells (Figure 2.10G). This 
suggests that MICU2 plays a role in tuning the MICU1-regulated MCU-gatekeeping threshold. To 
verify that the normal MCU-activation threshold of ~1.3 µM [Ca2+]c was indeed reduced to ~500 
nM in MICU2 KO cells, we simultaneously measured Ca2+ clearance from the cytoplasm and 
uptake into the matrix in permeabilized cells. Below ~1 µM [Ca2+]c, small (~200 nM) Ca2+ pulses 
produced step-changes in [Ca2+]c and small or negligible changes in [Ca2+]m in WT and MCU KO 
cells, respectively, whereas Ca2+ uptake (i.e. reduction in [Ca2+]c, Figure 2.10J), and concurrent 
increase in [Ca2+]m (Figure 2.10K) were observed in the MICU2 KO cells when [Ca2+]c reached 
~500 nM. 
Importantly, MCU-mediated Ca2+ uptake was greater in cells lacking MICU2 not only 
between 500 nM – 3 µM, but over the entire range of imposed [Ca2+]c, resulting in a markedly left-
shifted curve of the [Ca2+]c-dependence of Ca2+ uptake (Figure 2.10H). Notably, however, the 
slope of the logarithmic plot was similar: 3.1 and 2.5 for WT and MICU2 KO cells, respectively 
(Figure 2.10I & Table 2.1). Both effects were rescued by re-expression of MICU2 (Figure 2.10H-I 
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& Table 2.1). These results suggest that MICU2 plays two roles: First, it tunes the threshold for 
relief of MICU1-mediated gatekeeping in the low-[Ca2+]c regime. Second, it affects the gain of 
MCU activation, imposing a brake on the MICU1-mediated increase of MCU activity at higher 
[Ca2+]c by decreasing the apparent Ca2+ affinity of the activation mechanism without strongly 
affecting its cooperativity. 
Cooperative relief of gatekeeping requires Ca2+-binding to EF-hands of MICU1 and MICU2  
 
The ability of MICU1 and MICU2 to sense [Ca2+]c and regulate MCU activity has been 
attributed to the presence of two Ca2+-binding EF-hand domains in each protein. We investigated 
the roles of each EF hand in gatekeeping and cooperative activation, using expression constructs 
in which the EF hands were mutated to disrupt Ca2+ binding (Perocchi et al., 2010)(Kamer and 
Mootha, 2014). MICU2 was stably expressed with each MICU1 EF-hand mutant in MICU1 KO 
cells to ensure similar expression of each protein. MICU1-Flag immunofluorescence confirmed 
that all cells in clonal populations uniformly expressed the mutant proteins (not shown) and total 
expression levels were verified by western blotting (Figure 2.11A). Whereas Ca2+ stabilizes 
MICU1-MICU2 heterodimers in vitro (Kamer et al., 2017), in our clonal lines each EF-hand mutant 
formed proper MICU1/2 heterodimers (Figure 2.11A) that remained associated with MCU (Figure  
2.11B). Upon inhibition of NCLX-mediated Ca2+ extrusion at low [Ca2+]c (< 300 nM), mitochondrial 
Ca2+ uptake was absent in MICU1-EF1 and MICU1-EF2 cells and very low (< 0.1 nM/sec) in 
EF1/2 cells (Figure 2.12A-B), indicating that Ca2+-binding to MICU1 EF-hands is not required for 
gatekeeping. In agreement, resting [Ca2+]m was unchanged in MICU1-EF1, -EF2 or -EF1/2 
cells (Figure 2.11E-F).   
When [Ca2+]c was elevated to levels that overcame gatekeeping in WT cells, Ca2+ uptake 
was remarkably suppressed in all three MICU1 EF-hand mutant-cell lines across the full range of 
[Ca2+]c tested, to an extent that no [Ca2+]c steady state was reached during the subsequent 300 
seconds (Figures 2.12C-F). Logarithmic plots showed loss of cooperativity in both individual EF-
hand mutants as well as in the double mutant, with linear-fit slopes of 1.8, 1.8 and 1.4  
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Figure 2.11.  EF-hand mutations in MICU1 or MICU2 do not impair MCU complex assembly or elevate resting 
[Ca2+]m 
(A) Western blot of whole-cell lysates for MICU1 (top left) or MICU2 (bottom left) and -actin (right) from MICU1_KO 
cells with stable overexpression of [MICU1-EF1+MICU2], [MICU1-EF2+MICU2], [MICU1-EF1/2+MICU2], or 
[MICU1-Flag+MICU2] (MICU1-rescue) under non-reducing conditions. Bands at ~100 kDa represent disulfide-linked 
MICU1-Flag/MICU2 heterodimers and bands at >100 kDa represent MICU1-Flag homodimers. Bands at ~90 kDa 
are due to non-specific binding. (B) -Flag immunoprecipitation from MICU1_KO cells stably-expressing MICU2 and 
Flag-tagged MICU1, MICU1-EF1, MICU1-EF2, or MICU1-EF1/2. Immunoblots of whole-cell lysates with -MCU, 
-MICU1, and -MICU2 antibodies shown. Mutations of MICU1 EF hands do not prevent interactions with MICU2 or 
MCU. (C) Non-reducing western blots of MICU2 (top), MICU1 (middle) and actin (bottom) in whole-cell lysates from 
MICU2_KO cells stably over-expressing MICU2-EF1, MICU2-EF2, MICU2-EF1/2, or MICU2-Flag (MICU2 
rescue). Bands at ~100 kDa represent disulfide-linked MICU1-Flag/MICU2 heterodimers. (D) -Flag 
immunoprecipitation from MICU2_KO cells stably expressing Flag-tagged MICU2, MICU2-EF1, MICU2-EF2, or 
MICU2-EF1/2. Immunoblots of whole-cell lysates with -MCU, -MICU1, and -MICU2 antibodies shown. 
Mutations of MICU2 EF hands do not prevent interactions with MICU1 or MCU. (E) Basal mito-CAR-GECO1 
fluorescence in WT and MICU1_KO HEK-293T cells stably expressing MICU2 alone, MICU1-EF1+MICU2, MICU1-
EF2+MICU2, MICU1-EF1/2+MICU2, or MICU1-Flag+MICU2, imaged at 20x magnification. (F) Mitochondrial 
matrix [Ca2+] ([Ca2+]m) in WT (n = 12) and MICU1_KO cells stably expressing MICU2 alone (n =4), MICU1-
EF1+MICU2 (n = 5), MICU1-EF2+MICU2 (n =4), MICU1-EF1/2+MICU2 (n = 3), or MICU1-Flag+MICU2 (n = 4), 
calibrated from mito-CAR-GECO1 fluorescence. Bars represent mean [Ca2+]m +/- SEM. (*P < 0.05; **P < 0.01; 
Bonferroni’s multiple comparisons test). 
 
respectively (Figure 2.12G & Table 2.1). These results indicate that Ca2+-binding to both EF 
hands of MICU1 is necessary for full cooperative-activation of MCU in response to elevated 
[Ca2+]c. 
Similar experiments were performed using MICU2 KO cells in which MICU2 expression 
was rescued with -EF1, -EF2, or -EF1/2 mutants. Expression of each mutant protein was 
uniform across the cell population, and western blotting showed formation of MICU1/2 
heterodimers (Figure 2.11C), and each EF-hand mutant associated with MCU (Figure 2.11D). 
MCU activity below 300 nM [Ca2+]c was negligible in MICU2-EF1, -EF2, and -EF1/2 cells 
(Figure 2.13A-C), indicating that MICU2 EF hands play no role in gatekeeping, consistent with the 
lack of effect of MICU2 KO on MCU activity in low (< 500 nM) [Ca2+]c. In contrast, mutation of 
either MICU2 EF hand had striking effects on Ca2+ uptake in the higher-[Ca2+]c regime. Nearly 
complete inhibition of MCU activity was observed in MICU2-EF1 and -EF1/2 cells even at 
[Ca2+]c up to 9 µM (Figure 2.13D-E), and to a lesser extent in cells expressing MICU2-EF2. This 
implicates MICU2 EF1 as a critical Ca2+-binding site required for relief of gatekeeping. Notably, 
cooperativity of MCU activation was completely lost in MICU2-EF1 (slope = 1.6) and -EF1/2 
(slope = 1.2) cells, and to a lesser but significant extent in MICU2-EF2 cells (slope = 2.0) (Figure 
2.13F-G, Table 2.1). Thus, within the context of the physiological MICU1/2 heterodimer, Ca2+ 
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binding to EF hands in both MICU1 and MICU2 is required for cooperative activation of MCU by 
[Ca2+]c above the gatekeeping threshold. 
 
Slope +/- 95% CI 
(decade/decade) 
Uptake rate at 1 µM 
[Ca2+]c (nM/sec) 
R2 
WT (HEK-293T) 3.1 ± 0.08 0.9 0.99 
MICU1 KO 1.4 ± 0.06 14.3 0.99 
MICU1 KO+MICU2 1.4 ± 0.04 20.4 0.99 
MICU1 KO+MICU1-Flag 2.1 ± 0.07 2.0 0.99 
MICU1 KO+MICU1-
Flag+MICU2 
2.5 ± 0.10 1.6 0.98 
MICU2 KO 2.5 ± 0.15 8.7 0.97 
MICU2 KO+MICU2-Flag 2.7 ± 0.16 1.7 0.97 
MICU1 KO+MICU1-
EF1+MICU2 
1.8 ± 0.12 0.5 0.97 
MICU1_KO+MICU1-
EF2+MICU2 
1.8 ± 0.09 1.1 0.98 
MICU1_KO+MICU1-
EF1/2+MICU2 
1.4 ± 0.09 1.3 0.95 
MICU2 KO+MICU2-EF1 1.6 ± 0.07 0.7 0.99 
MICU2 KO+MICU2-EF2 2.0 ± 0.12 2.0 0.98 
MICU2 KO+MICU2-
EF1/2 
1.2 ± 0.09 0.8 0.97 
MCU KO 1.4 ± 0.11 0.1 0.97 
 
 
Table 2.1. Linear regression of log10 [Ca
2+]c vs. log10 Ca
2+ uptake rate 
Slope, uptake rate at 1 µM [Ca2+]c, and R
2 values for linear regression analyses of log10 Ca
2+-uptake rate vs. log10 
[Ca2+]c. Slope ~1 indicates non-cooperative increase in uptake rate while slope > 1 indicates cooperativity in the 
[Ca2+]c -dependent relief of MCU gatekeeping. 
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Figure 2.12.  Ca2+ binding to MICU1 EF hands promotes cooperative activation of MCU 
(A) Responses to CGP37157 in the low-[Ca2+] regime. Representative traces for each cell line (color coding in B) for 
n  5 independent replicates. Like WT, MICU1 EF-hand mutants show negligible Ca2+ uptake.  (B) Quantification of 
Ca2+ uptake rates after inhibition of NCLX-mediated efflux for cells in (A). Each point represents an independent 
experiment (n = 5 for each condition). Bars: mean +/- SEM. (*P < 0.05; **P < 0.01; n.s, not different; Bonferroni’s 
multiple comparisons test). Mutation of MICU1 EF hands does not affect gatekeeping at [Ca2+]c < 300 nM. (C-E) 
[Ca2+]c for cells in (A, B) after bolus additions of Ca
2+ to increase [Ca2+]c to 300-400 nM (C), 2.5-4 µM (D), or 7-9 µM 
(E). Representative traces shown from n ≥ 2 independent replicates for each cell line with similar peak [Ca2+]c after 
CaCl2 addition. (F-G) Ca
2+ uptake rate as a function of the peak [Ca2+]c after acute Ca
2+ additions. Each point 
represents an independent experiment. Solid lines: Hill-Equation (F) or linear (G) fits of Ca2+-uptake rate vs. [Ca2+]c 
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Figure 2.13.  Ca2+ binding to MICU2 EF hands tunes MICU1-mediated cooperative activation of MCU  
(A) Responses to CGP37157 in the low-[Ca2+] regime. Representative traces for each cell line (color coding in B) 
from n  5 independent replicates. (B) Quantification of Ca2+-uptake rates in response to CGP37157 for cells in (A). 
Each point represents an independent experiment (n = 5 for each condition). Bars: mean +/- SEM. (*P < 0.05; **P < 
0.01; n.s, not different; Bonferroni’s multiple comparisons test). Absence of MICU2 or mutation of its EF hands does 
not affect gatekeeping at [Ca2+]c < 300 nM. (C-E) [Ca
2+]c for cells in (A, B) after bolus additions of Ca
2+ to increase 
[Ca2+]c to 300-500 nM (C), 3-4.5 µM (D), or 7-9 µM (E). Representative traces shown from n ≥ 2 independent 
replicates for each cell line with similar peak [Ca2+]c. (F-G) Ca
2+ uptake rate as function of peak [Ca2+]c after acute 
Ca2+ additions. Each data point represents an independent experiment. Solid lines: Hill-Equation (F) or linear (G) fits 
of Ca2+-uptake rate vs. [Ca2+]c plotted on linear (F) or log10 (G) scales. MICU2 elevates the threshold for MICU1-
mediated MCU activation, and Ca2+ binding to its EF hands is required for cooperative MCU activation. 
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CHAPTER 3: The Relative Stoichiometry Between MCU and EMRE In Vivo 
 
An important question is whether the cryo-EM MCU-EMRE structure recapitulates the 
stoichiometry of MCU and EMRE in the functional channel complex in vivo. Furthermore, it is 
unknown whether the same or different numbers of EMRE subunits are required for MCU activity 
on the one hand, and normal MICU1/2-mediated gatekeeping and cooperative activation on the 
other.  It has been demonstrated that EMRE (but not MCU) is rapidly turned-over by degradation 
through the activity of IMM-associated matrix-AAA (mAAA) proteases (Tsai et al., 2017)(König et 
al., 2016). Such rapid turnover could result in variable relative steady-state expression levels of 
EMRE and MCU that could alter the stoichiometry in cells. If MCU requires four EMRE for its 
activity, then absence of a single EMRE subunit from the complex would lead to complete loss of 
channel activity. On the other hand, if fewer than four EMRE subunits per MCU tetramer are 
sufficient for activity but fail to properly tether MICU1/2 dimers to the complex, such channels may 
be functional but exhibit altered gatekeeping and cooperative-activation profiles.  
We have devised a two-pronged approach to address these questions and to determine 
the consequences of altering the number of EMRE subunits in each complex on both channel 
activity and regulation by MICU1/2. First, we engineered model systems to manipulate the 
relative MCU and EMRE protein expression ratios in cells and correlate them with functional 
features. Second, we created a series of MCU-EMRE concatemers with multiple concatenated 
MCU subunits fused to EMRE in order to “fix” the relative stoichiometry between EMRE and MCU 
in each channel complex. These approaches enabled functional and biochemical comparison of 
channels with a range of EMRE:MCU stoichiometries to endogenous channel complexes. Our 
results suggest that MCU largely exists in association with fewer than 4 and more than 1 EMRE 
subunit. 
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Materials and methods: 
Generation of the MCU/EMRE double-knockout (MEKO) cell line 
 
HEK-293T cells with genetic deletion of EMRE (EMRE KO cells) were a generous gift 
from Dr. Vamsi Mootha. Both genomic copies of MCU were inactivated in EMRE KO cells using 
CRISPR/Cas9-mediated gene editing. sgRNAs targeting the 5’ end of the MCU coding sequence 
were chosen using MIT CRISPR design tool (http://crispr.mit.edu). Two guides were chosen to 
target Exon 1 (guides 1 and 2) and two for Exon 2 (guides 3 and 4).  
Guide 1 (5’-3’):  
(Forward) CAGGAGCGATCTACCTGCGG 
(Reverse) CCGCAGGTAGATCGCTCCTG 
Guide 2 (5’-3’):  
(Forward) CAGCAGGAGCGATCTACCTG  
(Reverse) CAGGTAGATCGCTCCTGCTG 
Guide 3 (5’-3’):  
(Forward) TGACAGCGTTCACGCCGGGA  
(Reverse) TCCCGGCGTGAACGCTGTCA 
Guide 4 (5’-3’):  
(Forward) TGAACTGACAGCGTTCACGC  
(Reverse) GCGTGAACGCTGTCAGTTCA 
Oligonucleotides were annealed, treated with T4 polynucleotide kinase at 37C for 30 min, 95C 
for 5 min, and ramped from 95-25C (5C/min), and ligated into the pSPCas92A-GFP vector 
(Addgene, 48138) that had been digested with BbsI (NEB) and treated with Calf Alkaline 
Phosphatase (NEB). Ligation reactions were used to transform Turbo Competent E. coli (NEB), 
individual clones were isolated and the presence of each sgRNA was verified by sequencing. 
Maxi prep DNA for each sgRNA pair was used to transfect EMRE KO (HEK-293T) cells growing 
in DMEM containing 10% fetal bovine serum (HyClone) and 1x anti-biotic/anti-mycotic (Gibco) at 
37˚C and 5% CO2. One week after transfection GFP-positive cells were isolated at the expression 
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using flow cytometry (Wistar Institute) and clones were grown to confluence in 10 cm dishes.  
Loss of MCU expression in each clone was verified by western blot and genomic sequencing.  
Cell lines and cDNA expression constructs 
 
All HEK-293T cell lines were grown in DMEM containing 5-10% fetal bovine serum 
(HyClone) and 1x anti-biotic/anti-mycotic (complete medium) at 37˚C and 5% CO2. EMRE KO 
(HEK-293T) cells were a generous gift from Dr. Vamsi Mootha. cDNAs of full-length V5-tagged 
EMRE and Flag-tagged MICU1 in pCMV6-A-BSD and pCMV6-A-Puro vectors were obtained 
from Origene. MCU-V5-(6x)His cDNA in pDEST40 was purchased from Addgene and subcloned 
into pCMV6-A-BSD and pCMV6-A-Puro using standard molecular biology techniques. EMRE 
[P76I] cDNA in pCMV6-A-BSD and pCMV6-A-Puro was generated using a PCR-based site-
directed mutagenesis strategy. The MCU-EMRE concatemer described by Tsai et al. (2016) (+/- 
the EMRE [P76I]) mutation in pCMV6-A-BSD and pCMV6-A-Puro were created using a PCR-
based cloning strategy. Fusion proteins with additional MCU subunits fused to EMRE were 
synthesized and sequence-verified by Bio Basic Inc. and subcloned into pCMV6-A-Puro. Each 
additional MCU subunit added to the MCU-EMRE concatemer was encoded by a unique cDNA 
sequence to ensure stability of the construct and facilitate full-length sequencing (see 
Supplementary Experimental Procedures). Stable cell lines were created by transfection with 
Transit LT1 (Mirus) as per manufacturer’s protocol and maintained in complete medium with 5 
µg/mL blasticidin and/or 2 µg/mL puromycin until stable expression of each plasmid was 
achieved. Clones were isolated by limiting dilution for each condition and maintained in complete 
medium with antibiotics. 
Simultaneous determination of mitochondrial Ca2+ uptake and m in permeabilized cells 
 
 Concurrent measurement of mitochondrial Ca2+ uptake and IMM potential (m) in 
permeabilized HEK-293T cells was performed as described in Chapter 2 (Payne et al., 2017), 
with fluorescence measurements calibrated to represent bath (cytoplasmic) [Ca2+] and relative 
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m (normalized to response in the presence of CCCP). For determination of the gatekeeping 
[Ca2+]c threshold, the calculated [Ca2+]c 300 sec after challenge with 0.1 - 10 µM Ca2+ (Y) was 
plotted as a function of the (peak) initial [Ca2+]c achieved after bolus Ca2+ addition (X). Data were 
fitted using a one-phase association model where (Y0) is the Y value when X is zero, (P) is the 
plateau, or Y value at infinite X, and (K) is the rate constant, expressed in reciprocal of the X axis. 
𝑌 =  𝑌0 +  𝑃 − 𝑌0  1 − 𝑒
 −𝐾𝑋   
 
The value of (P) represents to the steady-state [Ca2+]c at which gatekeeping is re-established +/- 
the standard error of (P) determined from the fit. 
SDS-PAGE western blotting 
 
 For western blotting of whole-cell lysates, cells grown in in 150 mm plates were washed 
with DPBS, detached with Versene solution (0.48 mM EDTA in DPBS) and lysed with buffer 
containing (in mM): 50 Tris-HCl (pH 7.4), 150 NaCl, 0.05 EGTA, and 0.3 CaCl2 with 0.2% (w/v) n-
Dodecyl β-D-maltoside. Immediately prior to use, lysis buffer was supplemented with 1 mM 
PMSF and protease inhibitor cocktail (cOmplete, Roche). For western blots of mitochondrial 
proteins, mitochondria were isolated as previously described (Sancak et al., 2013). Total protein 
concentrations were calculated using BCA Protein Assay kit (Pierce), and samples for PAGE 
were prepared in 2x Laemmli sample buffer (Bio-Rad, 1610737) +/- 2-Mercaptoethanol (βME) 
(Bio-Rad, 1610710).  NuPAGE© gels (4-12%) were transferred to Immobilon© P PVDF 
membranes and probed with various antibodies. Antibodies used were anti-MCU (Cell Signaling 
Technologies, 14997S), anti-V5 tag (Cell Signaling Technologies, 13202S), anti-MICU2 (Abcam, 
ab101465), anti-DYKDDDDK (Flag tag) (Cell Signaling Technologies, 14793S), anti-β-Tubulin 
(Invitrogen, 32-2600), and anti-Hsp60 (Abcam, ab46798). Membranes were blocked in 5% fat-
free milk for 1 hr at RT, incubated overnight at 4°C with primary antibody, and then for 1 hr at RT 
with anti-rabbit IgG-HRP (Cell Signaling Technologies, 7074S) or anti-mouse IgG-HRP (Cell 
Signaling Technologies, 7076S) secondary antibodies conjugated to horseradish peroxidase 
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(HRP). Chemiluminescence detection was carried out using SuperSignal West Chemiluminescent 
Substrate (Thermo). The mean pixel density of bands was quantified using ImageJ (NIH), 
corrected for the intensity of the loading-control band (β-tubulin for whole-cell lysates or Hsp60 for 
isolated mitochondria), and normalized to the response in WT cells. For EMRE:MCU ratio 
calculations, the mean pixel density of the EMRE-V5 band was divided by the mean pixel density 
of the MCU-V5 band for each independent experiment. Predicted stoichiometry histograms were 
derived from the binomial probability equation where (n) is the number of possible combinations 
of EMRE and MCU that can assemble, (r) is the EMRE:MCU expression ratio determined from 
V5 western blot band intensities, and (x) is the number of EMRE subunits per channel. 
𝑃(𝑥) =  
(𝑛!)(𝑟𝑥)((1 − 𝑟)(𝑛−𝑥))
(𝑥!)( 𝑛 − 𝑥 !)
 
 
P(x) is the probability of obtaining (x) EMRE subunits per channel based on the EMRE:MCU 
expression ratio given random association of the two proteins. 
Immunofluorescence microscopy of mitochondrial proteins 
 
 Clear, 12-well tissue culture-treated plates (CytoOne, CC7682-7524) were seeded with 
2×105 cells/well on 12 mm glass coverslips in 500 µL/well of complete medium. Cells were grown 
for 24 hr prior to fixation in 1 mL of 4% (v/v) paraformaldehyde (Electron Microscopy Sciences, 
15713-S) in complete medium. Cells were fixed for 15 min at 37C, washed with DPBS, and 
permeabilized in 1 mL/well of 0.1% (v/v) Triton X-100 detergent (Sigma-Aldrich) for 30 min at RT. 
Permeabilization solution was decanted and 2 mL of (2x) casein blocking buffer (Sigma-Aldrich, 
B6429) was added to each well and incubated for 30 min at RT. Blocking solution was removed 
and replaced with 1 mL/well of rabbit anti-V5 antibody (Cell Signaling Technology, 13202S) and 
mouse anti-Flag M2 (Sigma-Aldrich, F3165) primary antibodies each diluted 1:2,000 in (1x) 
blocking buffer and incubated overnight at 4C with gentle agitation. The following day plates 
were removed from 4C, washed with 0.05% (v/v) Tween-20 (Bio-Rad, 1706531) in DPBS, and 1 
mL/well of anti-rabbit IgG Alexa Fluor 568-conjugated (Invitrogen, A-11011) and anti-mouse IgG 
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Alexa Fluor 488-conjugated (Invitrogen, A-11001) secondary antibodies each diluted 1:2,000 in 
(1x) blocking buffer was added to each well and incubated in the dark for 1 hr at RT. Coverslips 
from each well were mounted on standard glass slides using VECTASHIELD® Antifade Mounting 
Medium with DAPI (Vector Laboratories, H-1200) and images were collected on a Leica TCS SP8 
X system using a 100x/1.4 NA PL APO CS2 objective. Labeled V5-tagged proteins (MCU-EMRE 
concatemers) were excited using a continuously tunable white light laser set to 568 nm to detect 
fluorescence emission between 600-700 nm. Labeled Flag-tagged proteins (MICU1-Flag) were 
excited at 488 nm to detect fluorescence emission between 510-550 nm. DAPI was excited at 
408 nm to detect fluorescence emission between 430-470 nm. 
In-cell ELISA to quantify V5 expression 
 
 Clear, 96-well tissue culture-treated plates (Corning, 3603) were seeded with 2.5×104 
cells/well in 100 µL of complete medium. Each cell line was seeded in eight replicate wells across 
three replicate plates. Cells were grown for 24 hr then fixed, permeabilized and blocked as 
described above (200 µL/well). Blocking solution was removed and replaced with 100 µL/well of 
mouse anti-V5 antibody (Invitrogen, R960-25) diluted in (1x) blocking buffer and incubated 
overnight at 4C with gentle agitation. The following primary antibody dilutions were tested in 
triplicate wells: 1:1,000; 1:5,000, 1:25,000; 1:125,000; 1:250,000. One well for each cell line was 
reserved for the no primary antibody control. The following day plates were removed from 4C, 
washed as described above, and 100 µL/well of anti-mouse IgG HRP-linked secondary antibody 
(Cell Signaling Technology, 7076S) diluted 1:2,000 in (1x) blocking buffer was added to each well 
and incubated for 1 hr at RT with gentle agitation. Secondary antibody was decanted, plates were 
washed as previously described, and 100 µL/well of 1-Step™ Ultra TMB - ELISA Substrate 
solution (Thermo, 34028B) was added to each well and incubated for 10 min at RT. Absorbance 
at 650 nm of each well was measured in a Cytation 5 plate reader; three sequential 
measurements of each plate were made to ensure that the HRP reaction has reached 
completion. After reading, the substrate was removed and 50 µL of 0.3% (w/v) Janus Green B 
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(Sigma-Aldrich, 201677) dye solution was added to each well as a control for cell density and 
plates were incubated for 5 min at RT. The dye was decanted, plates were washed with diH2O to 
remove excess solution and 200 µL of 0.5 N HCl solution was added to each well. Absorbance at 
595 nm was measured in the Cytation 5 plate reader as previously described. The ELISA signal 
(Abs @ 650 nm) for each well was normalized for cell density (Abs @ 595 nm) the mean 
normalized response for cell line was plotted as a function of the primary antibody dilution. Data 
were fitted using a one site-total binding model where (Y) is the mean normalized ELISA 
response, (Bmax) is the relative total number of V5-binding sites, (X) is the primary antibody 
dilution factor, (KD) is the dissociation constant, (NS) represents the contribution of non-specific 
binding of the secondary antibody, and (Y0) is the background signal of the detector.  
𝑌 =   
 𝐵𝑚𝑎𝑥   𝑋 
𝐾𝐷 + 𝑋
 +  𝑁𝑆  𝑋 + 𝑌0 
 
BN-PAGE western blotting 
 
 Total protein concentrations of isolated mitochondrial preparations were determined 
using BCA Protein Assay kit (Pierce). 5 µg total protein of each sample for PAGE were prepared 
in 4x NativePage sample buffer (Invitrogen, BN2003) supplemented with 5% Digitonin. 
NativePAGE© gels (4-12%) were either stained with Coomassie blue protein stain (as a loading 
control and to detect NativeMark™ Unstained Protein Standard (Invitrogen)) or transferred to 
Immobilon© P PVDF membranes, fixed in 8% acetic acid, and probed with anti-MCU (Cell 
Signaling Technologies, 14997S) and anti-DYKDDDDK (Flag tag) (Cell Signaling Technologies, 
14793S) antibodies. Membranes were blocked in 5% fat-free milk for 1 hr at RT, incubated 
overnight at 4°C with primary antibody, and then for 1 hr at RT with anti-rabbit IgG-HRP (Cell 
Signaling Technologies, 7074S) secondary antibody conjugated to horseradish peroxidase. 
Chemiluminescence detection was carried out as described above.  
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Determination of molecular weights for MCU-EMRE concatemers and native channels 
Calibration of molecular weight was performed by plotting the peak intensity of each band 
of known molecular weight (X) from the marker as a function of the relative vertical position (Y) of 
each band on gels stained with Coomassie blue, and data were fitted using an exponential 
growth equation where (Y0) is the Y value when X is zero and (K) is the rate constant, expressed 
in reciprocal of the X axis : 
𝑌 =  𝑌0 × 𝑒
𝑘𝑋  
 
Pixel intensity for each lane in the MCU western blots sample was determined as previously 
described using ImageJ, and molecular weights from n = 3 independent experiments were 
interpolated from the fit above. 
Statistical analyses 
 
 Independent, normally-distributed rate measurements and steady states after uptake 
were analyzed using ordinary one-way ANOVA and Tukey’s multiple comparisons t-test to 
identify significant differences between all each cell line and all others. Normalized western blot 
band intensities were analyzed using ordinary one-way ANOVA and Dunnett’s multiple 
comparisons t-test to identify differences in expression relative to WT cells, or Welch’s unpaired t-
test for pairwise comparisons between cell types other than WT. Molecular weight measurements 
from BN-PAGE western blots were analyzed using repeated measures one-way ANOVA and 
Dunnett’s multiple comparisons t-test to identify differences relative to WT channel complexes. All 
statistical tests were performed using GraphPad Prism 7.0. P-values < 0.05(*); < 0.01(**); < 
0.001(***); and < 0.0001(****) were considered statistically significant.  
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Figure 3.1. MCU and MICU1/2-dimer expression in stable cell lines relative to WT 
(A) Western blots of MCU, V5-tag, MICU2, Flag-tag, and β-tubulin from whole-cell lysates of WT (HEK-293T) cells, 
or MCU/EMRE KO (MEKO) cells +/- stable expression of MICU1-Flag, MCU-V5, or MCU-V5 and EMRE-V5. Two 
bands for MCU-V5 protein are due to low-level degradation of the V5-tag. MICU2- and Flag-blots performed under 
non-reducing conditions, such that MICU2 bands represent MICU1/2 heterodimers and Flag bands represent 
MICU1-Flag homo-dimers. (B) Quantification of MCU western blot band intensity for cell lines in (A) from n > 4 
independent experiments. Mean pixel density corrected for β-tubulin intensity and normalized to endogenous MCU 
band intensity in WT cells for each experiment. Replicate measurements shown as hollow circles, boxes denote the 
25th-75th percentile with line at median, error bars represent range of all measurements. P-values: pairwise 
comparisons of each cell line with WT cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; 
Dunnett’s multiple comparisons test). (C) Quantification of MICU2 western blot band intensity for cell lines in (A) from 
n > 4 independent experiments under non-reducing conditions to preserve MICU1/2 heterodimers, quantified as 
described in (B). Replicate measurements shown as hollow circles, boxes denote the 25th-75th percentile with line at 
median, error bars represent range of all measurements. P-values: pairwise comparisons of each cell line with WT 
cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; Dunnett’s multiple comparisons test). 
Results: 
Restoration of EMRE and MCU expression in MCU/EMRE double-KO cells 
 
To create a system in which relative MCU and EMRE protein expression levels could be 
directly measured and correlated with functional outcomes, we first created a cell line in which all 
genomic copies of both MCU and EMRE were inactivated. This was accomplished by 
CRISPR/Cas9-mediated genetic knockout of MCU in HEK-293T cells in which all EMRE genes 
had already been inactivated (provided by Vamsi Mootha), hereafter referred to as MEKO cells. 
Inactivating mutations in the EMRE and MCU genes were verified by genomic sequencing. 
Western blotting revealed a complete loss of MCU protein expression (Figure 3.1A-B: red). We 
previously showed that MICU2 dimerizes with MICU1 under non-reducing conditions, but does 
not form homodimers when overexpressed in MICU1 KO cells (Payne et al., 2017). Thus, bands 
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Figure 3.2. The low EMRE:MCU ratio in MCU+EMRE cells predicts formation of channels with 1 or 2 EMRE subunits 
(A) V5 western blots from whole-cell lysates of MEKO cells with no transfection, transient transfection, or stable 
transfection of EMRE-V5. Bands shown are from different blots; each result is representative of n > 4 biological 
replicates and n > 3 technical replicates for each condition. Transient expression of EMRE-V5 results in bands 
corresponding to both the unprocessed (~14 kDa) and mature (~11 kDa) forms of EMRE while cells with stable 
expression show only the mature form of EMRE. (B) Quantification of the EMRE:MCU expression ratio in 
MCU+EMRE cells from V5 western-blot band intensity (n = 9 independent experiments). Ratio calculated by dividing 
the mean pixel density of EMRE-V5 band by that of the MCU-V5 band for each experiment. Replicate measurements 
shown as hollow circles, boxes denote 25th-75th percentile with line at median, and error bars represent range of all 
measurements. The EMRE:MCU expression ratio in MCU+EMRE cells is 0.09 +/- 0.07 (mean +/- SD). (C) Probability-
distribution histogram of number of EMRE subunits per MCU channel in MCU+EMRE cells based on mean 
EMRE:MCU expression ratio calculated in (B). Points represent mean probability of obtaining 0, 1, 2, 3, or 4 EMRE 
subunits per channel based on binomial distribution. Solid lines: spline fits of all data points. At this EMRE:MCU 
expression ratio, > 98% of channels are predicted to associate with 0, 1 or 2 EMRE subunits. 
at ~100 kDa observed in non-reducing western blots for MICU2 correspond to MICU1/2 
heterodimers. MEKO cells exhibited reduced expression of MICU1/2 dimers relative to WT cells 
(Figure 3.1A&C: red), which increased upon stable overexpression of MICU1-Flag 
(MEKO+MICU1 cells) to levels equivalent to those in WT cells (Figure 3.1A&C: blue). Similarly, 
stable transfection of MEKO cells with MCU-V5 (MEKO+MCU cells) restored both MCU and 
MICU1/2 dimer expression to WT levels (Figure 3.1A-C: yellow). Stable expression of EMRE-V5 
in MEKO+MCU cells (MCU+EMRE cells) did not change MCU or MICU1/2-dimer expression 
relative to WT cells (Figure 3.1A-C: green).  All EMRE expressed in these stable lines was fully 
processed to its mature form (Figure 3.2A). Notably, EMRE expression was ~10-fold lower than 
MCU in MCU+EMRE cells (Figure 3.2B). Given this EMRE:MCU ratio, binomial probability 
predicts that > 98% of MCU tetramers would associate with zero, one, or two EMRE proteins 
(Figure 3.2C). The lack of available antibodies specific to the processed form of endogenous 
EMRE in the IMM prevented a comparison of EMRE levels between the WT and MCU+EMRE 
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Figure 3.3. MCU channel activity requires expression of both MCU and EMRE 
(A) Cytoplasmic (bath) [Ca2+] ([Ca2+]c) of cell lines in (A) measured with Fura-FF (KD = 5.5 µM). Cells were treated 
with 0.004% digitonin (Dg) to permeabilize plasma membrane, 2 µM thapsigargin (Tg) to inhibit SERCA and prevent 
ER Ca2+ uptake, and 20 µM CGP37157 (CGP) to block mitochondrial Ca2+ efflux through NCLX, added at t = 50, 100 
and 400 sec, respectively, as indicated. A bolus addition of free-Ca2+ sufficient to raise [Ca2+]c to 8-10 µM added at t 
= 700 sec to stimulate Ca2+-uptake through MCU, and 2 µM CCCP added at t = 1000 sec to uncouple m and 
release mitochondrial Ca2+ content. Representative traces from n > 3 independent replicates for each cell line shown. 
Both MCU and EMRE are required for Ca2+ uptake activity. (B) Relative m for experiments shown in (A) measured 
using 1 µM TMRE. Sequestration of the dye by energized mitochondria leads to quenching of its fluorescence, which 
increases upon depolarization. Transient depolarization is observed in response to Ca2+ uptake, while addition of 2 
µM CCCP led to a sustained loss of m. 
cells. Consequently, whereas expression levels of MCU and MICU1/2 in MCU+EMRE cells were 
similar to those observed in WT cells, we do not know if the relative expression of MCU to EMRE 
in the MCU+EMRE cells was similar to that in WT cells.   
  To evaluate MCU function, we simultaneously measured MCU-mediated Ca2+ uptake and 
relative mitochondrial membrane potential (m) in permeabilized cells as previously described 
using the cell-impermeant Ca2+-indicator dye Fura-FF (KD  = 5.5 µM) (Mallilankaraman et al., 
2012b)(Payne et al., 2017) and tetramethylrhodamine ethyl ester (TMRE), respectively (9). 
Digitonin (Dg) was added to a suspension of cells to permeabilize the plasma membrane but 
leave the IMM intact (Figure 3.3A: t = 50 sec). Sequestration of TMRE by energized mitochondria 
quenches its fluorescence, which reached a steady state following cell permeabilization (Figure 
3.3B). Thapsigargin (Tg) was added to inhibit the Sarco/Endoplasmic Reticular Calcium ATPase 
(SERCA), preventing Ca2+ uptake into the ER and releasing the ER Ca2+ stores into the bath 
solution (Figure 3.3A: t = 100 – 400 sec). Next, CGP37157 (CGP), an inhibitor of mitochondrial 
Na+/Ca2+-antiporter (NCLX)-mediated Ca2+ efflux, was added to isolate MCU as the only pathway 
for transport of Ca2+ between mitochondria and cytoplasm (Figure 3.3A: t = 400 – 700 sec). Upon 
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Figure 3.4. MCU+EMRE cells show similar uptake rates to WT 
cells but a reduced steady-state [Ca2+]c at which uptake ceases 
(A) Ca2+-uptake rates for WT and MCU+EMRE cells in response to 
bolus additions of CaCl2 that increase [Ca
2+]c by ~5 µM from n > 3 
independent experiments. Replicate measurements shown as 
hollow circles, boxes denote the 25th-75th percentile with line at 
median, error bars represent range of all measurements. P-values: 
pairwise comparison of MCU+EMRE with WT cells (n.s., not 
different; Welch’s unpaired t-test). Ca2+ uptake rates were not 
different between WT and MCU+EMRE cells. (B) Steady-state 
[Ca2+]c for cell lines in (A) measured 300 sec after bolus addition of 
~5 µM free-Ca2+. Each point (hollow circle) represents an 
independent experiment (n > 3 for each condition). P-values: 
comparison of MCU+EMRE with WT cells (**P < 0.01; Welch’s 
unpaired t-test). The gatekeeping ([Ca2+]c) threshold after uptake in 
MCU+EMRE cells was reduced (~500 nM) relative to WT levels 
(1.5-2 µM). 
reaching a steady-state [Ca2+]c following CGP treatment, acute addition of a Ca2+ bolus to the 
bath solution (i.e. cytoplasm) immediately elevated the [Ca2+]c to 8-10 µM, which was followed by 
clearance of Ca2+ in WT cells that reduced [Ca2+]c to a steady-state level between 1-2 µM over 
the subsequent 300 seconds (Figure 3.3A: t = 700 – 1000 sec; black trace). A transient increase 
in TMRE fluorescence was observed (Figure 3.3B) as Ca2+ influx into the matrix depolarized m, 
which then recovered within 50-100 seconds as [Ca2+]c approached a steady state due to closure 
of MCU. This steady state represents 
the [Ca2+]c threshold at which uptake 
ceases, one of the hallmarks of 
MICU1/2-mediated MCU gatekeeping. 
Finally, the mitochondrial uncoupler 
carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP) was added to 
dissipate m (Figure 3.3B), leading to 
a rapid increase in [Ca2+]c as the total 
mitochondrial matrix Ca2+ content was 
released (Figure 3.3A: t = 1000 – 1100 
sec). The TMRE fluorescence in CCCP 
was used to determine the relative m 
between experiments.  
Upon challenge with boluses of 
free Ca2+ that increased [Ca2+]c to ~10 µM, permeabilized MEKO cells exhibited no reduction in 
[Ca2+]c (Figure 3.3A: red trace) or change in m (Figure 3.3B: red trace), reflecting a lack of 
mitochondrial Ca2+ uptake, as expected. MEKO+MICU1 cells (Figure 3.3A-B: blue traces) or 
MEKO+MCU cells (Figure 3.3A-B: yellow traces) also exhibited no MCU activity, in agreement 
with previous findings that EMRE is required for MCU channel activity (Sancak et al., 
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Figure 3.5. MCU+EMRE cells exhibit constitutive Ca2+ uptake in the low [Ca2+]c regime  
(A) [Ca2+]c response to acute inhibition of NCLX-mediated Ca
2+-efflux for WT (black), WT+MICU1 (gray), 
MCU+EMRE (green), and MCU+EMRE+MICU1 (purple) cells measured with the high-affinity indicator Fura-2. 
Representative traces from n > 3 independent replicates for each cell line shown. Overexpression of MICU1-Flag in 
MCU+EMRE cells rescued gatekeeping at low (< 300 nM) [Ca2+]c. (B) Quantification of mitochondrial Ca
2+-uptake 
rate below 600 nM [Ca2+]c in response to inhibition of NCLX-mediated Ca
2+ efflux for cell lines in (A). Each point 
represents initial Ca2+-uptake rate from an independent experiment (n > 3 for each condition) determined by single-
exponential fit to reduction of [Ca2+]c. Replicate measurements shown as hollow circles, boxes: the 25th-75th 
percentile with line at median, error bars: range of all measurements. P-values: pairwise comparisons of each cell 
line with WT cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; Tukey's multiple 
comparisons test). 
2013)(Kovács-Bogdán et al., 2014)(Yamamoto et al., 2016). In contrast, MCU+EMRE cells 
(Figure 3.3A-B; Figure 3.4A: green) exhibited mitochondrial Ca2+ uptake rates and transient depo- 
larizations at [Ca2+]c of 8-10 µM similar to WT cells (Figure 3.3A-B; Figure 3.4A: black). 
Surprisingly, whereas the steady-state [Ca2+]c achieved 200-300 sec after uptake ceased was 
~1.5-2 µM in WT cells (Figure 3.4B: black), it was reduced to ~500 nM in MCU+EMRE cells 
(Figure 3.4B: green). Reduction to levels lower than those achieved in WT cells is a feature of 
impaired gatekeeping (Mallilankaraman et al., 2012b)(Csordás et al., 2013)(Kamer and Mootha, 
2014)(Payne et al., 2017)(Patron et al., 2014)(Kamer et al., 2017). To test this further, we 
measured MCU activity at low (100-600 nM) [Ca2+]c using the high-affinity indicator Fura-2 (KD = 
140 nM) following CGP addition. As discussed in Chapter 2, CGP was required because NCLX-
mediated mitochondrial Ca2+ efflux can mask MCU-mediated influx even in the absence of 
MICU1/2-mediated gatekeeping (Figure 2.3). Acute CGP addition (t = 400 sec) was without effect 
on [Ca2+]c in WT cells (Figure 3.5A-B: black) due to MICU1/2 gatekeeping. A reduction in [Ca2+]c 
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Figure 3.6. MCU+EMRE cells show an apparent loss of cooperative activation due to lack of gatekeeping  
(A-B) Mitochondrial Ca2+-uptake in suspensions of permeabilized WT (A) and MCU+EMRE (B) cells in response to 
acute increases of [Ca2+]c to between 0.1 - 10 µM. Individual representative traces from independent experiments 
with different bolus additions shown. (C) Ca2+-uptake rates for WT and MCU+EMRE cells in response to acute 
challenge with [Ca2+]c between 0.1 - 10 µM as a function of the [Ca
2+]c immediately after bolus addition plotted on a 
log10/log10 scale. Each point (hollow circle) represents an independent experiment. Solid lines: linear fits of Ca
2+-
uptake rate vs. [Ca2+]c to demonstrate cooperativity of MCU activation and highlight differences in Ca
2+-uptake rates 
at low (< 1 µM) [Ca2+]c. Slope of the best-fit line is related to the cooperativity of the transition of MCU from the closed 
to the open state, which is reduced in MCU+EMRE cells (slope = 1.6) relative to WT cells (slope = 2.8). 
following acute addition of CGP, reflecting constitutive MCU activity, was observed in MICU1 KO 
cells (Figure 2.3B: red trace), as expected due to lack of gatekeeping (Mallilankaraman et al., 
2012b)(Csordás et al., 2013)(Kamer and Mootha, 2014)(Payne et al., 2017)(Patron et al., 2014). 
Notably, MCU+EMRE cells exhibited significant constitutive Ca2+ uptake (Figure 3.5A-B: green), 
confirming a lack of fully-functional MICU1/2-mediated gatekeeping. MICU1/2 also mediate 
cooperative activation of MCU in response to higher [Ca2+]c (Csordás et al., 2013)(Payne et al., 
2017). Determination of the Ca2+-uptake rates in response to acute additions of Ca2+ between 
0.1 - 10 µM, plotted on a log/log scale, yielded a slope of ~2.8 in WT cells (Figure 3.6A&C: black), 
as previously observed (Payne et al., 2017).  In contrast, the slope was ~1.6 in MCU+EMRE 
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cells, suggesting reduced cooperativity (Figure 3.6B-C: green). However, this apparent loss of 
cooperative activation was due solely to constitutive channel activity at low (< 1-2 µM) [Ca2+]c, 
and not a loss of cooperative activation at higher [Ca2+]c as seen in MICU1 KO cells. Thus, 
gatekeeping and cooperative activation of MCU were uncoupled in MCU+EMRE cells, a novel 
phenomenon not previously seen in cells lacking MICU1 and/or MICU2 expression (Csordás et 
al., 2013)(Payne et al., 2017). 
Overexpression of MICU1 only partially restores gatekeeping in MCU+EMRE cells 
 
Although MICU1/2-dimer expression in MCU+EMRE cells was similar to that in WT cells 
(Figure 3.1A&C), we considered that because of the low EMRE:MCU expression ratio in these 
cells, gatekeeping was disturbed because most channels lacked enough EMRE to tether 
sufficient MICU1/2 dimers to the channels. Because MICU1 can directly associate with MCU 
(Paillard et al., 2018)(Phillips et al., 2019), we reasoned that over-expression of MICU1 in MCU-
EMRE cells could restore gatekeeping despite low EMRE expression by directly interacting with 
MCU. To test this, MICU1-Flag was stably expressed in MCU+EMRE cells (MCU+EMRE+MICU1 
cells) and in WT cells (WT+MICU1 cells). The expression level of MCU (Figure 3.7A-B) and the 
EMRE:MCU expression ratio (Figure 3.7C-D) were similar in MCU+EMRE+MICU1 and 
MCU+EMRE cells. MICU1-Flag homodimers were present in the MICU1-overexpressing cells 
(Figure 3.7E), because of its high expression relative to MICU1 in WT cells (Figure 3.7F).  
Nevertheless, MICU1/2 dimer expression in MCU+EMRE+MICU1 cells (Figure 3.7G-H: purple) 
was not different from WT, although a small reduction was observed relative to MCU+EMRE cells 
(Figure 3.7G-H: green). In contrast, it was increased 2-3-fold in the WT+MICU1 cells compared to 
WT (Figure 3.7G-H: gray).  
We measured MCU activity at low (100-600 nM) [Ca2+]c as described above. As 
expected, acute CGP addition was without effect on [Ca2+]c in WT+MICU1 cells (Figure 3.5A-B: 
gray) due to MICU1/2 gatekeeping. Whereas the MCU+EMRE cells exhibited significant 
constitutive Ca2+ uptake (Figure 3.5A-B: green), gatekeeping at low [Ca2+]c was restored in  
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Figure 3.7. MCU, MICU1/2-heterodimer, and MICU1-Flag homodimer expression in stable cell lines 
(A) Western blot for MCU and β-tubulin from whole-cell lysates of WT, WT+MICU1, MEKO+MICU1, MCU+EMRE 
and MCU+EMRE+MICU1 cells under reducing conditions. (B) Quantification of MCU western blot band intensity for 
cell lines in (A) (n > 6 independent experiments). Mean pixel density corrected for β-tubulin intensity and normalized 
to endogenous MCU band intensity in WT cells for each experiment. Replicate measurements shown as hollow 
circles, boxes: the 25th-75th percentile with line at median, error bars: range of all measurements. P-values above 
each box: pairwise comparisons of each cell line with WT cells (**P < 0.01; ****P < 0.0001; n.s., not different; 
Dunnett's multiple comparisons test) and p-value above green and purple bars: pairwise comparison of MCU+EMRE 
and MCU+EMRE+MICU1 cells (unpaired t test with Welch's correction). (C) Western blot for V5 and β-tubulin from 
whole-cell lysates of MCU+EMRE and MCU+EMRE+MICU1 cells under reducing conditions. EMRE-V5 is evident as 
a dim band at ~11 kDa while dark bands at ~35 kDa represent MCU-V5. (D) Quantification of the EMRE:MCU 
expression ratio for cells in (C) from V5 western blot band intensity (n > 7 independent experiments). Replicate 
measurements shown as hollow circles, boxes: 25th-75th percentile with line at median, error bars: range of all 
measurements. P-value: comparison of MCU+EMRE and MCU+EMRE+MICU1 cells (n.s., not different; unpaired t 
test with Welch's correction). (E) Western blot for Flag (MICU1) for cell lines in (B) under non-reducing conditions to 
preserve MICU1 homodimers (~110 kDa). (F) Western blot for MICU1 in mitochondria isolated from WT, 
MEKO+MICU1, MCU+EMRE and MCU+EMRE+MICU1 cells under reducing (left) and non-reducing conditions to 
preserve MICU1 homodimers (~110 kDa) (right). Expression of MICU1-Flag exceeds that of endogenous MICU1. (G) 
Western blot for MICU2 for cell lines in (A) under non-reducing conditions to preserve MICU1/2 heterodimers. The 
increase in molecular weight from 90 kDa to 100 kDa with MICU1-Flag expression is due to MICU1-Flag/MICU2 
heterodimers. (H) Quantification of MICU2 western blot band intensity for cell lines in (A) (n > 6 independent 
experiments) as described in (B). Replicate measurements shown as hollow circles, boxes: 25th-75th percentile with 
line at median, error bars: range of all measurements. P-values above each box: pairwise comparisons of each cell 
line with WT cells (**P < 0.01; ****P < 0.0001; n.s., not different; Dunnett's multiple comparisons test) and p-value 
above green and purple bars: pairwise comparison of MCU+EMRE and MCU+EMRE+MICU1 cells (unpaired t test 
with Welch's correction).  
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Figure 3.8. Gatekeeping is only partially restored in MCU+EMRE+MICU1 cells 
(A-B) Mitochondrial Ca2+-uptake in suspensions of permeabilized WT+MICU1 (A) and MCU+EMRE+MICU1 (B) cells 
in response to acute increases of [Ca2+]c to between 0.1 - 10 µM. Individual representative traces from independent 
experiments with different bolus additions shown. (C) Ca2+-uptake rates for WT+MICU1 and MCU+EMRE+MICU1 
cells in response to acute challenge with [Ca2+]c between 0.1 - 10 µM as a function of the [Ca
2+]c immediately after 
bolus addition plotted on log10/log10 scale. Each point (hollow circle) represents an independent experiment. Solid 
lines: linear fits of Ca2+-uptake rate vs. [Ca2+]c. Cooperativity of MCU activation is identical between WT and 
WT+MICU1 cells (slope = 2.8), while MCU+EMRE+MICU1 cells show increased cooperativity (slope = 2.1) relative 
to MCU+EMRE cells (slope = 1.6). (D) Ca2+-uptake rates for WT, WT+MICU1, MCU+EMRE, and 
MCU+EMRE+MICU1 cells in response to bolus additions of CaCl2 that increase [Ca
2+]c by ~5 µM (n > 3 independent 
experiments). Replicate measurements shown as hollow circles, boxes: the 25th-75th percentile with line at median, 
error bars: range of all measurements. P-values: pairwise comparison of each cell line with all other cell lines (*P < 
0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; Tukey's multiple comparisons test). Ca2 -uptake 
rates were similar between all cell lines shown. (E) Steady-state [Ca2+]c for cell lines in (D) measured 300 sec after 
bolus addition of 0.1 - 10 µM Ca2+ plotted as function of the initial peak [Ca2+]c achieved immediately after addition. 
Each point (hollow circle) represents an independent experiment (n > 12 for each condition). Solid lines: one-phase 
association fits of steady-state [Ca2+]c vs. the initial [Ca
2+]c after addition. (F) Comparison of gatekeeping-threshold 
[Ca2+]c from non-linear fits in (E). Bars: mean of the plateau parameter for each fit +/- SEM. P-values: comparison of 
each cell line with all other cell lines (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; Tukey's 
multiple comparisons test). 
 
MCU+EMRE+MICU1 cells (Figure 3.5A-B: purple). This result suggests that gatekeeping can be 
reconstituted by EMRE-independent association of MICU1 with MCU. Ca2+-uptake rates in 
response to Ca2+ boluses that elevated [Ca2+]c by ~5 µM were not different between WT (Figure 
3.6A), WT+MICU1 (Figure 3.8A), MCU+EMRE (Figure 3.5B) and MCU+EMRE+MICU1 (Figure 
3.8B) cells (Figure 3.8D). There was an apparent increase in cooperative channel activation in 
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MCU+EMRE+MICU1 cells (slope ~2.1) (Figure 3.8C: purple) relative to MCU+EMRE cells (slope 
~1.6) (Figure 3.6C: green), but this could be attributed solely to the restoration of gatekeeping at 
low [Ca2+]c. Cooperativity of MCU activation was similar between the WT (Figure 3.6C: black) and 
WT+MICU1 (Figure 3.8C: gray) cells (slope ~2.8 for both). The normal threshold [Ca2+]c for MCU 
activation was observed in WT and WT-MICU1 cells (~1.5 µM – Figure 3.8E-F), despite 
enhanced expression of MICU1 and 2.  In contrast, the threshold in MCU+EMRE+MICU1 cells 
was ~800 nM (Figure 3.8E-F: purple), still below that observed in WT cells. Thus, whereas 
MICU1 overexpression restored gatekeeping at low [Ca2+]c in MCU+EMRE cells, presumably by 
directly interacting with MCU, it was insufficient to fully restore normal gatekeeping. We 
hypothesized that the low EMRE:MCU ratio in MCU+EMRE+MICU1 cells resulted in sub-
stoichiometric association of EMRE with MCU that enabled channel gating but was insufficient to 
tether enough MICU1/2 dimers to reconstitute fully-functional gatekeeping.  
 
Increasing EMRE expression enhances MICU1/2-mediated gatekeeping  
 
To test this hypothesis, we increased the EMRE:MCU ratio by enhancing steady-state 
EMRE expression. Under normal conditions, mitochondrial proteins AFG3L2 and SPG7 assemble 
in the matrix and comprise mAAA proteases that degrade EMRE in the IMM (Tsai et al., 
2017)(König et al., 2016). Substitution of a proline (P) residue with isoleucine (I) at amino acid 
position 76 in EMRE inhibits its degradation, increasing its expression without affecting channel 
function or gatekeeping (Tsai et al., 2017) (Figure 3.9A-B). We stably overexpressed C-terminal 
V5-tagged P76I-EMRE and MCU along with MICU1-Flag (to ensure sufficient MICU1 expression 
to occupy all functional EMRE:MCU complexes) in the MEKO background (MCU+P76I-
EMRE+MICU1 cells) and assessed expression levels of various components of the channel 
complex by western blot. EMRE expression was increased ~6-fold in MCU+P76I-EMRE+MICU1 
cells compared with MCU+EMRE+MICU1 cells (Figure 3.10A-B), whereas expression of MCU 
(Figure 3.10C-D) and MICU1/2 (Figure 3.10E-F) were similar between the two lines. Assuming 
random assembly of MCU/EMRE complexes, > 95% of MCU tetramers are predicted to associate  
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Figure 3.9. The EMRE [P76I] mutation does not affect MCU channel function or gatekeeping 
(A) Mitochondrial Ca2+-uptake in suspensions of permeabilized WT (black trace) or EMRE KO cells stably expressing 
either EMRE-V5 (red trace) or P76I-EMRE-V5 (orange trace) in response to acute 5 µM increases of [Ca2+]c. Traces 
are representative of n > 3 independent experiments. (B) [Ca2+]c response to acute addition of CGP37157 to inhibit 
NCLX-mediated Ca2+ efflux for cell lines in (A) measured with the high-affinity indicator Fura-2. No uptake below 500 
nM [Ca2+]c observed in any of the cell lines tested.  
 
with three or four EMRE subunits in these cells (Figure 3.10G: orange), in contrast to the one or 
two in the cells expressing WT EMRE (MCU+EMRE+MICU1 cells – Figure 3.10G: purple).  
In the low-[Ca2+]c regime, no differences in Ca2+ uptake were observed between WT, 
WT+MICU1, MCU+EMRE+MICU1 and MCU+P76I-EMRE+MICU1 cells (Figure 3.11A), indicating 
that MICU1/2-mediated gatekeeping at low [Ca2+]c was intact. In the higher-[Ca2+]c regime (8-10 
µM), the rate of Ca2+ uptake (Figure 3.11B-C) and cooperative activation (Figure 3.11B&D) were 
similar in MCU+EMRE+MICU1 and MCU+P76I-EMRE+MICU1 cells. Importantly, the steady-state 
[Ca2+]c achieved after uptake was significantly higher (~1.8 µM) than in MCU+EMRE+MICU1 cells 
(~800 nM) (Figure 3.11E-F). These results indicate that increasing the EMRE:MCU ratio elevates 
the [Ca2+]c threshold required for relief of MICU1/2-mediated gatekeeping. Together, the data 
imply that MCU can associate with fewer than 4 EMRE molecules per channel, which is sufficient 
to reconstitute channel activity and cooperative channel activation but insufficient to fully 
reconstitute MICU1/2-mediated channel gatekeeping. These results suggest that MCU activity 
can be differentially modulated by the number of EMRE subunits associated with the channel  
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Figure 3.10. The EMRE mutation [P76I] stabilizes EMRE expression  
(A) Western blot for V5 and β-tubulin from whole-cell lysates of WT, WT+MICU1, MEKO+MICU1, 
MCU+EMRE+MICU1 MCU+P76I-EMRE+MICU1 cells under reducing conditions. (B) Quantification of EMRE:MCU 
expression ratio from V5 western-blot band intensity for whole-cell lysates of MCU+EMRE+MICU1 and MCU+P76I-
EMRE+MICU1 cells (n > 5 independent experiments). Ratio calculated by dividing mean pixel density of EMRE-V5 
band by mean pixel density of MCU-V5 band for each experiment. Replicate measurements shown as hollow circles, 
boxes: 25th-75th percentile with line at median, error bars: range of all measurements. P-value: comparison of 
MCU+EMRE+MICU1 cells with MCU+P76I-EMRE+MICU1 cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; 
n.s., not different; unpaired t test with Welch's correction). The EMRE:MCU expression ratio in MCU+P76I-
EMRE+MICU1 cells is 0.92 +/- 0.21 (Mean +/- SD). (C) Western blot for MCU and β-tubulin from whole-cell lysates 
of cell lines in (A) under reducing conditions. (D) Quantification of MCU western-blot band intensity for cells in (B) (n 
> 5 independent experiments). Mean pixel density corrected for β-tubulin intensity and normalized to endogenous 
MCU band intensity in WT cells for each experiment. Replicate measurements shown as hollow circles, boxes: 25th-
75th percentile with line at median, error bars: range of all measurements. P-value: comparison of 
MCU+EMRE+MICU1 cells with MCU+P76I-EMRE+MICU1 cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; 
n.s., not different; unpaired t test with Welch's correction). (E) Western blot for MICU2 (top) and Flag (MICU1 - 
bottom) from whole-cell lysates of cell lines in (A) under non-reducing conditions. (F) Quantification of MICU2 
western blot band intensity from (E) (n > 5 independent experiments). Mean pixel density corrected for β-tubulin 
intensity and normalized to endogenous MICU2 band intensity in WT cells for each experiment. Replicate 
measurements shown as hollow circles, boxes: 25th-75th percentile with line at median, error bars: range of all 
measurements. P-values above each box: comparison of each cell line with WT cells (*P < 0.05; **P < 0.01; ***P < 
0.001; ****P < 0.0001; n.s., not different; Dunnett's multiple comparisons test) and p-value above line spanning green 
and purple bars: pairwise comparison of MCU+EMRE+MICU1 and MCU+P76I-EMRE+MICU1 cells (unpaired t test 
with Welch's correction). (G) Probability-distribution histogram of the expected number of EMRE subunits per MCU 
channel in MCU+EMRE+MICU1 and MCU+P76I-EMRE+MICU1 cells based on mean EMRE:MCU expression ratios 
calculated in (B). Points represent mean probability of obtaining 0, 1, 2, 3, or 4 EMRE subunits per channel based on 
binomial distribution. Solid lines: spline fits of all data points. EMRE:MCU expression ratio in MCU+P76I-
EMRE+MICU1 cells predicts that > 95% of MCU tetramers associate with 3 or 4 EMRE subunits. 
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Figure 3.11. Increasing EMRE expression enhances MICU1/2-mediated gatekeeping 
(A) [Ca2+]c response to acute inhibition of NCLX-mediated Ca
2+-efflux for WT, WT+MICU1, MCU+EMRE+MICU1 and 
MCU+P76I-EMRE+MICU1 cells measured with the high-affinity indicator Fura-2. Representative traces from n > 3 
independent replicates for each cell line shown. (B) Mitochondrial Ca2+ uptake in suspensions of permeabilized 
MCU+P76I-EMRE+MICU1 cells in response to acute increases of [Ca2+]c to between 0.1 - 10 µM. Individual traces 
from independent experiments with series of bolus additions shown. The gatekeeping threshold in MCU+P76I-
EMRE+MICU1 cells was restored to WT levels. (C) Ca2+-uptake rates for MCU+EMRE+MICU1 and MCU+P76I-
EMRE+MICU1 cells in response to bolus additions of CaCl2 that increase [Ca
2+]c by ~5 µM (n > 3 independent 
experiments). Replicate measurements shown as hollow circles, boxes: 25th-75th percentile with line at median, error 
bars: range of all measurements. P-values: comparison of MCU+EMRE+MICU1 cells with MCU+P76I-
EMRE+MICU1 cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; unpaired t test with 
Welch's correction).  (D) Ca2+-uptake rates between 0.1 - 10 µM [Ca2+]c measured in (B and Figure 3.8B) plotted on 
log10/log10 scale. Each point (hollow circle) represents an independent experiment. Solid lines: linear fits of (log10) 
Ca2+-uptake rate vs. (log10) [Ca
2+]c. Slope of the best-fit line is a measure of the cooperativity of the MCU transition 
from closed- to the open-state, which was similar between MCU+EMRE+MICU1 and MCU+P76I-EMRE+MICU1 
cells. (E) Steady-state [Ca2+]c for experiments in (D) measured 300 sec after bolus addition of 0.1 - 10 µM Ca
2+ 
plotted as function of the initial peak [Ca2+]c achieved immediately after addition. Each point (hollow circle) represents 
an independent experiment (n > 12 for each condition). Solid lines: one-phase association fits of steady-state [Ca2+]c 
vs. the initial [Ca2+]c after addition. (F) Comparison of gatekeeping-threshold [Ca
2+]c from non-linear fits in (E). Bars: 
mean of plateau parameter for each fit +/- SEM. P-value: comparison of MCU+EMRE+MICU1 cells with MCU+P76I-
EMRE+MICU1 cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; unpaired t test with 
Welch's correction). The gatekeeping threshold in MCU+P76I-EMRE+MICU1 was elevated relative to 
MCU+EMRE+MICU1 cells. 
 
 
complex, likely by determining the number of MICU1/2-dimers associated with it. Accordingly, a 4 
EMRE:1 channel stoichiometry may not be fixed in cells. 
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Creation of MCU-EMRE concatemers to form channels with fixed EMRE:MCU stoichiometries 
 
Co-expression of MCU and EMRE at known ratios cannot determine the stoichiometries 
of the two proteins in the functional channel complex. To address this, we created a system in 
which we could establish fixed EMRE:MCU stoichiometries. We expressed a synthetic protein in 
which a truncated EMRE (N30 a.a.) peptide containing a C-terminal V5 tag was fused to the C-
terminus of MCU (Figure 3.12A). This construct was previously shown to reconstitute MCU 
channel activity in the absence of endogenous MCU and EMRE expression (Tsai et al., 2016). 
We stably transfected the MCU-EMRE fusion protein (hereafter referred to as ME) in MEKO cells. 
Western blotting for V5 demonstrated that the fusion protein was expressed at the expected size 
but probing with an -MCU antibody revealed the presence of a smaller band at the approximate 
molecular weight of MCU (Figure 3.13A). We surmised that this was caused by proteolytic 
cleavage. To minimize this degradation, we introduced the P76I mutation into the ME concatemer 
(ME[P76I]). The degradation observed with the original construct was mitigated by expression of 
the mutant construct (Figure 3.13A).  
Expression of ME[P76I] in MEKO cells is predicted to result in a 1:1 EMRE:MCU 
stoichiometry in all channel complexes (Figure 3.12B). We also created MCU-EMRE[P76I] fusion 
proteins with two, three or four concatenated MCU subunits fused to P76I-EMRE (hereafter 
referred to as MME, MMME and MMMME respectively). MME is predicted to dimerize, forming 
complexes with two EMRE subunits/MCU channel (Figure 3.12C), and MMMME is predicted to 
form complexes with one EMRE subunit/MCU tetramer. In contrast, MMME should be unable to 
form tetramers in MEKO cells, although alternate assemblies (e.g. hexamers) may form that still 
retain channel activity (Figure 3.12D). MEKO cells were stably transfected with each concatemer 
together with MICU1-Flag to ensure sufficient MICU1. Three clones were identified for each 
condition and whole-cell lysates were analyzed for MCU and MICU1/2-heterodimer expression by 
western blot (Figure 3.13B). Surprisingly, the MMMME construct failed to express (Figure 3.13E). 
Thus, to create channels with a single EMRE subunit/MCU tetramer, the MMME concatemer and 
MICU1-Flag were expressed in EMRE KO (HEK-293T) cells (Figure 3.12E) and three stable  
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clones were isolated as described. The presence of endogenous MCU in these cells should allow 
a single MCU monomer to associate with the MMME concatemer to form tetrameric channel  
complexes containing only one EMRE subunit. To probe the integrity of each concatemer, 
mitochondria were isolated from selected clones and analyzed by western blot. The ME[P76I],  
Figure 3.12 
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Figure 3.12. Creation of MCU-EMRE concatemers to form channels with fixed EMRE:MCU stoichiometries 
(A) The MCU-EMRE fusion protein comprised of full-length MCU fused directly to an EMRE peptide with the 30-
residue mitochondrial-targeting sequence truncated from its N-terminus, followed by C-terminal V5 tag. (B) Assembly 
of the ME concatemer (ME[P76I]) enforces a 1:1 EMRE:MCU stoichiometry in all channel complexes when 
expressed in MEKO cells. (C) The MME concatemer assembles as an MCU tetramer containing 2 EMRE subunits in 
MEKO cells. (D) The MMME concatemer cannot assemble as an MCU tetramer, but formation of hexamers or other 
higher-order oligomers may lead to assembly of functional channels in MEKO cells. (E) Expression of MMME in 
EMRE KO cells allows formation of channel complexes containing a single EMRE subunit due to the presence of 
endogenous MCU monomers. (F) Western blot for MCU and Hsp60 in isolated mitochondria from representative 
clones of WT+MICU1, MEKO+ME[P76I]+MICU1, MEKO+MME+MICU1, MEKO+MMME+MICU1 or EMRE 
KO+MMME+MICU1 cells under reducing conditions. (G) Quantification of molecular weight from normalized band 
intensity for -MCU western blots in (F). Traces: mean of n = 3 replicate experiments. A single ~40 kDa band was 
observed in cells expressing ME[P76I]; MME exhibited bands at ~80 and 160 kDa; MMME ran at ~110 and 220 kDa. 
Band at ~35 kDa in EMRE KO+MMME+MICU1 cells represents endogenous MCU. (H) Immunofluorescence 
microscopy for V5 (MCU-EMRE concatemers), Flag (MICU1) and DAPI in representative clones of cell lines in (F). 
All cell lines tested showed strong colocalization of both tags in mitochondria. 
 
MME, and MMME concatemers were all predominantly expressed as full-length proteins 
(ME~40kDa; MME~80 kDa, and MMME~110 kDa respectively - Figure 3.12F-G). Localization of 
each concatemer and MICU1-Flag to mitochondria was confirmed by confocal 
immunofluorescence microscopy (Figure 3.12H). It was possible to compare MCU expression 
levels in ME[P76I] clones with that in WT cells as this concatemer exhibited a single band in 
western blots and contained a single MCU epitope. ME[P76I] was ~2-fold overexpressed in one 
clone (#3), modestly (< 2-fold) overexpressed in a second clone (#1), and slightly lower (~2-fold) 
than WT cells in a third clone (#2) (Figure 3.13C). The presence of high molecular weight bands 
in cells expressing MME and MMME made it difficult to assess the relative MCU levels. This was 
further confounded by possible differences in MCU antibody binding to fusion proteins containing 
multiple MCU subunits. We therefore employed V5-epitope ELISA assays on each clonal cell line. 
Based on the relationship in ME[P76I] clone #2 between western blot expression and the relative 
number of V5-binding sites per cell, the MCU expression level was estimated to vary by only 2-
fold in the different concatemeric clones (Figure 3.14A). MICU1/2 dimer expression in all clones 
was at least as high as in WT cells (Figure 3.13B&D). 
We assessed mitochondrial Ca2+ uptake in each cell line at both high (5-8 µM) and low (< 
600 nM) [Ca2+]c to determine (i) whether each concatemer was sufficient to form functional 
channels in the absence of endogenous MCU or EMRE expression, and (ii) if the channels 
exhibited MICU1/2-mediated gatekeeping. Each concatemer reconstituted MCU activity, with  
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some variability among clones in the Ca2+-uptake rates (ranging from ~100 to 400 nM/sec) in 
response to 5 µM Ca2+ boluses (Figure 3.14B). Six out of twelve clones displayed intact 
gatekeeping at low (< 600 nM) [Ca2+]c (Figure 3.14C). For further analysis, we selected individual 
clones for each concatemeric construct that had mean Ca2+-uptake rates at 5-8 µM [Ca2+]c most 
similar to WT cells and intact gatekeeping in the low-[Ca2+]c regime (Figure 3.14A-C – red 
arrows). For each, we measured both the Ca2+-uptake rates in response to 0.1 - 10 µM [Ca2+]c  
Figure 3.13 
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Figure 3.13. MCU and MICU1/2 expression in MCU-EMRE concatemer cell lines 
(A) Western blot for V5 (top) and MCU (bottom) for whole-cell lysates of clonal MEKO cells stably-expressing ME 
(WT) (lane 1) or ME[P76I] (lanes 2-5). The EMRE [P76I] mutation prevents degradation of the ME concatemer in 
three of four clones. (B) Western blot for MCU, MICU2 (under non-reducing conditions) and β-tubulin from whole-cell 
lysates of WT, MEKO+MICU1, three clones of WT+MICU1, and three clones each of MEKO cells expressing 
ME[P76I]+MICU1, MME+MICU1, or MMME+MICU1. MICU1-Flag overexpression in each clone is evident from the 
increase in molecular weight of MICU1/2 dimers under non-reducing conditions. (C) Quantification of MCU western 
blot band intensity from whole-cell lysates of WT, MEKO+MICU1, WT+MICU1 and three clones of 
MEKO+ME[P76I]+MICU1 cells (n > 3 independent experiments). Mean pixel density corrected for β-tubulin intensity 
and normalized to endogenous MCU band intensity in WT+MICU1 cells for each experiment. Replicate 
measurements shown as hollow circles, boxes: 25th-75th percentile with line at median, error bars: range of all 
measurements. P-values: comparison of each cell line with WT cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 
0.0001; n.s., not different; Dunnett’s multiple comparisons test). (D) Quantification of MICU2 western blot band 
intensity for cells in (B) from n > 3 independent experiments quantified as described in (C). Replicate measurements 
shown as hollow circles, boxes: 25th-75th percentile with line at median, error bars: range of all measurements. Total 
MICU1/2 dimer expression is higher than WT in all cell lines expressing MICU1-Flag. (E) Western blot for V5 and 
Hsp60 of isolated mitochondria from representative clones of WT+MICU1, MEKO+MICU1, 
MEKO+ME[P76I]+MICU1, MEKO+MME+MICU1 and MEKO+MMMME+MICU1 cells under reducing conditions. No 
detectable MMMME expression observed. 
 
and the subsequent steady-state [Ca2+]c at which gatekeeping was re-established (Figure 3.15A-
D). Plotting the uptake rate as a function of the peak [Ca2+]c immediately after Ca2+ addition and 
fitting the data to a Hill equation revealed similar profiles for the different concatemers, with the 
rate for cells expressing ME[P76I] notably right-shifted to higher [Ca2+]c (Figure 3.15E). Linear fits 
of the data on a log/log scale showed that cooperativity in the transition of MCU from the closed- 
to the open-state was the same for each concatemer (slope = 2.5), and similar to WT+MICU1 
cells (Figure 3.15F), suggesting that MICU1/2 regulation was properly coupled to the channel in 
each concatemeric complex. However, the threshold at which gatekeeping was re-established for 
each concatemer (Figure 3.15G) was elevated uniquely in cells expressing ME[P76I] (Figure 
3.15H). This result is consistent with the right-shifted Ca2+-dependence of MCU activation 
observed in these cells and suggests that gatekeeping is particularly potent in MCU complexes 
containing 4 EMRE/channel. In contrast, the gatekeeping threshold in cells expressing 
concatemers predicted to form channels with fewer than 4 EMRE subunits were not different from 
WT (Figure 3.15H). These results strongly suggest that channels containing 4 EMRE subunits 
tether more MICU1/2 dimers to the channel complex than are normally present in WT cells, 
consistent with the analysis above that EMRE:MCU stoichiometry, and by analogy, the MICU1/2 
dimer:MCU stoichiometry, may not be 4:4 or invariant in cells. This is also consistent with prior 
studies showing that the relative MICU1 and MCU stoichiometry in cells from different tissues 
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Figure 3.14. Biochemical and functional characterization of MCU-EMRE concatemers in clonal cell lines 
(A) ELISA quantification of V5 expression for three clones each of WT+MICU1 (pooled), MEKO+ME[P76I]+MICU1, 
MEKO+MME+MICU1, MEKO+MMME+MICU1 and EMRE KO+MMME+MICU1. Bars: mean of Bmax parameter for 
each fit +/- SEM (n = 3). Red arrows: lowest expressing clone for each condition. (B) Quantification of mitochondrial 
Ca2+-uptake rates in response to bolus additions to raise [Ca2+]c by 5 µM for cell lines in (A). Each point represents 
initial Ca2+-uptake rate from an independent experiment (n > 3 for each condition) determined by single-exponential 
fit to reduction of [Ca2+]c. Replicate measurements shown as hollow circles, bars: mean +/- SEM. Clones with mean 
uptake rates most closely approximating WT for each condition shown by red arrows. (C) Quantification of 
mitochondrial Ca2+-uptake rate below 600 nM [Ca2+]c in response to inhibition of NCLX-mediated Ca
2+ efflux for cell 
lines in (A). Each point represents initial Ca2+-uptake rate from an independent experiment (n > 3 for each condition) 
determined by single-exponential fit to reduction of [Ca2+]c. Replicate measurements shown as hollow circles, bars: 
mean +/- SEM. Clones with uptake rates < 0 nM/sec (denoted by red arrows) exhibit intact gatekeeping at low 
[Ca2+]c. 
 
affects both the [Ca2+]c gatekeeping threshold and cooperativity of gatekeeping (Paillard et al., 
2017). 
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Figure 3.15 
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Figure 3.15. Function of MCU-EMRE concatemers 
(A-D) Mitochondrial Ca2+ uptake in suspensions of permeabilized MEKO+ME[P76I]+MICU1 (A), 
MEKO+MME+MICU1 (B), MEKO+MMME+MICU1 (C) and EMRE KO+MMME+MICU1 (D) cells in response to acute 
increases of [Ca2+]c to between 0.1 - 10 µM. Individual traces from independent experiments with different bolus 
additions shown. (E) Ca2+-uptake rates for cell lines in (A-D) in response to challenge with [Ca2+]c between 0.1 - 10 
µM. Each point (hollow circle) represents an independent experiment. Solid lines: Hill equation fits of Ca2+-uptake 
rate vs. initial [Ca2+]c after bolus addition. ME[P76I]+MICU1 cells exhibited a right-shift in the [Ca
2+]c-dependence of 
MCU activation compared to all other cell lines. (F) Ca2+-uptake rates between 0.1 - 10 µM [Ca2+]c measured in (E) 
plotted on log10/log10 scale. Each point (hollow circle) represents an independent experiment. Solid lines: linear fits of 
(log10) Ca
2+-uptake rate vs. (log10) [Ca
2+]c. Slope of the best-fit line is a measure of the cooperativity of the MCU 
transition from closed- to the open-state, which was similar among all cell lines. (G) Steady state [Ca2+]c for cells in 
(E) measured 300 sec after bolus addition of 0.1 - 10 µM Ca2+ plotted as a function of initial peak [Ca2+]c immediately 
after addition. Each point (hollow circle) represents independent experiment (n > 6 for each condition). Solid lines: 
one-phase association fits of steady-state gatekeeping-threshold [Ca2+]c vs. initial [Ca
2+]c after addition. (H) 
Comparison of gatekeeping-threshold [Ca2+]c 300 sec after bolus additions of Ca
2+ from non-linear fits in (G). Bars: 
mean of plateau parameter for each fit +/- SEM. P-values: pairwise comparisons of each cell line with WT+MICU1 
cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; Tukey’s multiple comparisons test). The 
gatekeeping threshold [Ca2+]c was elevated in ME[P76I]+MICU1 cells compared to all other cell lines. 
 
Biochemical analyses of complexes formed by MCU-EMRE concatemers 
To compare the relative sizes of channel complexes in cells expressing MCU-EMRE 
concatemers with endogenous complexes, we performed BN-PAGE western blotting of MCU 
from isolated mitochondria. The MCU complex in WT cells ran as a single band at ~440 kDa 
(Figure 3.16A,C-D&F: black), in line with previous reports (Sancak et al., 2013)(König et al., 
2016). Overexpression of MICU1-Flag in WT cells had no effect on the size of the complex 
(Figure 3.16A,C-D&F: gray). In addition, MCU ran at approximately the same size in MICU1 KO 
mitochondria as in WT mitochondria (Figure 3.16A,C-D&F; red), with a minor band of lower 
molecular weight similar in size to that observed in EMRE KO mitochondria (~350 kDa) (Figure 
3.16A,C-D&F: orange). This result is consistent with a previous report that MICU1 may stabilize 
interactions between MCU and EMRE, and that MCU-containing bands at ~440 kDa do not 
contain MICU proteins (König et al., 2016). Re-probing the same blots with an -Flag antibody 
revealed that MICU1 assembled in complexes of ~250 and ~400 kDa in the absence of MCU and  
EMRE (Figure 3.16B) further indicating that complexes at ~440 kDa detected with the -MCU 
antibody contained only MCU and EMRE subunits.  
Importantly, complexes from mitochondria expressing ME[P76I] with an enforced 1:1 
EMRE:MCU stoichiometry (Figure 3.16A,C,E-F: blue) were significantly larger (~490 kDa) than  
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those observed in WT or WT+MICU1 mitochondria, suggesting that endogenous MCU channels 
contain fewer than four EMRE subunits. A minor band at ~700 kDa was observed in ME[P76I] 
mitochondria, possibly corresponding to a dimer of MCU tetramers. Bands at ~440 and ~700 kDa 
were also seen in mitochondria from cells expressing MME and MMME, although higher 
molecular weight oligomers were evident (Figure 3.16A&C: pink, gold, and green). This could 
indicate a tendency for the concatemers to form complexes containing more than one MCU 
channel. Importantly, analysis of only the lowest molecular weight bands revealed that MME and  
Figure 3.16 
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Figure 3.16. Biochemical analyses of channel complexes formed by MCU-EMRE concatemers 
(A) BN-PAGE MCU western blot of mitochondria isolated from WT, MICU1 KO, EMRE KO, MEKO+MICU1 cells and 
representative clones of WT+MICU1, MEKO+ME[P76I]+MICU1, MEKO+MME+MICU1, MEKO+MMME+MICU1, and 
EMRE KO+MMME+MICU1 cells. Endogenous MCU channel complexes observed as single band at ~440 kDa. (B) 
BN-PAGE western blot for Flag (MICU1) in mitochondria isolated from representative clones of MEKO+MICU1, 
WT+MICU1, MEKO+ME[P76I]+MICU1, MEKO+MME+MICU1, MEKO+MMME+MICU1, and EMRE 
KO+MMME+MICU1 cells. MICU1 formed complexes at ~250 and ~400 kDa in cells lacking MCU and EMRE. (C) 
Quantification of raw intensity and molecular weight from -MCU BN-PAGE western blots in (A). Traces: mean of n = 
3 replicate experiments. All MCU-EMRE concatemers showed bands between 300-600 kDa (similar to WT cells), as 
well as bands at > 700 kDa that likely represent complexes containing > 4 MCU subunits. (D-E) Molecular-weight 
profile of the smallest band (200-600 kDa) from -MCU BN-PAGE western blots of cell lines in (C). Traces: mean of 
n = 3 replicate experiments. Data are normalized to band with maximal intensity for each condition. (D) MCU 
complexes in MICU1 KO cells (red) were similar to WT (+/- MICU1 – black & gray), with a minor band similar in size 
to complexes formed in EMRE KO cells (orange). (E) Concatemers of MCU and EMRE exhibited molecular weights 
that varied in size proportionally to the predicted number of EMRE subunits per complex. (F) Statistical analysis of 
molecular weight profiles in (D-E). Replicate measurements shown as hollow circles (n = 3). Bars: mean calculated 
size of each complex derived from peak intensity of band between 200-600 kDa +/- SEM. P-values: pairwise 
comparisons of each cell line with WT cells (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; n.s., not different; 
Dunnett’s multiple comparisons test). Complexes with 4 EMRE subunits per channel (ME[P76I] – blue) were 
significantly larger than those in WT cells (black), while complexes containing only 1 EMRE subunit (EMRE 
KO+MMME – green) were smaller. 
 
MMME complexes were not different in size from endogenous channels (Figure 3.16E-F: pink 
and gold). Interestingly, complexes in EMRE KO cells expressing MMME, which are predicted to 
contain a single EMRE subunit, were significantly smaller than those in WT cells (Figure 
3.16A,C,E-F: green), suggesting that endogenous MCU channels associate with more than one 
EMRE. 
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CHAPTER 4: Conclusions and Future Directions 
 
MICU2 restricts spatial crosstalk between InsP3R and MCU channels by regulating 
threshold and gain of MICU1-mediated inhibition and activation of MCU  
 
 In Chapter 2, I have quantitatively described the roles of MICU1 and MICU2 in regulating 
MCU activity in situ over a full range of [Ca2+]c experienced by the channel under resting 
conditions and during agonist stimulation. We found that each protein plays important but distinct 
roles in both the inhibition of MCU-channel activity in the low-[Ca2+]c regime and in the highly 
cooperative activation of the channel as [Ca2+]c is elevated. Our studies clarify the specific 
functions of each MICU protein in MCU gatekeeping and highlight the requirement for Ca2+ 
binding to three or all four EF-hand domains in the MICU1/2 dimer to activate mitochondrial Ca2+ 
uptake.   
MICU1 and MICU2 have distinct roles in MCU inhibition   
 
In the low-[Ca2+]c regime approximating resting-cytoplasmic conditions, MICU1, but not 
MICU2, plays a fundamental role in the suppression of MCU activity referred to as “gatekeeping”. 
In the absence of MICU1, MCU becomes constitutively active, in agreement with previous reports 
(Mallilankaraman et al., 2012b)(Csordás et al., 2013)(Patron et al., 2014)(Liu et al., 2016). 
Whereas some previous studies were confounded by reduced MICU2 expression in cells with 
MICU1 knocked-down or deleted, here we observed similar constitutive activity even when 
MICU2 was re-expressed to normal levels in MICU1 KO cells. Thus, MICU2 is not the dominant 
mechanism of gatekeeping as previously suggested (Patron et al., 2014). Constitutive MCU 
activity in MICU1 KO cells activates NCLX-mediated Ca2+ extrusion, but this is insufficient to 
defend normal resting [Ca2+]m. Thus, in the absence of MICU1, constitutive influx and efflux 
constitutes an ongoing Ca2+ cycling across the IMM that establishes a new, higher steady state 
[Ca2+]m. This could in part explain the disease phenotypes observed in patients with loss-of-
function mutations in MICU1. 
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Figure 4.1. Model for MICU1-MICU2 regulation of MCU at resting [Ca2+]c  
MICU2 tunes MCU activation by elevating the [Ca2+]c threshold for relief 
of MICU1-mediated inhibition of MCU. 
 
 
We found that MICU2 is not required for channel gatekeeping. Deciphering its role has 
been complicated by the fact that it requires MICU1 for its association with MCU. Here we 
demonstrated that MICU2 deletion leaves channel inhibition intact, indicating that MICU1 
homodimers are capable of inhibiting MCU-channel activity in low [Ca2+]c. Although MICU2 is 
dispensable for inhibition of MCU in the low-[Ca2+]c regime (50-500 nM), it nevertheless plays a 
role in regulating MICU1-mediated gatekeeping by tuning the normal threshold for relief of 
channel inhibition. Deletion of MICU2 lowered the [Ca2+]c threshold for relief of inhibition from 
~1.3 µM in WT cells to ~500 nM. Thus, in the range of [Ca2+]c between 500 nM and ~1.5 µM, 
MICU2 plays a critical role by tuning the activity of MICU1 to inhibit MCU (Figure 4.1). Under 
normal conditions with both MICU proteins present in a heterodimeric complex, the Ca2+-binding 
EF hands appear to play little or no role in MCU channel inhibition in the low-[Ca2+]c regime. Since  
mutation of EF hands did not 
affect heterodimer formation or 
association with MCU, MICU2 
tunes the MICU1-mediated 
threshold for activation through 
distinct Ca2+-binding properties of 
MICU1 homo- vs. heterodimers. 
Previous studies have reported a 
loss of gatekeeping in cells with 
MICU2 deleted (Vais et al., 
2016). However, those 
measurements used a low-affinity Ca2+ indicator (Fura-FF; KD = 5.5 µM) that provided inaccurate 
measurements below 1 µM. By probing Ca2+ uptake using a high-affinity indicator (Fura-2, KD = 
140 nM), we determined that the MICU1 homodimer inhibits MCU below ~500 nM [Ca2+]c. Lack of 
appreciation of this role of MICU2 and of the need to study its function under rigorously controlled 
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Figure 4.2. Model for MICU1-MICU2 regulation of MCU in response to 
elevations in [Ca2+]c  
MICU2 tunes mitochondrial Ca2+ uptake by raising the [Ca2+]c threshold and 
reducing the gain of MICU1 activation of MCU. 
 
and quantified [Ca2+]c probably accounts for previous discrepant results regarding its effects on 
gatekeeping (Patron et al., 2014)(Kamer and Mootha, 2014)(Vais et al., 2016).  
MICU2 sets the gain of cooperative activation of MCU by MICU1  
Activation of MCU is mediated by elevated [Ca2+]c with high cooperativity. As for channel 
inhibition in low [Ca2+]c, MICU1 plays a dominant role in channel activation. First, channel 
activation at [Ca2+]c > 5 µM is strongly reduced in cells lacking MICU1. This observation likely 
accounts for the initial (Perocchi et al., 2010) and subsequent (Csordás et al., 2013)(Patron et al., 
2014) conclusion that MICU1 mediates channel activation rather than inhibition, since those 
studies employed high-[Ca2+]c pulses where MICU1 is shown here to play an activating role. 
Second, cooperativity of channel activation is lost when MICU1 is absent. Third, [Ca2+]c 
dependent MCU activation remains highly cooperative in cells with MICU2 deleted. Nevertheless, 
MICU2 profoundly influences Ca2+-dependent MCU activation. In its absence, activation by  
MICU1 homodimers remains highly cooperative, but the [Ca2+]c -dependence is shifted to much 
lower concentrations. Thus, a primary function of MICU2 is to set the gain of the cooperative 
mechanism of channel activation (Figure 4.2). Cooperative channel activation requires Ca2+  
binding not only to each of the EF hands in MICU1, but also to those in MICU2. Mutation of EF1 
in MICU2 had a more profound 
effect than mutation of EF2, 
which is interesting since 
MICU2 EF1 has been 
implicated in MICU2 
dimerization in vitro (Li et al., 
2016)(Kamer et al., 2019). 
Thus, cooperativity of [Ca2+]c 
dependent MCU activation 
derives from Ca2+ binding to 
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Figure 4.3. Ca2+ binding to the EF hands of MICU1 and MICU2 is necessary for cooperative activation MCU  
Ca2+ binding to 3-4 EF hands in the MICU1/2 heterodimer are required for MCU activation. 
three or all four EF hands in the MICU1/2 heterodimer (Figure 4.3).  
 
In support of these findings, Kamer et al. (2017) demonstrated that recombinant 
truncated-MICU1 and full-length MICU2 form a heterodimer with high Ca2+ affinity (~650 nM). The 
apparent Ca2+ affinity of MICU1 was ~300-400 nM, whereas MICU2 had a lower affinity (~1 µM). 
These results are in good agreement with the apparent affinities of the full-length proteins in situ 
observed here. A MICU1 apparent-affinity of 300-400 nM is in good agreement with the 500-nM 
threshold we determined in cells lacking MICU2, and the lower Ca2+ affinity of the MICU1/2 dimer 
is consistent with the role of MICU2 determined here to raise the [Ca2+]c threshold and lower the 
apparent Ca2+ affinity of the MICU dimer. 
The cell physiological significance of MICU2  
It is interesting to note that MICU1 alone is able to accomplish the same things as a 
MICU1/2 heterodimer. MICU1 homodimers (and possibly monomers) associate with MCU and 
mediate channel inhibition in low [Ca2+]c and highly-cooperative activation at elevated [Ca2+]c. 
MICU2 does not form a homodimer, nor does it associate with MCU in the absence of MICU1. 
Although ratios of MICU1 and MICU2 mRNA levels vary among tissues, it is unknown if MICU1 
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homodimers exist in vertebrate tissues. Paillard et al. (2017) observed different MICU1/MCU 
expression ratios between cardiac myocytes and hepatocytes, and attributed different 
mitochondrial Ca2+-uptake properties between these tissues to altered MICU1/MCU ratios. 
However, the results, i.e. lower threshold and reduced gain in myocytes, could also be accounted 
for, at least in part, by different ratios of MICU1 homo- versus heterodimers, as shown here.  It is 
interesting to consider the physiological implications of the evolution of the MICU1/2 heterodimer. 
Our studies suggest that the fundamental role of MICU2 is to reduce the apparent Ca2+ affinity of 
MICU1. In the low-[Ca2+]c regime, MICU2 raises the [Ca2+]c threshold for MCU activation from 
~500 nM to ~1.3 µM. In the high-[Ca2+]c regime, MICU2 reduces the [Ca2+] sensitivity without 
affecting the cooperativity of channel activation, enabling strong channel-activation at [Ca2+]c > 
4.5 µM compared with ~1.5 µM for MICU1 homodimers. Considering the requirement of Ca2+ 
binding to MICU2 EF hands for channel activation, it is notable that whereas the two MICU1 EF 
hands are canonical, those in MICU2 are not, with the normal glycines at position 6 replaced with 
glutamates. This may suggest that the MICU2 EF hands have a lower Ca2+-binding affinity, in 
agreement with recent measurements (Kamer et al., 2017), that within the context of the MICU1/2 
heterodimer confers reduced [Ca2+]c-sensitivity.  
The cell physiological implication of these effects of MICU2 may be to enforce a more-
proximal physical localization between MCU and Ca2+ sources required for mitochondria to sense 
and take up Ca2+. Using the physiological Ca2+ current through a single open InsP3R Ca2+-release 
channel, we can compute the spatial profile of [Ca2+]c as a function of distance from the channel 
according to (Vais et al., 2010). Assuming moderate cytoplasmic buffering (between the values 
for high and low buffering in Vais et al.) and [Ca2+]ERlumen  =  300 µM, modeling predicts that with a 
MICU1/2 heterodimer as part of the MCU complex, an MCU channel needs to be located within 
~120 nm from the axis of a single open InsP3R channel for the inhibition threshold to be 
breached, enabling MCU activation. In contrast, an MCU channel associated with a MICU1 
homodimer could be twice as far away and become activated (Figure 4.4). Thus, the presence of 
MICU2 requires an MCU channel to be closer to an InsP3R to enable the gatekeeping threshold  
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Figure 4.4. MICU2 enforces tighter localization of Ca2+ crosstalk between ER and mitochondria (adapted from Vais 
et al., 2010)  
Assuming [Ca2+]ER = 300 µM, MCU channels associated with a MICU1/2 heterodimer must be located within 60 nm 
of the axis of an open InsP3R channel for cooperative activation and within 120 nm for the gatekeeping threshold-
[Ca2+]c to be exceeded, whereas MCU associated with a MICU1 homodimer could be over 120 nm and 240 nm 
away, respectively. 
to be overcome. A MICU1/2 heterodimer strongly activates MCU channel activity when [Ca2+]c 
achieves ~4.5 µM, requiring that the MCU channel be within 60 nm of an InsP3R, whereas a 
MICU1 homodimer-activated MCU channel can be over twice as far away (Figure 4.4). Again, the 
presence of MICU2 spatially restricts Ca2+ crosstalk between single InsP3R and MCU channels. It 
is predicted, therefore, that stimulation of InsP3-mediated Ca2+ release in cells lacking MICU2 
would be associated with a larger proportion of released Ca2+ entering mitochondria.  
To test this, we stimulated intact cells with an InsP3-mobilizing agonist and 
simultaneously measured [Ca2+]c and [Ca2+]m. Notably, the magnitude of the transient increase in 
global [Ca2+]c was suppressed in MICU2 KO cells compared with WT cells (Figure 4.5A) whereas 
the peak increase in [Ca2+]m was similar between the two (Figure 4.5B). While the most 
reasonable explanation for the diminished cytoplasmic response in the MICU2 KO cells is 
enhanced mitochondrial buffering, as predicted by our model, it is possible that it was due to  
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Figure 4.5. The cell physiological role of MICU2 in spatially restricting mitochondrial Ca2+ uptake  
(see Chapter 2 Methods and Materials) (A-B) Simultaneous measurements of [Ca2+]c (A) and [Ca
2+]m (B) in intact WT 
and MICU2 KO cells in response to 500 µM ATP. Traces representative of n = 5 independent experiments for each 
condition. MICU2 KO cells exhibit similar transient increase in [Ca2+]m to WT cells despite reduced global [Ca
2+]c 
increase. (C) Quantification of increase in [Ca2+]m at peak of the transient divided by mean increase in [Ca
2+]c 
([Ca2+]m/[Ca
2+]c). Bars: mean +/- SEM. (P = 0.0004; Student’s t-test). A larger proportion of ER-released Ca
2+ 
enters mitochondria in MICU2 KO cells.  
 
clonal differences in, for example, expression of purinergic receptors. Nevertheless, similar 
mitochondrial Ca2+ uptake in WT and MICU2 KO cells despite much lower [Ca2+]c in the MICU2 
KO cells (Figure 4.5C) is consistent with our prediction that more Ca2+ can be taken up by 
mitochondria lacking MICU2 because of a less stringent requirement for close spatial proximity 
between ER Ca2+ release sites and mitochondrial Ca2+ uptake sites (Figure 4.4). Future studies 
are necessary to determine if indeed the evolutionary imperative for MICU2 is to promote a 
stricter spatial proximity or Ca2+ crosstalk between ER and mitochondria, and to determine its 
physiological rationale. 
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Variable assembly of EMRE and MCU creates functional channels with distinct 
gatekeeping profiles 
 
Based on the work described in Chapter 3, we propose that the human uniporter complex 
largely exists in association with fewer than 4 and more than 1 EMRE subunit, but complexes 
with 1, 2, 3, or 4 EMRE exhibit channel activity and full or partial MICU1/2-mediated gatekeeping. 
Moreover, the more EMRE subunits that associate with each MCU channel, the higher the [Ca2+]c 
threshold required for channel activation. 
 
MCU complexes with fewer than four EMRE subunits can assemble as fully-functional channels.  
 
Mitochondria from MCU+EMRE cells, which exhibit ~10-fold higher expression of MCU 
relative to EMRE, took up Ca2+ at rates similar to WT cells at [Ca2+]c above 5 µM (Figures 3.1 & 
3.4). Furthermore, MCU-EMRE concatemers that form channels with less than four EMRE 
subunits were functional (Figure 3.15). If only channels with four EMRE were functional, the 
gatekeeping profile in the MCU+P76I-EMRE+MICU1 cells would be the same as cells expressing 
ME[P76I], which was not observed. While BN-PAGE revealed that higher-order MCU oligomers 
(e.g. MCU hexamers or octamers containing excess MCU subunits that do not contribute to pore 
formation) were present in mitochondria expressing the MME or MMME concatemers (Figure 
3.16), bands corresponding to MCU tetramers with one or two EMRE subunits (250-550 kDa) 
predominated. Thus, under circumstances where endogenous EMRE expression is insufficient to 
occupy all four binding sites in each channel, complexes with fewer than four EMREs retain full 
channel activity when the gatekeeping threshold is exceeded. Thus, we conclude that the MCU 
complex will form with a 1:1 EMRE:MCU stoichiometry if sufficient EMRE is present, but it is more 
likely that a range of possible stoichiometries is possible (Figure 4.6). 
The endogenous MCU channel in HEK-293T cells likely contains two EMRE subunits. No 
differences in the [Ca2+]c-dependence of MCU activity or in the steady-state [Ca2+]c gatekeeping 
threshold were observed between channels with two EMRE subunits (MEKO+MME+MICU1) and 
WT cells (Figure 3.15), suggesting that these channels recapitulate the stoichiometry of 
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endogenous channels. Of note however, the functional profile of cells expressing the MMME 
concatemer, which are predicted to form channels containing a single EMRE subunit, were 
functionally indistinguishable from MEKO+MME+MICU1 (or WT) cells. This could be attributed to 
formation of higher-order oligomers in the MMME-expressing cells (Figure 3.16) that created 
channels containing more than one EMRE, as depicted in Figure 3.12D.  The [Ca2+]c threshold for 
MCU activity in these cells likely arises from channels with one or two EMRE subunits.   
BN-PAGE analyses also suggest that endogenous complexes in HEK-293T cells contain 
greater than one and less than four EMRE per channel (Figure 3.16). The size of complexes 
between 250-550 kDa depended on the number of EMRE subunits per channel, and not on 
incorporation of MICU proteins as they were not present in the complexes. Importantly, channels 
formed by expression of MME concatemers were not different in size from those in WT cells, 
while complexes containing a single EMRE were significantly smaller. Thus, the size of the native 
complex in WT cells is consistent with a channel complex containing two EMRE subunits bound 
to each MCU tetramer.  The rapid degradation of unassociated EMRE subunits by mAAA 
proteases (König et al., 2016)(Tsai et al., 2017), along with our findings that the EMRE [P76I] 
mutation is required to prevent degradation of EMRE from the ME concatemer (Figure 3.13A), 
are consistent with the hypothesis that channels with four EMRE subunits may be rare in vivo.  
The gatekeeping-threshold [Ca2+]c increases with the number of EMRE subunits per channel 
 
The second major conclusion of Chapter 3 is that MCU channels containing more EMRE 
subunits have enhanced gatekeeping (Figure 4.6). The EMRE [P76I] mutation increased the 
steady-state expression of EMRE without affecting MCU expression (Figures 3.10 & 3.11). 
Therefore, any differences in channel function and regulation between MCU+EMRE+MICU1 and 
MCU+P76I-EMRE+MICU1 cells were due solely to the elevated EMRE:MCU ratio in the P76I-
EMRE cells. Both cell lines showed similar uptake rates and cooperativity of channel activation, 
but the right-shift in plots of initial-uptake rate vs. [Ca2+]c and the elevated gatekeeping threshold 
in MCU+P76I-EMRE+MICU1 cells indicate that MICU1/2-mediated gatekeeping in channels with 
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Figure 4.6. Proposed functional stoichiometry of the uniporter complex 
MCU complexes with fewer than four EMRE subunits can assemble as fully-functional channels, but channels 
containing more EMRE subunits tether additional MICU1/2-dimers to the channel and enhance gatekeeping 
three or four EMRE is enhanced compared with those associated with only one or two. These 
findings are reinforced by the functional profile of the ME[P76I] concatemer, in which all channels 
are predicted to contain 4 EMRE (Figures 3.14B & 3.15). Like MCU+P76I-EMRE+MICU1 cells, 
ME[P76I]+MICU1 cells showed a right-shift in the Ca2+-uptake rate vs. initial [Ca2+]c relationship 
and an elevated gatekeeping threshold compared with WT+MICU1 cells, with no difference in 
uptake rate and cooperative activation. 
These findings are relevant in light of the recent structure of human MCU that revealed 
four EMRE subunits bound to the MCU tetramer. We confirmed here that such a channel is 
functional with intact MICU1/2-mediated gatekeeping. Our results provide further evidence that 
EMRE performs two independent roles in MCU-channel regulation.  First, it allows MCU to adopt 
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an open channel conformation upon binding of only a single EMRE. In contrast, its role in 
tethering MICU1/2 to the complex to mediate channel gatekeeping is modulated by the number of 
EMRE subunits per channel. Such a phenomenon is not unique, as demonstrated by the 
functional modulation of BK channels by auxiliary subunits γ1 and β (Gonzalez-Perez et al., 
2018). Similar to the role of EMRE in MCU activation, γ1 has been described as having an “all-or-
none” effect of the voltage-dependence of BK channel gating, in which a single subunit 
associating with the pore forming subunits is sufficient to promote the full effect. On the other 
hand, each β-subunit that associates with the BK tetramer leads to an incremental shift in the 
voltage-dependence of channel gating such that the full shift is observed only when four β-
subunits are present in the channel complex. This is also reminiscent of the functional 
stoichiometry of channel inactivation in the Drosophila voltage-gated potassium (Kv) channel 
Shaker, which assembles as a homotetramer (MacKinnon et al., 1993). The N-terminus of the 
channel contains a “ball and chain” domain that acts as a gate to mediate (N-type) channel 
inactivation (i.e. spontaneous closing following voltage-dependent activation). Incorporation of a 
single functional gate is necessary and sufficient to inhibit the channel, but the presence 
additional gates increases the rate at which inactivation occurs. This is analogous to our finding 
that a single EMRE subunit per MCU channel is sufficient to reconstitute gatekeeping (provided 
MICU1 expression is high enough to occupy all channels), while the presence of additional EMRE 
subunits enhances gatekeeping by elevating the [Ca2+]c  threshold required for channel activity. It 
is possible that this enhanced gatekeeping arises from an increase in the rate at which apo-
MICU1 re-establishes its inhibitory interactions with the MCU pore in channels containing four 
EMRE subunits compared to those with fewer, but this conclusion requires detailed kinetic 
measurements of the relevant kinetic process beyond the scope of this work. 
Our studies suggest that the endogenous MCU channel complex in HEK-293T cells likely 
contains four MCU monomers assembling as a tetramer that, on average, associates with two or 
three EMRE subunits. We predict therefore that under resting [Ca2+]c, two apo-MICU1/2 dimers 
associate with the complex through interactions with the C-terminus of EMRE and residues in two 
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Figure 4.7. Ca2+ uptake in EMRE KD cells is no different from WT (adapted from Fernandez Garcia, E. – 
unpublished) 
(A) Quantification of relative EMRE mRNA expression in WT +/- stable shRNA-mediated genetic KD of EMRE 
(qPCR performed by E.F.G.). Relative mRNA expression was calculated by normalizing CT values for EMRE KD 
cells to C values for WT cells. Bars: mean; error bars: SEM for n = 3 independent experiments.  (B) Mitochondrial 
Ca2+-uptake in suspensions of permeabilized WT (black trace) or two clones of stable EMRE KD cells in response to 
acute 5 µM increases of [Ca2+]c. Traces are representative of n = 3 independent experiments. 
MCU subunits (Figure 4.6), mediating inhibition of the channel (i.e. gatekeeping). When the local 
[Ca2+]c becomes elevated, Ca2+-binding to the EF hands of MICU1 and 2 promote dissociation of 
MICU1 from the pore and relieve MCU inhibition. Under these conditions, the role of EMRE in 
tethering MICU1/2 dimers to the complex is essential to ensure that gatekeeping is re-established 
quickly enough to ensure that channel activity ceases at the proper [Ca2+]c threshold after uptake 
has occurred. Future work to address the structure of MCU channels with fewer than four EMRE 
subunits, and in the presence of MICU1/2 dimers is necessary to confirm this hypothesis. 
Nevertheless, it does help to explain the recent finding from our lab (Emily Fernandez Garcia - 
unpublished data) that ~80% knockdown of EMRE mRNA expression (EMRE KD) has no effect 
on Ca2+ uptake by mitochondria in HEK-293T cells (Figure 4.7). EMRE mRNA levels may not 
accurately reflect the steady-state protein expression due to the rapid turnover of EMRE by 
mAAA proteases. Thus, 80% KD of EMRE may not be sufficient to reduce the endogenous 
EMRE:MCU protein expression ratio to levels at which gatekeeping is affected (e.g. MCU+EMRE 
cells; EMRE:MCU ~1:10). To obtain direct evidence for this it would be necessary to accurately 
quantify the relative, steady-state protein expression of endogenous EMRE and MCU, a 
measurement which is difficult using standard biochemical approaches. 
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Outstanding questions and future directions 
 
Despite the many recent advances regarding the structure and function of the uniporter 
and its role in mitochondrial physiology and disease, numerous outstanding questions remain. 
The work described here highlights gaps in in our understanding as to the molecular basis of 
MCU channel regulation, which present opportunities for future work regarding the role of 
mitochondrial Ca2+ transport in cell physiology. 
 
Pathophysiology of loss-of-function mutations in MICU1  
 
Here we have, for the first time, quantified the steady state [Ca2+]m in cells lacking MICU1 
as ~300-400 nM compared with ~100 nM in WT cells. These observations corroborate those in 
fibroblasts from patients with genetic defects in MICU1 that result in absence of MICU1 
expression (Bhosale et al., 2017). Perhaps surprisingly, the increase in [Ca2+]m by 200-300 nM we 
observed is not excessively high, suggesting that mitochondria in MICU1 KO cells may not be as 
Ca2+ over-loaded as has been inferred (Mallilankaraman et al., 2012a)(Logan et al., 2013)(Antony 
et al., 2016)(Liu et al., 2016)(Bhosale et al., 2017).  Several mechanisms could account for why 
[Ca2+]m is not elevated to much higher levels. It is possible that NCLX-mediated Ca2+-extrusion 
can compensate for uninhibited influx through MCU, or that MCU is inhibited by elevated [Ca2+]m, 
limiting Ca2+ uptake. Moreover, measurements of [Ca2+]m may not reflect total matrix Ca2+ 
content. However, mitochondrial Ca2+ content in hepatocytes (Antony et al., 2016) and brains (Liu 
et al., 2016) of mice with MICU1 constitutively deleted were either not different or increased by 
only 50%, respectively, compared with normal cells. Nevertheless, pathogenesis in MICU1 KO 
animals has been attributed to mitochondrial Ca2+ overload (Liu et al., 2016). The relatively 
modest matrix free-Ca2+ elevation under resting conditions may not be the (sole) cause of 
disease pathogenesis in animal models (Antony et al., 2016)(Liu et al., 2016) and patients (Logan 
et al., 2013)(Lewis-Smith et al., 2016)(Bhosale et al., 2017). Rather, pathogenesis in neuronal 
tissue and striated muscle might be caused by sensitized gain-of-function responses to transient 
increases in [Ca2+]c up to the normal threshold of ~1.3 µM, an inability of mitochondria to properly 
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buffer cytoplasmic Ca2+ signals due to a loss of cooperative channel activation, or reduced ATP 
production. 
This raises the question of whether the phenotypes observed in humans and animals 
lacking MICU1 are consistent with those expected from mitochondrial Ca2+ overload. One might 
expect that elevated [Ca2+]m could lead to opening of the mPTP, triggering mitochondrial 
depolarization that in turn leads to an increase in excessive mitophagy and/or Ca2+-induced cell 
death. We have obtained conflicting results regarding the resting m in MICU1 KO (HEK293T) 
cells; there is a partial (25-40%) decrease compared to WT cells when measured with TMRE 
(Figure 2.6B), but no difference in measurements using JC-1 (Figure 2.7A-B insets). Moreover, 
fibroblasts from patients with loss-of-function mutations in MICU1 (MICU1) showed no 
differences in Ca2+-induced cell death, mitochondrial ROS production, or mitophagic flux (Bhosale 
et al., 2017). Nevertheless, the mitochondrial network appears fragmented in MICU1 fibroblasts, 
indicating an imbalance between fission and fusion (Logan et al., 2013). This led to the 
hypothesis that disease results from a bioenergetic deficiency arising from a futile cycling of Ca2+ 
across the IMM. 
In this model, Bhosale et al. (2017) propose that constitutively elevated [Ca2+]m (due to a 
lack of MCU gatekeeping) leads to excessive NCLX-mediated Ca2+ efflux, which in turn elevates 
resting matrix [Na+]. To maintain ion homeostasis, Na+ efflux is mediated through an 
electroneutral H+-coupled antiport mechanism, which reduces the proton-motive force (but not 
necessarily m - see Chapter 1, P. 23) that drives ATP synthesis.  This hypothesis is in line with 
the finding that NAD(P)H levels were elevated in mitochondria from MICU1 fibroblasts (Logan et 
al., 2013), suggesting reduced activity of the entire respiratory chain (CI-CV) despite the likely 
increase in TCA-cycle flux due to elevated [Ca2+]m. However, Bhosale’s model presumes the 
existence of an unknown mitochondrial Na+/H+ exchanger (mNHE) that mediates the antiport of 
Na+ and H+ ions across the IMM (for review see Brierley (1976)). The evidence for such a 
mechanism is summarized in an excerpt from a review by Crompton et al. (1978), as follows: 
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Crompton and Heid (1978), also showed that the mNHE is likely distinct from the mitochondrial 
Na+/Ca2+ exchanger (NCLX). This is based on the observation that while addition of (2.5 mM) Na+ 
to suspensions of isolated heart mitochondria induces an efflux of Ca2+ that reaches a steady 
state after ~15 minutes, a rapid (occurring within seconds) influx of H+ is observed immediately 
after Na+ addition, the latter attributed to the mNHE. A later review described the mNHE as 
responsible for “(a)n apparently unregulated Na+/H+ antiport (that) keeps matrix [Na+] low and the 
Na+-gradient equal to the H+-gradient.” (Brierley et al., 1994). Despite the preponderance of 
physiological evidence for the mNHE, there remains a lack of genetic evidence for existence. 
Initially, the human mNHE was thought to be the protein NHE6 based on its abundance in 
“mitochondrion-rich tissues” and its apparent localization to mitochondria when fused to GFP and 
overexpressed in HeLa cells (Numata et al., 1998). These findings were later contradicted by 
Miyazaki et al. (2001), who showed that NHE6 localized to the ER and plasma membrane. NHE6 
also contained an N-terminal signal peptide and endoglycosidase-H resistant carbohydrate 
moieties, leading to the conclusion that the protein was targeted to the ER membrane and 
transported to the plasma membrane by the canonical secretory pathway. Due to the conflicting 
evidence, the molecular identity of the human mNHE - or whether such an entity even exists - 
remains unclear. It is also possible that the bioenergetic deficiency in MICU1 patients is not due 
to a reduction in mitochondrial ATP production per se, but rather to insufficient sequestration of 
cytoplasmic Ca2+ by mitochondria in response to transient elevations in [Ca2+]c that normally 
induce cooperative activation of MCU (Perocchi et al., 2010). The need to compensate for this 
constitutive increase in [Ca2+]c would require additional energy expenditure by SERCA or the 
plasma membrane CaATPase, ultimately resulting in a global ATP deficiency in cells. 
“There is considerable evidence for the existence of a carrier that catalyses an exchange 
between Na+ and H+ across the inner membrane of liver and heart mitochondria (sic). The 
existence of this system was investigated with mitochondria that exhibit Na+-induced efflux of 
Ca2+. In all cases, the mitochondria were observed to swell rapidly when introduced into iso-
osmotic sodium acetate, and to swell little in potassium acetate... This behaviour is explicable 
in terms of Na+ entry in exchange for H+ and entry of acetate as the undissociated acid.” 
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The relationship between MICU1/2-mediated gatekeeping and cooperative channel activation 
 
 The dual role of MICU1 in both gatekeeping (i.e. inhibition at low [Ca2+]c) and cooperative 
activation of the channel has been the subject of much debate. Despite being widely accepted as 
the “fundamental gatekeeper” of MCU, MICU1 was originally identified in a screen for genes that 
were required for Ca2+ uptake (Perocchi et al., 2010). Moreover, we and others have confirmed 
that Ca2+ -flux into mitochondria is impaired in MICU1 KO cells at higher [Ca2+]c, suggesting that 
cooperative activation of the channel is not simply a ‘relief of gatekeeping”. Additionally, the 
apparent “uncoupling” of gatekeeping and cooperative activation in MCU+EMRE cells (see 
Chapter 3 – P. 65) suggests that they represent distinct mechanisms of channel regulation. In 
addition, it is unclear whether either mechanism involves a direct modulation of channel open 
probability (Po) by MICU1 and or 2. The maximal MCU current densities in mitoplast patch-clamp 
experiments are no different in the presence or absence of MICU1 (Vais et al., 2016), despite the 
fact that these assays are performed under conditions where the cytoplasmic (bath) [Ca2+] (0.1 – 
1 mM) far exceeds the level required for cooperative activation. Moreover, similar experiments in 
the presence of MICU1 or MICU2 EF-hand mutants show no constitutive suppression of MCU 
currents relative to those in the presence or absence of (WT) MICU1 (Horia Vais, Ph.D. - 
unpublished data), suggesting that gatekeeping itself may not be as simple as the “lid” 
mechanism mediated by direct binding of MICU1 to the channel pore (Paillard et al., 
2018)(Phillips et al., 2019). That being said, [Ca2+]m does appear to modulate the channel Po 
under certain conditions, through a mechanism that requires the presence of both MICU1 and 2 
(Vais et al., 2016 - see below).   
 These findings have important implications regarding the role of MICU1 (and 2) in 
regulating mitochondrial Ca2+-uptake and suggest that gatekeeping and/or cooperative activation 
may represent indirect mechanisms that pertain only to Ca2+ -flux measurements across the IMM 
rather than to direct modulation of channel activity. This idea is supported by a number of 
findings: First, MICU1 has been shown to interact with the mitochondrial Mg-ATP/Pi transporter 
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(SLC25A23) (Hoffman et al., 2014) and thus could modulate MCU activity by affecting counter-ion 
(Pi) transport. Additionally, MICU1 has been implicated as a regulator of cristae structure and 
function (Gottschalk et al., 2019), which could indirectly affect MCU channel assembly or activity. 
Finally, a recent study found that in Drosophila, MICU1 loss-of-function mutations were lethal, but 
that this phenotype was not rescued in the absence of MCU or EMRE (Tufi et al., 2019), 
suggesting that lethality was not due to excessive MCU activity. Future work is necessary to 
reconcile the discrepancies between Ca2+-flux measurements and electrophysiological 
approaches, and ultimately elucidate the molecular mechanisms by which MICU proteins regulate 
mitochondrial Ca2+ uptake. 
 
Other modes of uniporter regulation 
 
In addition to regulation by Ca2+-binding to MICU1/2 and variable assembly of EMRE and 
MCU, channel activity is modulated by post-translational modification of components of the 
uniporter complex. Akt-mediated phosphorylation of S124 in MICU1 has been shown to increase 
resting [Ca2+]m in HeLa cells and enhance mitochondrial Ca2+ uptake in response to intracellular 
Ca2+ signals (Marchi et al., 2019). This phenotype, which resembles that of MICU1 KO (HEK-
293T) cells, suggests that phosphorylation of S124 represents a mechanism to enhance MCU 
activity in response to Akt activation by relieving MICU1/2-mediated gatekeeping. In addition, 
MCU can be phosphorylated at S57 by AMP kinase, increasing mitochondrial Ca2+ uptake by in 
histamine-stimulated HeLa cells and promoting mitotic progression (Zhao et al., 2019). While it is 
unclear whether this enhancement in channel activity is due to an increase in open probability, 
number of functional complexes, or a relief of gatekeeping, it again suggests that phosphorylation 
is an important mechanism for regulating Ca2+ uptake in response to the dynamic energy 
requirements of cells. Other than phosphorylation, oxidation of MCU C97 in the presence of high 
ROS levels in the matrix has been to promote the formation of higher-order oligomers and 
enhance Ca2+ uptake in human pulmonary microvascular endothelial cells (Dong et al., 2017). 
Moreover, given the unique milieu of proteins, metabolites and ions in the matrix it is possible that 
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Figure 4.8. MCU channel activity is modulated by a mechanism dependent upon matrix [Ca2+] (adapted from Vais et 
al., 2016) 
(A) Response of MCU Ca2+-current density at Vm = -160 mV, with 1 mM Ca
2+ in the bath, as function of free [Ca2+] in 
pipette (matrix) solution ([Ca2+]m). Data are fitted with a biphasic Hill equation (continuous line). (B) [Ca
2+]m between 
50 – 800 nM inhibit channel activity even at [Ca2+]c that promote MICU1/2-mediated cooperative activation. 
post-translational modifications to MCU or EMRE such as acetylation or succinylation represent 
additional modes of regulation.  
Aside from post-translational modification of the uniporter complex, recent structures of 
the NTD of human MCU identified a putative divalent-ion binding site, which was proposed to 
modulate assembly and subsequently function of the channel complex (Lee et al., 2016). This is 
particularly interesting in light of work from our lab describing a novel phenomenon, [Ca2+]m-
dependent regulation of MCU activity (Vais et al., 2016). We measured whole-mitoplast Ca2+ 
currents using patch-clamp electrophysiology and observed a distinct bi-phasic dependence on 
[Ca2+]m (Figure 4.7), that required the presence of MICU1 and 2 on the opposite side of the inner 
membrane. Interestingly, peak-inhibition occurred at ~400 nM [Ca2+]m, similar to the resting 
[Ca2+]m in MICU1 KO cells. Our discovery prompts a revision of the current model for MCU 
activity that includes [Ca2+] sensing on both sides of the IMM. How these signals are integrated to 
govern channel activity is still unknown. Originally, our results suggested that EMRE was a 
[Ca2+]m sensor that mediated this novel form of regulation, but the now generally-accepted 
membrane topology of EMRE and its lack of putative Ca2+-binding sites imply that additional sites 
may be involved, possibly in the MCU protein itself. We are currently working to verify the 
presence of divalent cation-binding sites in the NTD of MCU, as well as determine their role in 
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[Ca2+]m-regulation of channel activity. It is also possible that Ca2+ binding to MCU directly is not 
involved in the [Ca2+]m regulation of channel activity. In this case, additional Ca2+-binding proteins 
in the mitochondrial matrix must be identified. Alternatively, this unidentified [Ca2+]m sensor could 
not be a protein at all, but rather another molecule in the mitochondrial matrix that associates with 
MCU and modulates its function. Interestingly, cardiolipin, a lipid component of the IMM, is known 
to bind to Ca2+ with an apparent KD similar to that of the half maximal effective concentration 
(~800 nM) for MCU activation by [Ca2+]m  (Kamer et al., 2017). Hopefully, in the near future, these 
approaches will identify the mechanisms by which coupled [Ca2+]m- and [Ca2+]c -mediated 
regulatory mechanisms control MCU channel activity. 
If mitochondria are a cell within a cell, then the processes I’ve described in this work 
constitute its action potential. The resting membrane potential is set by activity of the respiratory 
complex rather than channel-mediated diffusion of K+. External stimuli trigger depolarization 
through voltage-gated Na+-channels in the plasma membrane and MCU in the IMM, which is 
followed by a repolarization phase due to increased K+ permeability in cells and increased 
electron flux through CI-CV in mitochondria. These events culminate in the rapid transmission of 
signals, both electrical and chemical, that ultimately bestow humans with the ability to rapidly 
respond to dynamic changes in our environment. I hope that this work will inform future 
discoveries that build our understanding of the myriad roles of mitochondria in sustaining cellular 
energetics and homeostasis, as well as provide insight into new therapies targeting dysregulated 
mitochondrial Ca2+ uptake in human disease.  
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APPENDICES 
 
Appendix A: Amino acid sequences encoded by cDNAs used in all studies 
 
1. Human EMRE (C-terminal V5 tag): 
MASGAARWLVLAPVRSGALRSGPSLRKDGDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKM
SFGLLRVFSIVIPFLYVGTLISKNFAALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST 
 
2. Human EMRE [P76I] (C-terminal V5 tag): 
MASGAARWLVLAPVRSGALRSGPSLRKDGDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKM
SFGLLRVFSIVIIFLYVGTLISKNFAALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST  
 
3. Human MCU (C-terminal V5-(6x)His tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDCPTFLYKVVDLEGPRFEGKPIPNPLLGLDSTRTGHH
HHHH 
 
4. Human MICU1 (C-terminal Myc-Flag tag): 
MFRLNSLSALAELAVGSRWYHGGSQPIQIRRRLMMVAFLGASAVTASTGLLWKRAHAESPPCV
DNLKSDIGDKGKNKDEGDVCNHEKKTADLAPHPEEKKKKRSGFRDRKVMEYENRIRAYSTPDKI
FRYFATLKVISEPGEAEVFMTPEDFVRSITPNEKQPEHLGLDQYIIKRFDGKKISQEREKFADEGSI
FYTLGECGLISFSDYIFLTTVLSTPQRNFEIAFKMFDLNGDGEVDMEEFEQVQSIIRSQTSMGMRH
RDRPTTGNTLKSGLCSALTTYFFGADLKGKLTIKNFLEFQRKLQHDVLKLEFERHDPVDGRITER
QFGGMLLAYSGVQSKKLTAMQRQLKKHFKEGKGLTFQEVENFFTFLKNINDVDTALSFYHMAGA
SLDKVTMQQVARTVAKVELSDHVCDVVFALFDCDGNGELSNKEFVSIMKQRLMRGLEKPKDMG
FTRLMQAMWKCAQETAWDFALPKQTRTRPLEQKLISEEDLAANDILDYKDDDDK 
 
5. Human MICU2 (no tag): 
MAAAAGSCARVAAWGGKLRRGLAVSRQAVRSPGPLAAAVAGAALAGAGAAWHHSRVSVAAR
DGSFTVSAQKNVEHGIIYIGKPSLRKQRFMQFSSLEHEGEYYMTPRDFLFSVMFEQMERKTSVK
KLTKKDIEDTLSGIQTAGCGSTFFRDLGDKGLISYTEYLFLLTILTKPHSGFHVAFKMLDTDGNEMI
EKREFFKLQKIISKQDDLMTVKTNETGYQEAIVKEPEINTTLQMRFFGKRGQRKLHYKEFRRFME
NLQTEIQEMEFLQFSKGLSFMRKEDFAEWLLFFTNTENKDIYWKNVREKLSAGESISLDEFKSFC
HFTTHLEDFAIAMQMFSLAHRPVRLAEFKRAVKVATGQELSNNILDTVFKIFDLDGDECLSHEEFL
GVLKNRMHRGLWVPQHQSIQEYWKCVKKESIKGVKEVWKQAGKGLFTRTRPLEV 
 
6. Human MICU2 (C-terminal Myc-Flag tag): 
MAAAAGSCARVAAWGGKLRRGLAVSRQAVRSPGPLAAAVAGAALAGAGAAWHHSRVSVAAR
DGSFTVSAQKNVEHGIIYIGKPSLRKQRFMQFSSLEHEGEYYMTPRDFLFSVMFEQMERKTSVK
KLTKKDIEDTLSGIQTAGCGSTFFRDLGDKGLISYTEYLFLLTILTKPHSGFHVAFKMLDTDGNEMI
EKREFFKLQKIISKQDDLMTVKTNETGYQEAIVKEPEINTTLQMRFFGKRGQRKLHYKEFRRFME
NLQTEIQEMEFLQFSKGLSFMRKEDFAEWLLFFTNTENKDIYWKNVREKLSAGESISLDEFKSFC
HFTTHLEDFAIAMQMFSLAHRPVRLAEFKRAVKVATGQELSNNILDTVFKIFDLDGDECLSHEEFL
GVLKNRMHRGLWVPQHQSIQEYWKCVKKESIKGVKEVWKQAGKGLFTRTRPLEQKLISEEDLA
ANDILDYKDDDDK 
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7. MCU-EMRE concatemer (C-terminal V5 tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKMSFG
LLRVFSIVIPFLYVGTLISKNFAALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST 
 
8. MCU-EMRE [P76I] concatemer (C-terminal V5 tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKMSFG
LLRVFSIVIIFLYVGTLISKNFAALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST 
 
9. MCU-MCU-EMRE [P76I] concatemer (C-terminal V5-tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDASGGSGGGSGGGSGVHQRIASWQNLGAVYCSTVV
PSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRV
AASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERE
LIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTY
FITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLK
RLRDPLQVHLPLRQIGEKDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKMSFGLLRVFSIVIIFL
YVGTLISKNFAALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST 
 
10. MCU-MCU-MCU-EMRE [P76I] concatemer (C-terminal V5-tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDASGGSGGGSGGGVHQRIASWQNLGAVYCSTVVPS
DDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAA
STGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELI
ERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTYFI
TYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLKR
LRDPLQVHLPLRQIGEKDASGGSGGGSGGGSGVHQRIASWQNLGAVYCSTVVPSDDVTVVYQ
NGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAASTGIDLLLL
DDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELIERLEDLKE
QLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTYFITYGSAMA
MYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLKRLRDPLQVH
LPLRQIGEKDVSAAWSGSGRSLVPSRSVIVTRSGAILPKPVKMSFGLLRVFSIVIIFLYVGTLISKNF
AALLEEHDIFVPEDDDDDDGKPIPNPLLGLDST 
 
11. MCU-MCU-MCU-MCU-EMRE [P76I] concatemer (C-terminal V5-tag): 
MAAAAGRSLLLLLSSRGGGGGGAGGCGALTAGCFPGLGVSRHRQQQHHRTVHQRIASWQNLG
AVYCSTVVPSDDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAI
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YSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIE
QHQLNKERELIERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEY
SWDIMEPVTYFITYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKD
AIAQAEMDLKRLRDPLQVHLPLRQIGEKDASGGSGGGSGGGVHQRIASWQNLGAVYCSTVVPS
DDVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAA
STGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELI
ERLEDLKEQLAPLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTYFI
TYGSAMAMYAYFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLKR
LRDPLQVHLPLRQIGEKDASGGSGGGSGGGVHQRIASWQNLGAVYCSTVVPSDDVTVVYQNGL
PVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAASTGIDLLLLDDF
KLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELIERLEDLKEQLA
PLEKVRIEISRKAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTYFITYGSAMAMYA
YFVMTRQEYVYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLKRLRDPLQVHLPL
RQIGEKDASGGSGGGSGGGSGVHQRIASWQNLGAVYCSTVVPSDDVTVVYQNGLPVISVRLPS
RRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAASTGIDLLLLDDFKLVINDLTYH
VRPPKRDLLSHENAATLNDVKTLVQQLYTTLCIEQHQLNKERELIERLEDLKEQLAPLEKVRIEISR
KAEKRTTLVLWGGLAYMATQFGILARLTWWEYSWDIMEPVTYFITYGSAMAMYAYFVMTRQEY
VYPEARDRQYLLFFHKGAKKSRFDLEKYNQLKDAIAQAEMDLKRLRDPLQVHLPLRQIGEKDVSA
AWSGSGRSLVPSRSVIVTRSGAILPKPVKMSFGLLRVFSIVIIFLYVGTLISKNFAALLEEHDIFVPE
DDDDDDGKPIPNPLLGLDST 
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Appendix B: R-script syntax for generating unique nucleotide sequences for a given 
protein sequence (Pagès et al., 2017) 
 
library(Biostrings) 
cds<- DNAString("<PASTE FASTA AMINO ACID SEQUENCE HERE>") 
cds 
c<-codons(cds) 
 
#Shuffle 1 
#Valine 
c1a<-gsub("GTA", "GTG", c, perl=TRUE) 
c2a<-gsub("GTC", "GTA", c1a, perl=TRUE) 
c3a<-gsub("GTT", "GTC", c2a, perl=TRUE) 
 #Histidine 
c4a<-gsub("CAC", "CAT", c3a, perl=TRUE) 
 #Glutamine 
c5a<-gsub("CAG", "CAA", c4a, perl=TRUE) 
 #Arginine 
c6a<-gsub("AGA", "CGG", c5a, perl=TRUE) 
c7a<-gsub("AGG", "AGA", c6a, perl=TRUE) 
c8a<-gsub("CGT", "AGG", c7a, perl=TRUE) 
c9a<-gsub("CGC", "CGT", c8a, perl=TRUE) 
c10a<-gsub("CGA", "CGC", c9a, perl=TRUE) 
 #Isoleucine 
c11a<-gsub("ATC", "ATA", c10a, perl=TRUE) 
c12a<-gsub("ATT", "ATC", c11a, perl=TRUE) 
 #Alanine 
c13a<-gsub("GCT", "GCA", c12a, perl=TRUE) 
c14a<-gsub("GCC", "GCT", c13a, perl=TRUE) 
c15a<-gsub("GCG", "GCC", c14a, perl=TRUE) 
 #Asparagine 
c16a<-gsub("AAT", "AAC", c15a, perl=TRUE) 
 #Leucine 
c17a<-gsub("TTG", "CTT", c16a, perl=TRUE) 
c18a<-gsub("CTA", "TTG", c17a, perl=TRUE) 
c19a<-gsub("CTG", "CTA", c18a, perl=TRUE) 
c20a<-gsub("CTC", "CTG", c19a, perl=TRUE) 
c21a<-gsub("TTA", "CTC", c20a, perl=TRUE) 
 #Glycine 
c22a<-gsub("GGA", "GGT", c21a, perl=TRUE) 
c23a<-gsub("GGG", "GGA", c22a, perl=TRUE) 
c24a<-gsub("GGC", "GGG", c23a, perl=TRUE) 
 #Tyrosine 
c25a<-gsub("TAT", "TAC", c24a, perl=TRUE) 
 #Cysteine 
c26a<-gsub("TGC", "TGT", c25a, perl=TRUE) 
 #Serine 
c27a<-gsub("AGC", "TCG", c26a, perl=TRUE) 
c28a<-gsub("AGT", "AGC", c27a, perl=TRUE) 
c29a<-gsub("TCC", "AGT", c28a, perl=TRUE) 
c30a<-gsub("TCT", "TCC", c29a, perl=TRUE) 
c31a<-gsub("TCA", "TCT", c30a, perl=TRUE) 
 #Threonine 
c32a<-gsub("ACT", "ACA", c31a, perl=TRUE) 
c33a<-gsub("ACC", "ACT", c32a, perl=TRUE) 
c34a<-gsub("ACG", "ACC", c33a, perl=TRUE) 
 #Proline 
c35a<-gsub("CCT", "CCA", c34a, perl=TRUE) 
c36a<-gsub("CCC", "CCT", c35a, perl=TRUE) 
c37a<-gsub("CCG", "CCC", c36a, perl=TRUE) 
 #Aspartate 
c38a<-gsub("GAT", "GAC", c37a, perl=TRUE) 
 #Glutamate 
c39a<-gsub("GAA", "GAG", c38a, perl=TRUE) 
 #Phenylalanine 
c40a<-gsub("TTC", "TTT", c39a, perl=TRUE) 
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 #Lysine 
c41a<-gsub("AAG", "AAA", c40a, perl=TRUE) 
 
#Switch 1 
 #Valine 
c0b<-gsub("GTA", "GTC", c41a, perl=TRUE) 
c1b<-gsub("GTG", "GTT", c0b, perl=TRUE) 
 #Histidine 
c2b<-gsub("CAT", "CAC", c1b, perl=TRUE) 
 #Glutamine 
c3b<-gsub("CAA", "CAG", c2b, perl=TRUE) 
 #Arginine 
c4b<-gsub("CGG", "CGA", c3b, perl=TRUE) 
 #Isoleucine 
c5b<-gsub("ATA", "ATT", c4b, perl=TRUE) 
 #Alanine 
c6b<-gsub("GCA", "GCG", c5b, perl=TRUE) 
 #Asparagine 
c7b<-gsub("AAC", "AAT", c6b, perl=TRUE) 
 #Leucine 
c8b<-gsub("CTT", "TTA", c7b, perl=TRUE) 
 #Glycine 
c9b<-gsub("GGT", "GGC", c8b, perl=TRUE) 
 #Tyrosine 
c10b<-gsub("TAC", "TAT", c9b, perl=TRUE) 
 #Cysteine 
c11b<-gsub("TGT", "TGC", c10b, perl=TRUE) 
 #Serine 
c12b<-gsub("TCG", "TCA", c11b, perl=TRUE) 
 #Threonine 
c13b<-gsub("ACA", "ACG", c12b, perl=TRUE) 
 #Proline 
c14b<-gsub("CCA", "CCG", c13b, perl=TRUE) 
 #Aspartate 
c15b<-gsub("GAC", "GAT", c14b, perl=TRUE) 
 #Glutamate 
c16b<-gsub("GAG", "GAA", c15b, perl=TRUE) 
 #Phenylalanine 
c17b<-gsub("TTT", "TTC", c16b, perl=TRUE) 
 #Lysine 
c18b<-gsub("AAA", "AAG", c17b, perl=TRUE) 
#Shuffle 2 
#Valine 
c1c<-gsub("GTA", "GTG", c41a, perl=TRUE) 
c2c<-gsub("GTC", "GTA", c1c, perl=TRUE) 
c3c<-gsub("GTT", "GTC", c2c, perl=TRUE) 
 #Histidine 
c4c<-gsub("CAC", "CAT", c3c, perl=TRUE) 
 #Glutamine 
c5c<-gsub("CAG", "CAA", c4c, perl=TRUE) 
 #Arginine 
c6c<-gsub("AGA", "CGG", c5c, perl=TRUE) 
c7c<-gsub("AGG", "AGA", c6c, perl=TRUE) 
c8c<-gsub("CGT", "AGG", c7c, perl=TRUE) 
c9c<-gsub("CGC", "CGT", c8c, perl=TRUE) 
c10c<-gsub("CGA", "CGC", c9c, perl=TRUE) 
 #Isoleucine 
c11c<-gsub("ATC", "ATA", c10c, perl=TRUE) 
c12c<-gsub("ATT", "ATC", c11c, perl=TRUE) 
 #Alanine 
c13c<-gsub("GCT", "GCA", c12c, perl=TRUE) 
c14c<-gsub("GCC", "GCT", c13c, perl=TRUE) 
c15c<-gsub("GCG", "GCC", c14c, perl=TRUE) 
 #Asparagine 
c16c<-gsub("AAT", "AAC", c15c, perl=TRUE) 
 #Leucine 
c17c<-gsub("TTG", "CTT", c16c, perl=TRUE) 
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c18c<-gsub("CTA", "TTG", c17c, perl=TRUE) 
c19c<-gsub("CTG", "CTA", c18c, perl=TRUE) 
c20c<-gsub("CTC", "CTG", c19c, perl=TRUE) 
c21c<-gsub("TTA", "CTC", c20c, perl=TRUE) 
 #Glycine 
c22c<-gsub("GGA", "GGT", c21c, perl=TRUE) 
c23c<-gsub("GGG", "GGA", c22c, perl=TRUE) 
c24c<-gsub("GGC", "GGG", c23c, perl=TRUE) 
 #Tyrosine 
c25c<-gsub("TAT", "TAC", c24c, perl=TRUE) 
 #Cysteine 
c26c<-gsub("TGC", "TGT", c25c, perl=TRUE) 
 #Serine 
c27c<-gsub("AGC", "TCG", c26c, perl=TRUE) 
c28c<-gsub("AGT", "AGC", c27c, perl=TRUE) 
c29c<-gsub("TCC", "AGT", c28c, perl=TRUE) 
c30c<-gsub("TCT", "TCC", c29c, perl=TRUE) 
c31c<-gsub("TCA", "TCT", c30c, perl=TRUE) 
 #Threonine 
c32c<-gsub("ACT", "ACA", c31c, perl=TRUE) 
c33c<-gsub("ACC", "ACT", c32c, perl=TRUE) 
c34c<-gsub("ACG", "ACC", c33c, perl=TRUE) 
 #Proline 
c35c<-gsub("CCT", "CCA", c34c, perl=TRUE) 
c36c<-gsub("CCC", "CCT", c35c, perl=TRUE) 
c37c<-gsub("CCG", "CCC", c36c, perl=TRUE) 
 #Aspartate 
c38c<-gsub("GAT", "GAC", c37c, perl=TRUE) 
 #Glutamate 
c39c<-gsub("GAA", "GAG", c38c, perl=TRUE) 
 #Phenylalanine 
c40c<-gsub("TTC", "TTT", c39c, perl=TRUE) 
 #Lysine 
c41c<-gsub("AAG", "AAA", c40c, perl=TRUE) 
 
#Switch 2 
 #Valine 
c0d<-gsub("GTA", "GTC", c41c, perl=TRUE) 
c1d<-gsub("GTG", "GTT", c0d, perl=TRUE) 
 #Histidine 
c2d<-gsub("CAT", "CAC", c1d, perl=TRUE) 
 #Glutamine 
c3d<-gsub("CAA", "CAG", c2d, perl=TRUE) 
 #Arginine 
c4d<-gsub("CGG", "CGA", c3d, perl=TRUE) 
 #Isoleucine 
c5d<-gsub("ATA", "ATT", c4d, perl=TRUE) 
 #Alanine 
c6d<-gsub("GCA", "GCG", c5d, perl=TRUE) 
 #Asparagine 
c7d<-gsub("AAC", "AAT", c6d, perl=TRUE) 
 #Leucine 
c8d<-gsub("CTT", "TTA", c7d, perl=TRUE) 
 #Glycine 
c9d<-gsub("GGT", "GGC", c8d, perl=TRUE) 
 #Tyrosine 
c10d<-gsub("TAC", "TAT", c9d, perl=TRUE) 
 #Cysteine 
c11d<-gsub("TGT", "TGC", c10d, perl=TRUE) 
 #Serine 
c12d<-gsub("TCG", "TCA", c11d, perl=TRUE) 
 #Threonine 
c13d<-gsub("ACA", "ACG", c12d, perl=TRUE) 
 #Proline 
c14d<-gsub("CCA", "CCG", c13d, perl=TRUE) 
 #Aspartate 
c15d<-gsub("GAC", "GAT", c14d, perl=TRUE) 
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 #Glutamate 
c16d<-gsub("GAG", "GAA", c15d, perl=TRUE) 
 #Phenylalanine 
c17d<-gsub("TTT", "TTC", c16d, perl=TRUE) 
 #Lysine 
c18d<-gsub("AAA", "AAG", c17d, perl=TRUE) 
 
 
Code1<-c41a 
Code2<-c18b 
Code3<-c41c 
Code4<-c18d 
 
Code1 
Code2 
Code3 
Code4 
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